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Abstract 
Ataxia telangiectasia-mutated (ATM), the protein kinase that is mutated in patients 
with ataxia telangiectasia (A-T), is a central player in the cellular response to DNA 
damage. ATM is activated following double-strand breaks by MRE11-RAD50-NBS1 
complex (MRN), which acts as an initial sensor of DSB. ATM is also activated by 
stimuli that change chromatin structure such as chloroquine and hypotonic shock, 
which depends on the ATM-interactor protein (ATMIN) as a cofactor.  
 
In this study, I show that there exists competition between ATMIN and NBS1 for 
ATM binding and this can regulate ATM signalling. The absence of one cofactor 
can lead to enhanced signalling through the alternative pathway. Furthermore, I 
also characterise the role of an E3 ligase that regulate the interaction between 
ATMIN and ATM by mediating ATMIN mono-ubiquitination. Thus ATMIN 
ubiquitination could be an important step in ensuring robust ATM activation after IR.  
 
In addition, I also show that ATMIN is required for ATM signalling after replication 
stress to protect against genomic instability in the form of anaphase bridges and 
aberrant chromosome segregations. ATM is activated by replication stress and is 
required for the formation of 53BP1-containing nuclear bodies, which protect fragile 
sites. ATMIN interacts with WRNIP and RAD18 in a complex that is required to 
activate ATM at sites of stalled replication forks. 
 
Furthermore, using a genome-wide screening approach, I identified additional 
factors that regulate ATM signalling after replication stress. The 8-oxo-guanosine 
repair pathway could represent a link between ATM signalling and genomic 
instability. I show that the components of base excision repair pathway are required 
for the activation of ATM and formation of 53BP1 nuclear bodies that protect fragile 
sites in the maintenance of genome stability. 
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Chapter 1. Introduction 
1.1 Canonical ATM signalling after double-strand breaks is 
mediated by the MRN complex 
1.1.1 The role of PIKKs in DNA damage and disease 
The ability to maintain genome integrity is fundamental to cell survival and a key 
contributor to preventing oncogenesis. Cells suffer a wide range of genotoxic 
insults, such as those generated endogenously by reactive oxygen species from 
the mitochondria, and by external agents such as UV, drugs that interfere with DNA 
replication and chemical clastogens. The most severe form of DNA damage is 
double-strand breaks (DSBs), which are formed as a result of cellular events such 
as V(D)J and class switch recombination in lymphocytes or meiotic recombination, 
or a deleterious consequence when a replication fork collapses or telomeres 
become uncapped. DSBs can also be induced by γ-irradiation and radiomimetics, 
such as neocarzinostatin and bleomycin. It is estimated that the DSB occurs at a 
spontaneous rate of approximately 50 per cell cycle per cell in replicating human 
cells (Vilenchik and Knudson, 2003), which is equivalent to the number of DSBs 
induced by 2Gy of irradiation. By impeding cellular replication, DSBs could lead to 
cell death or genomic rearrangements that can predispose the cell for further DNA 
aberrations and oncogenesis.  
 
Three kinases of the phosphatidylinositol 3 kinase-related (PIKK) kinases family, 
ATM, ATR and DNA-PK, play central roles in the cellular defence against DNA 
damage. While ATM and ATR primarily respond and transduce upstream signals 
following DSBs and ssDNA breaks respectively, DNA-PK regulates downstream 
DNA repair via the nonhomologous end-joining pathway (Figure 1). Mutations or 
loss of these kinases lead to radiosensitivity and DNA repair defects, seen in 
patients as well as in mouse models.  
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Figure 1: ATM, ATR and DNA-PK activation in response to DNA damage in the presence 
of their cofactors.  
ATR-ATRIP is activated upon ssDNA breaks and phosphorylates Chk1 in order to 
execute cell cycle checkpoints and suppress late origin firing. ATM is activated by DSB 
and phosphorylates many downstream substrates to halt the cell cycle and leads to 
DNA repair, chromatin decondensation and apoptotic responses. DNA-PK is also 
activated by DSB and promotes NHEJ repair by phosphorylating Artemis and XRCC4. 
Some substrates are common between the PIKKs such as H2AX and p53.  
 
The Ataxia-Telangiectasia syndrome (A-T) is an inherited autosomal recessive 
disorder characterised by clinical features such as early onset progressive 
cerebellar ataxia, ocular telangiectasia, growth retardation, immunodeficiency, 
neurodegeneration, radiosensitivity and susceptibility to cancer, especially 
lymphoid tumours (Lavin et al., 2005). The gene responsible for A-T was identified 
to be ataxia-telangiectasia mutated (ATM)(Savitsky et al., 1995) that encodes a 
large protein of 350kDa. Over four hundred mutations in ATM have been so far 
identified, mostly resulting in truncations (Gilad et al., 1996, Byrd et al., 1996). The 
Atm knockout mouse model also shows similar phenotypes of growth retardation, 
neurologic dysfunction, radiosensitivity and tumour predisposition. In addition, the 
Atm mouse also displays male and female sterility (Barlow et al., 1996). 
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Other related disorders that have overlapping phenotypes with A-T are due to 
mutations in the MRN complex (Mre11-Rad50-Nbs1), which functions as a cofactor 
in recruiting ATM to DSB sites. Nijmegen breakage syndrome occurs due to a 
mutation in NBS1, where most patients harbor a hypomorphic 5bp deletion in exon 
6 (657∆5). This results in the generation of 2 truncation proteins, p26 and p70 that  
encode FHA-BRCT domains and ATM phosphorylation sites respectively. NBS 
patients have microcephaly, dysmorphic facial features, mild growth retardation, 
ovarian dysgenesis, immunodeficiency, increased cancer predisposition and 
radiosensitivity (Digweed and Sperling, 2004). While the clinical phenotypes closely 
overlap with A-T, there is no cerebellar degeneration. As NBS1 knockout is 
embryonic lethal, several murine models with truncation mutations have been 
established to reproduce the human disease. In the nbs1∆B/∆B model, the BRCT 
domain of NBS1 was deleted to produce a N-terminal 80kDa truncation protein. 
This mimics some aspects of NBS, such as radiosensitivity, intra-S checkpoint 
defect and synthetic lethality with ATM deficiency (Williams et al., 2002). However, 
there is no cancer predisposition, immunodeficiency or female infertility as 
observed in humans. Another NBS1 mouse model with N-terminal truncation 
(nbs1m/m) produces more similar phenotypes to human NBS such as thymic 
lymphoma and female sterility, but does not produce the p70 NBS1 protein found in 
NBS cells (Kang et al., 2002). Finally, in a humanised NBS1 mouse model, human 
hNBS1(657∆5) was able to rescue the lethality of NBS1-/- mice and fully recapitulate 
the human NBS phenotypes (Difilippantonio et al., 2005).  
 
A single case of NBS-like disorder has been reported as a result of heteroallelic 
mutation in Rad50 gene, giving rise to low levels of RAD50 protein. Similar to NBS 
syndrome, the characteristics are microcephaly, mental retardation, ‘bird-like’ face, 
and short stature. Fibroblasts derived from the patient are also characterised by 
defective ATM signalling after IR, impaired checkpoint responses post IR and 
radiosensitivity. However, unlike NBS syndrome, there is no immunodeficiency and 
or cancer incidence. Moreover, the phenotypes of RAD50-deficient cells were 
rescued by overexpressing wildtype RAD50 (Waltes et al., 2009). 
 
A related, milder form of A-T, AT-like disorder (ATLD) is caused by mutation in 
Mre11. While these patients exhibit similar but milder characteristics of A-T like 
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cerebellar ataxia and immunodeficiency, there is no known predisposition to cancer 
(Theunissen et al., 2003). Similarly, Mre11ATLD1/ATLD1 mice, while having defect in 
ATM-mediated checkpoint functions, are not prone to lymphoma like atm-/- mice 
(Taylor et al., 2004). 
 
1.1.2 ATM kinase structure and domains 
As a member of the PIKK family, ATM is a large protein of 3056 amino acids and 
shares similarities with related kinases such as ATR, DNA-PKcs (DNA dependent 
protein kinase catalytic subunit), mTOR (mammalian TOR) and hSMG1(suppressor 
of mutagenesis in genitalia 1) in its domain structure, with a C-terminal kinase 
domain flanked by a FAT domain (conserved in FRAP, ATM and TRRAP) and a 
FAT-C domain, as well as its roles in signalling after cellular stress. TRRAP 
(transformation/transcription domain-associated protein) is the only member of FAT 
proteins that lacks catalytic activity. The N-terminus of ATM contains a region 
(amino acids 91-97) required for binding to substrates such as NBS1, p53 and 
BRCA1 (Fernandes et al., 2005). The FAT-C domain, on the other hand, is 
required for interaction with the acetyltransferase TIP60, whose acetylation of ATM 
on Lys3016 is a crucial step in its activation (Jiang et al., 2006). Recently, it has 
been shown that damage-induced phosphorylation of Tyr44 of TIP60 promotes the 
latter binding to chromatin and triggers the ATM acetylation (Kaidi and Jackson, 
2013). (Figure 2).   
 
        
Figure 2. Scheme of ATM major protein domains  
ATM has several domains conserved with other PIKK family members such as FAT 
and FATC domains. Some of the posttranslational modifications on ATM are also 
indicated. 
 
ATM phosphorylates substrates and itself on Ser/Thr residues that precede a Glu 
(SQ/TQ motif). Several autophosphorylation sites have been characterised on ATM 
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that are important for its activation and regulation discussed below. These are 
Ser367, Ser1893 (Kozlov et al., 2006), Ser1981 (Bakkenist and Kastan, 2003), 
Ser2996 (Kozlov et al., 2011). While other phosphorylation sites have been 
identified in large-scale proteomic studies, their exact roles in regulating ATM 
function have not been elucidated (Matsuoka et al., 2007, Daub et al., 2008, 
Oppermann et al., 2009). 
 
1.1.3 Mechanism of MRN-dependent ATM activation following IR  
1.1.3.1 The roles of the MRN complex and interaction with ATM 
The canonical pathway of ATM activation following a DSB involves the upstream 
sensor MRN complex. MRE11 has both N-terminal phosphoesterase activity and 
C-terminal DNA binding ability; this enables it to act as a ssDNA endonuclease as 
well as a 3’ to 5’ dsDNA exonuclease. Rad50, on the other hand, forms an ABC 
type ATPase domain with a long antiparallel coiled-coiled domain. MRE11 and 
RAD50 form a complex that is conserved across all kingdoms that plays an 
important role in DNA repair (Aravind et al., 1999), through homology directed 
repair (HDR) and non-homologous end-joining (NHEJ) pathways. The Mre11-
Rad50 complex can tether the DNA ends and carry out resection of DSB ends to 
promote repair (Mimitou and Symington, 2009). Structural studies show that the 
Mre11-Rad50 forms a heterotetrameric complex with the Rad50 ATPase activity 
catalysing conformation changes that bind DNA and modulating the exonuclease 
activity of Mre11 (Hopfner et al., 2001, de Jager et al., 2001). Recent data from 
small-angle X-ray scattering (SAXS) showed that MRE11 dimers adopt a four-
lobed U-shaped structure that is crucial for its assembly and DNA binding (Williams 
et al., 2008). Using an ATP analog-sensitive mutant of ATM, Lee et al. showed that 
a “closed,” ATP-bound state of MRN is essential for ATM stimulation as well as for 
NBS1 binding to the complex (Lee et al., 2013).  
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Figure 3. Structure of MRN complex binding to DSB. 
The coiled-coil domain of RAD50 mediates dimerisation and formation of the MRN 
complex, while the Walker A and Walker B domains bind the DSB ends. Mre11 
interacts with both NBS1 and RAD50 and can promote resection to facilitate HR repair.  
 
NBS1, unlike the Mre11-Rad50 complex, is conserved only in Eukaryotes and 
forms a signalling adaptor and regulatory component to recruit signalling proteins 
such as ATM to site of DNA damage and localises the MRN complex in the nucleus. 
NBS1 has an FHA (forkhead associated) domain and a BRCT (Breast cancer 
carboxy-terminal) domain in the N-terminus, which mediates binding to 
phosphoproteins such as CTIP (Lloyd et al., 2009) and MDC1 (Chapman and 
Jackson, 2008). NBS1 also has a C-terminal motif that is required for interaction 
with Mre11 (Desai-Mehta et al., 2001, Tauchi et al., 2001, Williams et al., 2009) 
and ATM (You et al., 2005) (Falck et al., 2005). Complementation studies using 
NBS-deficient cell lines and NBS1 constructs that lack the ATM interaction motif 
(AIM) show that while the AIM is required for ATM phosphorylation of its substrates 
and rescue of intra-S and G2/M checkpoint functions, it is not required for ATM 
autophosphorylation, which is the marker of active ATM. Moreover, in vitro studies 
also showed that NBS1 is dispensable for ATM activation in vitro stimulated by only 
purified MRE11 and RAD50 (Lee and Paull, 2004). The discrepancy as to whether 
the NBS1 AIM is required for ATM activation could be due to differences in species 
and systems used. The current evidence suggests that NBS1 AIM is not absolutely 
required for ATM autophosphorylation and activation, but is required for recruiting 
the active ATM and bridging it with other ATM substrates in vivo. Together, the 
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MRN complex acts as an early, upstream sensor that recruits ATM to the site of a 
DSB (Carson et al., 2003) (Kitagawa et al., 2004).  
 
The recruitment of MRN complex to DSB is independent of ATM (Mirzoeva and 
Petrini, 2001). ATM autophosphorylation, DSB retention and target phosphorylation 
were all impaired in the absence of the MRN complex (Uziel et al., 2003), hence 
the MRN complex is upstream of ATM in DSB detection and facilitates full ATM 
activation. Activated ATM, in turn, can phosphorylate MRE11 and NBS1 to 
stimulate their activity. It was shown in S.cerevisiae that MRE11 and the NBS1 
homologue, XRS2, are phosphorylated after DNA damage in a manner that 
depends on TEL1, the yeast homologue of ATM (D'Amours and Jackson, 2001). 
Several proteomics studies have also provided evidence of phosphorylation on 
MRE11 by ATM and/or ATR (Matsuoka et al., 2007) (Beausoleil et al., 2004, Kim et 
al., 1999, Olsen et al., 2006). Evidence also shows that processing of DNA breaks 
by the MRN complex produce oligonucleotides that stimulate ATM activity in vitro 
and in vivo (Jazayeri et al., 2008). Hence, the cooperation between ATM and MRN 
has been shown to contribute to the full activation of ATM signalling.  
1.1.3.2 ATM dimer dissociation and autophosphorylation 
A crucial step in ATM activation upon DSB involves the dissociation of the ATM 
dimer into monomers, which coincides with its autophosphorylation of S1981 by the 
kinase domain (Bakkenist and Kastan, 2003). Bakkenist et al. showed an increase 
of 32P radioactive label in ATM after IR, in a manner that depended on the kinase 
activity of ATM. This phosphorylated residue was identified to be S1981, conserved 
in human, mouse and Xenopus. Using phospho-specific antisera, it was shown that 
the phosphorylation on S1981 (pS1981) increases after IR. Biochemical evidence 
also showed that S1981 is also important in binding the kinase domain, and 
transfected wildtype ATM loses binding to wildtype ATM but still interacts with 
kinase dead or S1981A mutant forms of ATM. Hence, the auto-phosphorylation is a 
switch in triggering monomerisation of ATM and is important for ATM checkpoint 
function in vivo (Bakkenist and Kastan, 2003). Recently, other ATM 
phosphorylation sites have been identified by mass spectrometry at Ser367, S1893 
and Ser2996. IR induces these phosphorylations in a manner that depends on 
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ATM kinase activity, and with the exception of Ser2996, immunofluorescence 
staining using phosphoantibodies shows that they all localise to DSBs like Ser1981. 
Mutants in these sites fail to rescue IR-induced apoptosis and cell cycle defects in 
A-T cells and show defective ATM signalling after IR (Kozlov et al., 2006, Kozlov et 
al., 2011).  
 
However, there has been considerable debate over the requirement for 
autophosphorylation on ATM. While S1981A ATM has dominant negative activity 
over wild-type ATM and cannot reconstitute ATM activity in A-T cells (Bakkenist 
and Kastan, 2003), the S1981A mutant still displays kinase activity in vitro (Lee and 
Paull, 2005).  You et al. showed that ATM loading onto DNA fragments could occur 
prior to autophosphorylation(You et al., 2007). Furthermore, a transgenic mouse 
model that expresses only S1987A (corresponding to human S1981) mutant ATM 
showed normal checkpoint responses to IR, ATM recruitment to DSBs and 
phosphorylation of substrates. Even a triple mutant (Ser367A, Ser1893A, 
Ser1987A) mouse model retains normal ATM kinase activity and ATM functions in 
vivo (Daniel et al., 2008). To reconcile these data, it has been shown that ATM 
autophosphorylation, while not required for initial recruitment to DSB and early 
signalling, is required for sustained retention of ATM at DSBs (So et al., 2009). An 
alternative hypothesis suggests that ATM activation follows a two-step model, 
whereby ATM can first bind DNA and dissociate into monomers without 
autophosphorylation, followed by MRN-dependent activation and 
autophosphorylation of ATM (Dupre et al., 2006).  
 
The discrepancy between in vitro data and atm mouse models could be attributed 
to species differences in ATM activation or contribution by other factors such as 
phosphatases and chromatin remodellers in vivo that influence ATM activation. 
Arguably, the differences in results could also stem from different systems and 
techniques used, such as in vitro DNA fragments for some and high intensity 
microlaser to generate DSB for others, which could elicit different cellular 
responses owing to the factors such as chromatin structure, cellular components 
present and the extent of damage generated.  
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1.1.3.3 Additional players in the canonical ATM activation 
In addition to autophosphorylation, ATM activation also requires the acetylation at 
Lys3016 by TIP60 histone acetyltransferase (HAT) (Sun et al., 2005, Sun et al., 
2007). Mutation of Lys3016 or inactivation of TIP60 HAT activity prevents ATM 
activation and phosphorylation of substrates, and sensitises cells to IR.  
 
Upon full ATM activation, ATM phosphorylates a number of substrates to further 
amplify the signalling cascade. H2AX is phosphorylated (𝜸H2AX) along both sides 
of the break to serve as a platform for the recruitment of downstream factors such 
as MDC1 (Stucki et al., 2005) that amplifies the DSB signal and induces chromatin 
modifications. Other substrates such as p53 and CHK2 cause cell cycle arrest at 
the G1/S and S phase checkpoint respectively, while phosphorylation of SMC1 
(Schar et al., 2004) and KAP1 (Noon et al., 2010) regulates chromatin 
modifications to facilitate access by other DNA repair proteins, and phosphorylation 
of BRCA1 up-regulates DNA repair (Zhang et al., 2004). The DNA damage 
response (DDR) is accompanied by many post-translational modifications including 
phosphorylation, ubiquitination, sumoylation, methylation, acetylation and poly-
(ADP)ribosylation as well as epigenetic changes to facilitate the detection and 
repair of damage. While the canonical pathway is evident after DSB, evidence is 
mounting that ATM can also be activated by other stimuli in an MRN-independent 
manner.  
1.1.4 Alternative models of ATM activation by chromatin modifications 
Recently, it has been shown that oxidative stress can directly activate ATM 
independently of DNA damage and the MRN complex. Cells that lack ATM display 
sensitivity to reactive oxygen species (Barzilai et al., 2002). Paull et al. showed that 
ATM could phosphorylate a subset of its substrates such as p53 and CHK2 after 
oxidative stress induced by H2O2 that does not cause DSB per se. They found that 
oxidation could induce ATM activation by the formation of an intermolecular 
disulphide bond on C2991 (Guo et al., 2010b). Mutation of this residue abrogated 
ATM signalling after oxidative stress but does not affect MRN and DNA-dependent 
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ATM activation. Hence, this finding suggests that ATM could also be activated by 
dimer formation that is independent of the MRN complex. 
 
Recently, Soutoglou et al. showed, using an elegant system of tethering individual 
DDR factors via fusion with a fluorescently tagged E. coli lacR protein to a stably 
integrated lacO array in mammalian genome, that ATM-dependent DDR can be 
activated in the absence of DNA lesions. By tethering NBS1, MRE11 or a fragment 
of ATM that contains the kinase domain, γH2AX foci formed at the site in an ATM-
dependent manner and cells also showed an increase in ATM- and Chk2-
dependent G2/M arrest (Soutoglou and Misteli, 2008). Hence, ATM activation can 
be activated independently of DSBs and the MRN complex, provided that ATM is 
recruited to the chromatin. In another study, the induction of senescence was 
shown to trigger pan-nuclear ATM activation and γH2AX formation in the absence 
of DSBs, although it was unclear what was the molecular stimulus and whether the 
MRN complex was required (Pospelova et al., 2009).  
 
In addition, ATM can also be activated by hypoxia (<0.1% oxygen), which has been 
shown to induce replication stress and activation of ATR and ATM (Hammond et al., 
2007, Bencokova et al., 2009, Olcina et al., 2010). Under hypoxic conditions, ATM 
is auto-phosphorylated in a manner that is independent of the MRN complex as 
well as DNA-PK and ATR. While 𝜸H2AX formed foci reminiscent of DSB signalling, 
neither ATM, pATM nor 53BP1 formed foci after hypoxia (Bencokova et al., 2009). 
MDC1 was shown to be required for ATM-mediated KAP1 phosphorylation in 
hypoxia conditions. Moreover, ATM can be activated by UV or hydroxyurea (HU) 
treatment in an ATR-dependent manner (Stiff et al., 2006). Under these conditions, 
ATM autophosphorylation and H2AX phosphorylation were unaffected by the ATM 
inhibitor KU-55933, and ATM activation does not require the C-terminus of NBS1, 
suggesting a non-canonical, ATR-mediated mode of ATM activation. 
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1.1.5 DNA repair  
Following DSB formation, there are two pathways of repair; the error-prone NHEJ 
pathway that promotes direct ligation at the DSB ends, and HR that involves 
resection of DSBs and subsequent error-free repair by using the homologous DNA 
as a template. While NHEJ is active throughout the cell cycle and is the favoured 
mechanism in G1 cells, HR predominantly occurs after DNA replication in S and G2 
phase when an identical sister chromatid is available.  
1.1.5.1 Non-homologous end joining pathway of DNA repair 
During NHEJ, the Ku70-Ku80 heterodimer is rapidly recruited to DSBs and 
encircles the broken DNA ends via its symmetrical ring topology. The crystal 
structure of Ku heterodimer bound to DNA revealed that Ku does not make specific 
contacts with DNA bases and backbone, but is positioned to fit into the major and 
minor grooves of DNA to support the broken ends during end processing and 
ligation (Walker et al., 2001). Furthermore, Ku has 5'dRP (5’-deoxyribose-5-
phosphatase)/AP lyase activity, which facilitates the removal of abasic sites near 
DSBs and favour NHEJ pathway over HR (Roberts et al., 2010).  
The binding of Ku to DNA is required for recruitment of DNA-PKcs, which in turn 
facilitates the translocation of Ku to the extreme DNA termini (Yoo and Dynan, 
1999) (Calsou et al., 1999). Subsequent assembly of the XRCC4-ligase IV complex, 
which is responsible for the ligation step, is also dependent on the Ku and DNA-
PKcs as well DNA-PKcs-mediated phosphorylation (Chen et al., 2000, Calsou et al., 
2003, Nick McElhinny et al., 2000). In addition, XLF4 (XRCC4-like factor) is also 
recruited by Ku and stimulates the activity of XRCC4-ligase IV (Hentges et al., 
2006) (Tsai et al., 2007). Artemis endonuclease is an additional described NHEJ 
component that is mutated in radiosensitive severe combined immunodeficiency 
(RS-SCID) sydrome (Moshous et al., 2001). Artemis is required during end-
processing for the repair of a subset of IR-induced DSBs (10%) in an ATM- and 
DNA-PK dependent manner (Riballo et al., 2004, Lobrich and Jeggo, 2005).  
 
Another pathway of error-prone end joining is the microhomology-mediated end 
joining (MMEJ) which involves limited resection (4-6 nucleotides) and the use of 5-
25bp of microhomologous sequence for annealing prior to the rejoining of broken 
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ends, thereby resulting in a deletion of the flanking sequence. There are evidence 
for the inhibitory effects of NHEJ proteins on MMEJ, such as Ku and DNA-PK, 
hence MMEJ might serve as an alternative repair mechanism when NHEJ fails to 
complete or when DNA ends are not compatible with NHEJ repair (McVey and Lee, 
2008).  
1.1.5.2 DNA repair by homologous recombination 
In comparison, HR is initiated by extensive 5’-3’ resection of DNA ends by the MRN 
complex aided by Sae2/CtIP to generate 3’ ssDNA tails. DNA resection is regulated 
in a cell-cycle dependent manner by phosphorylation of CtIP Ser847 by CDK2 
(Huertas and Jackson, 2009), which is required for effective ssDNA generation, 
RPA recruitment, and RPA phosphorylation at DSBs. Following resection, the 
ssDNA ends are rapidly coated by RPA and replaced by RAD51 faciliated by 
RAD52. The formation of RA51 nucleofilaments allows homology search and 
strand invasion. BRCA2 interacts with RAD51 via its BRC repeat and the C-
terminus to facilitate the Rad52 recombinase activity (Xia et al., 2001, Moynahan et 
al., 2001). A double holliday junction intermediate is generated, which could be 
either resolved by resolvases including Mus81-EME1, SLX1/SLX4 and GEN1 
(Wyatt et al., 2013) to form crossover products, or undergo dissolution by BLM-
TOPOIIIα-RMI1/2 to form non-crossover products (Wu and Hickson, 2006).  
1.1.5.3 ATM is required for the repair of DSBs in heterochromatin  
Whilst the majority of DSBs are repaired rapidly within 4-6 hours in a manner that is 
independent of ATM and its downstream substrates, a slower repair is observed 
(>8hours) for a subset heterochromatin-associated, which is refractory to repair and 
requires ATM and KAP1 (Murray et al., 2012). Kap1, a transcriptional corepressor 
that associates with heterochromatin, is phosphorylated by ATM at Ser847 after IR 
(Ziv et al., 2006) and its rentention on heterochromatin also decreases after IR 
(Goodarzi et al., 2008). The knockdown of Kap1 rescues the DSBR defect after 
ATM inhibition, and also alleviates a similar defect after the knockdown of 53BP1, 
RNF168 and RNF8. Hence, Kap1 plays a role in the ATM- and 53BP1-dependent 
repair of DSBs in heterochromatin. Using immunofluorescence readouts, Noon et 
al showed that pKap1 was pan-nuclear at early time point post-IR, but localised to 
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discrete foci that colocalised with heterochromatin markers at 4-8 hours post-IR. 
The formation of late pKap1 foci was dependent on 53BP1, which was proposed to 
act by promoting MRN accumulation and thereby concentrating ATM activity at 
late-repairing DSBs (Noon et al., 2010).  
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1.2 ATMIN defines an NBS1-independent pathway of ATM 
activation 
1.2.1 ATMIN as a novel interactor of ATM 
Other forms of chromatin modifications which do not cause DSB per se, such as 
hypotonic shock and chloroquine which causes chromatin decondensation 
(Kobliakova Iu et al., 2001) (Mahut et al., 2012), can also activate ATM without the 
requirement of NBS1, as shown by Nbs1-null cells which can still activate ATM 
following these stimuli (Difilippantonio et al., 2005).  
 
ATMIN was recently identified as an ATM interacting protein that stabilises ATM 
and which is required for ATM signalling after these chromatin modification stimuli 
but not after IR-induced DNA damage (Kanu and Behrens, 2007). While a 
truncated version of the protein was firstly identified as ASCIZ (ATM/ATR-substrate 
CHK2-interacting Zn2+ finger protein) (McNees et al., 2005), the full protein was 
subsequently found to contain two additional N-terminal exons.  ATMIN has a C-
terminal ATM interaction motif that is homologous to that of NBS1, a putative PEST 
sequence associated with ubiquitin-mediated proteolysis, and 18 SQ/TQ ATM 
phosphorylation motifs (Figure 4). As shown by immunofluorescence and co-IP, 
ATMIN interacts with ATM under basal conditions but not after IR. Moreover, the 
dissociation of ATMIN from ATM post-IR was also shown to be dependent upon 
NBS1, suggesting a non-overlapping role of ATMIN with NBS1. An ATMIN 
knockout mouse model was generated by using PGK-cre and lox P sites flanking 
exon 4, which encode most of the protein (amino acids 209-818), from germline 
stage (Kanu and Behrens, 2007). MEFs derived from these mice with a 
homozygous germline deletion of atmin exon 4 do not express detectable ATMIN 
protein, hence resulting in a null mutation. ATMIN knockout is embryonic lethal but 
heterozygotes are viable and fertile. Moreover, ATMIN∆/∆ MEFs shows impaired 
ATM signalling after hypotonic shock and replication stress. Hence ATMIN is 
required for ATM activation under these non-canonical stimuli.  
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Figure 4. ATMIN domains showing N-terminal zinc fingers, putative PEST domain and C-
terminal ATM interaction motif that is homologous to that of NBS1. 
Another report suggested a function for ATMIN in DNA repair of DNA alkylating 
damage. ATMIN was reported to form foci after methylmethane sulphonate (MMS), 
that colocalise with Rad51 (McNees et al., 2005). Moreover, in the absence of 
ATMIN, Rad51 foci formation after MMS is impaired and this is accompanied by 
increased cell death. The increased apoptosis in ATMIN depleted cells was 
dependent on the presence of MLH1, a DNA endonuclease that functions in 
mismatch repair. Since mismatch repair involves the formation of a ssDNA gap 
intermediate, the data suggests that ATMIN is downstream of MLH1 and is 
recruited to form foci at ssDNA gaps. However, there is a lack of evidence that 
ATMIN colocalises with RPA, a protein that coats ssDNA, or biochemical data to 
support the hypothesis that ATMIN binds preferentially to ssDNA. While the 
colocalisation of ATMIN and RAD51 foci implies a role of ATMIN in DNA repair, 
there is insufficient evidence to show the effect of ATMIN on homologous 
recombination (HR) and other repair pathways such as non-homologous end 
joining (NHEJ). Indeed, another study used ATMIN knockout chicken DT40 cell line 
to study Immunoglobulin (Ig) gene conversion, which leads to the diversification of 
Ig V segments initiated by activation-induced deaminase (AID) and repair by HR or 
translesion synthesis-dependent hypermutation. While the loss of ATMIN increased 
Ig conversion, the efficiency of DSB repair by HR or BER-dependent hypermutation 
was not affected. Hence, ATMIN does not directly control homologous 
recombination or formation of abasic sites (Oka et al., 2008). 
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In addition to a possible role in DNA repair, ATMIN is also required for ATM 
signalling triggered by oxidative stress. atmin∆/∆ MEFs are more susceptible to 
oxidative damage and show impaired recruitment of ATM to basal ROS-induced 
DNA damage (Kanu et al., 2010). Using an atminf/f; nestin-cre model to 
conditionally delete ATMIN in the mouse brain, our laboratory observed increased 
loss of neurons associated with aging and impaired ATM activation in spite of 
greater accumulation of 𝜸H2AX in aging ATMIN∆N mouse brains.  
 
While ATMIN acts as a cofactor for ATM activation under specific stimuli, the 
ATMIN-ATM pathway seems to activate similar downstream ATM phosphorylation 
substrates as NBS1-dependent ATM signalling, such as KAP1, SMC1 and p53. 
Hence, these substrates shall be used in assessing ATM pathway activation in this 
thesis. It is not clear whether ATMIN directs ATM to additional substrates, as this 
awaits further studies using results from ATMIN genome screen (Section 6) and 
other proteomic analysis.  
1.2.2 Role of ATMIN as a transcription factor 
ATMIN has been implicated as a transcription factor from evidence that tethering 
ATMIN to yeast Gal4-DNA binding domain or luciferase reporters can transactivate 
reporter genes (Jurado et al., 2010). Two studies further showed Dynll1 as a 
transcriptional target of ATMIN as identified from yeast-two-hybrid screens (Jurado 
et al., 2012a) (Rapali et al., 2011). As a regulator of protein dimerisation, DYNLL 
can interact with ATMIN and regulate its foci formation after MMS, and was also 
identified as a target in a siRNA screen for loss of ATMIN foci formation. 
Interestingly, the binding of DYNLL dampens the transcription activation by ATMIN, 
thereby forming an auto-feedback loop that limits DYNLL expression (Jurado et al., 
2012a). However, while the SQ/TQ cluster on ATMIN was shown to be sufficient for 
activation of yeast and luciferase promoters, in the latter study transcription was 
dependent on ATMIN zinc fingers in mammalian cells. It is also not clear whether 
the DYNLL-ATMIN interaction is important for cell viability and whether it is DNA 
damage-dependent. While Rapali et al. reported that the overexpression of DYNLL 
also blocked ATMIN foci formation, Jurado et al. observed that overexpressed 
DYNLL colocalised with overexpressed ATMIN and knockdown of DYNLL impairs 
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ATMIN foci formation. Hence, more evidence is needed to understand the 
physiological role of ATMIN as a transcription factor.  
 
1.2.3 Role of ATMIN in the development of the immune system and other 
organs 
ATMIN also plays a role in the maturation and safeguarding of the genomic stability 
of immune cells. Using CD19-cre; atminf/f to delete ATMIN from the pro-B cell stage 
(atmin∆B/∆B), previous work from our laboratory showed that loss of ATMIN impaired 
B cell maturation and class switch recombination (CSR) (Loizou et al., 2011). 
Moreover, atmin-null B cells displayed reduced ATM signalling in response to 
hypotonic shock. More strikingly, the physiological importance of ATMIN is 
highlighted by the high frequency of B cell lymphoma (40% of cohort after 6 months 
of age) in atmin-null animals. This is further supported by transcriptional profiling 
data from human patients with B cell acute lymphoblastic leukemia (B-ALL) that 
atmin expression was reduced in B-ALL compared to normal B cells. Hence, 
ATMIN could be a tumour suppressor in the development of human B cell 
lymphomas.  
 
A similar finding was reported that showed the loss of ATMIN resulted in defect in B 
cell development (Jurado et al., 2012b). An atminf/f; Mx1-cre model was used, 
which activates cre upon interferon or polyinosinic:polycytidylic acid injection. 
However, the authors did not observe B cell lymphoma due to loss of ATMIN but a 
reduction in mature B cell numbers. The basis of the phenotype was attributed to 
ATMIN transcription factor function in regulating DYNLL, which attenuates the pro-
apoptotic effect of Bim, since the B cell lymphopenia was rescued by crossing with 
Bim knockout. Bim has been shown to induce apoptosis in auto-reactive B cells, 
but the physiological role and expression level of Bim in normal, non-autoreactive B 
cells is not clear. Hence, whether the effect of ATMIN on B cell maturation is via 
ATM signalling or DYNLL transcription regulation will require more data for 
elucidation. However, since the phenotype of atmin∆B/∆B mice closely resemble that 
of atm-/-, such as normal mature B cell numbers, defective CSR and genomic 
instability, and both atmin∆B/∆B mice and human A-T patients have increased 
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lymphoma susceptibility, these suggests that ATMIN’s role in DNA damage 
signalling could be more relevant, but at this stage we cannot rule out the 
possibility that its transcriptional function also plays a role. 
 
In addition to the immune system, ATMIN is also essential for normal development 
of the lungs and brain. atmin -null embryos fail to develop lung and trachea even 
though they are able to initially specify the respiratory endoderm. However, they 
are unable to remodel the endoderm required for initiation of lung budding and 
trachea formation (Jurado et al., 2010). ATMIN null embryos also display 
exencephaly (25% of embryos), which indicate that ATMIN is required for neural 
tube development. Deletion of ATMIN in the central nervous system (CNS) using 
nestin-cre also leads to greater neurodegeneration in old mice compared to 
controls animals (Kanu et al., 2010). 
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1.3 The functions of ubiquitination in ATM signalling 
Post-translational modifications play an important role in regulating protein activity, 
interaction and stability. One of the most prevalent modifications, ubiquitination, 
has been identified as a key modulator of the DDR. As well as the DDR following 
DSBs, the Fanconi anemia pathway for the repair of interstrand crosslinks during 
DNA replication, and DNA damage bypass by translesion synthesis also rely on 
ubiquitination in their activation and signalling cascade. While the primary function 
of the ubiquitin system is the regulation of proteasome-dependent proteolysis, 
increasing evidence points towards the importance of non-degradative 
ubiquitination in the context of DNA damage signalling.  
1.3.1 Components of the ubiquitin system  
The ubiquitin system comprises of three key enzymes and the 76-amino acid 
ubiquitin moiety. An ubiquitin activating enzyme (E1) first uses ATP to covalently 
attach the ubiquitin moiety to itself via a cysteine to form E1~Ub thioester 
intermediate. Then the ubiquitin is transferred onto a cysteine residue on a 
ubiquitin conjugating enzyme (E2), before being passed onto a substrate by a 
ubiquitin ligase enzyme (E3). RING domain E3 ligases, such as the SCF (Skp, 
Cullin, F-box containing) complex usually form large, multi-protein complexes that 
bridges between the E2 and the substrate. Moreover, the E2 usually dictates the 
substrate specificity and chain linkage type, whether it is K63, K48, K11 linkage 
etc. HECT domain E3s, on the other hand, contain an active site cysteine that 
gets charged with the ubiquitin from E2 before transferring it to the substrate 
acceptor lysine residue. Hence, HECT domain E3s need to recognise both the E2 
and the substrate and usually determine the substrate specificity (Komander and 
Rape, 2012) (Figure 5). In mammals, ubiquitination involves two E1s, over 35 E2s, 
and over 600 E3s (Jackson and Durocher, 2013). Given the large number of E2s 
and E3s identified so far, it is likely that there are many more substrate selection 
and ubiquitin linkage topologies possible. Ubiquitin chain formation can occur at 
any of the seven internal lysine residues of ubiquitin, and result in different 
topologies and functions, such as mono-, multi-mono- and polyubiquitination. 
Polyubiquitin chains can be homotypic (a single type of linkage, such as Lys6) or 
heterotypic (more than one linkage type). The latter can also take on a linear or 
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branched topology. While Lys48 chain formation targets the substrate for 
proteolysis, Lys63 plays a role amplifying DDR signal at DSB. Recently, other 
atypical ubiquitin chains have also been identified. Lys6-chains are made by 
BRCA1/BARD1 E3 ligase during DDR, Lys11-chains have been implicated in 
proteasome degradation and endocytosis, Lys27 plays a role in autophagy of the 
mitochondria, Lys29 functions together with Lys48 chain linkage in ubiquitin fusion 
degradation, and Lys33 linkage plays a role in regulating protein interaction in the 
T cell receptor signalling (Kulathu and Komander, 2012). 
 
         
Figure 5. HECT domain E3 ligase-mediated ubiquitination reaction.  
The ubiquitination reaction is initiated by an E1 enzyme that uses ATP to form a 
charged E1-Ubi intermediate. Then the ubiquitin is transferred onto a cysteine residue 
on an ubiquitin conjugating enzyme (E2), before being passed onto a substrate by an 
ubiquitin ligase enzyme (E3). HECT domain E3s need to recognise both the E2 and 
the substrate in order to accept the charged ubiquitin from the E2 before transferring 
it to the substrate acceptor lysine.   
 
Another aspect of ubiquitination is the reversibility of signalling; the ubiquitin code 
can be removed by deubiquitinases (DUBs). Human cells contain approximately 
100 DUBs that reverse the activity of E3s; these include ubiquitin C-terminal 
hydrolases (UCHs), ubiquitin-specific proteases (USPs), ovarian tumour 
proteases (OTUs), Josephin domain DUBs and JAMM (JAB1/MPN/MOV34) 
family DUBs (Komander et al., 2009). While it is still unclear how the specificity of 
linkage recognition by DUBs is achieved, DUBs can be highly specific for their 
substrates, for instance POH1 shows Lys63 linkage specificity towards its 
substrate histone H2A (Cooper et al., 2009). In addition to simply reversing the 
activity of E3s, DUBs add another level of regulation and control; DUBs may bind 
an E3 that auto-ubiquitinates itself and thereby stabilise the E3, DUBs may help to 
switch off activated signalling pathways, DUBs can also fine-tune ubiquitination of 
a substrate by acting on both the substrate and E3 (such as in the case of USP7 
acting on MDM2 and p53 (Brooks et al., 2007), and by coupling E3 and DUB 
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activity on a single protein allow concomitant regulation of many substrates (Wertz 
et al., 2004). 
 
Here, I shall focus on the functions of ubiquitin in regulating the DDR, especially in 
response to DSBs that are sensed by the MRN complex and trigger ATM 
signalling.  
 
1.3.2 Ubiquitin-Based DSB Signalling by RNF8 and RNF168 
Upon the formation of a DSB, ATM activation by the MRN complex leads to a 
myriad of phosphorylation and ubiquitination events, which serve to amplify the 
signal and increase retention of DNA repair factors at the damage site. ATM 
phosphorylates H2AX, which in turn recruits MDC1 via the latter’s BRCT domain 
(Stucki et al., 2005). MDC1 is also a substrate of ATM phosphorylation, and has 
been shown by biochemical and structural studies to interact and recruit RNF8 to 
the site (Mailand et al., 2007, Kolas et al., 2007, Huen et al., 2007). RNF8 is a 
RING domain E3 ligase that works with UBC13 to add Lys63 linked ubiquitin 
chains on target proteins such as H2A (Wang and Elledge, 2007). The activity of 
RNF8 is facilitated by HERC2 (HECT domain and RCC1-like domain-containing 
protein 2), a HECT domain-containing protein whose recruitment to DSBs is itself 
dependent on RNF8 and MDC1. HERC2 interacts with RNF8 and enhances the 
RNF8-UBC13 interaction, such that RNF8 is stabilised and its Lys63-type 
ubiquitination of substrates is increased (Bekker-Jensen et al., 2010). Contributing 
to the ubiquitination signal, RNF168 also works with UBC13 to amplify Lys63-type 
ubiquitination at DSBs. RNF168 is recruited by ubiquitinated products of RNF8, 
such as ubiquitinated H2A, and also by its own ubiquitination products. 
Interestingly, while an RNF8-UBC13 fusion protein can rescue the recruitment of 
53BP1 foci that arise due to loss of RNF8 or UBC13 alone, it cannot rescue the 
same phenotype after knockdown of RNF168, suggesting that RNF168 is crucial 
for boosting the ubiquitination signal in order to retain repair factors at DSBs. 
Bilallelic mutations in rnf168 result in the recessive RIDDLE syndrome 
(Radiosensitivity, immunodeficiency, dysmorphic features, and learning 
difficulties), that results from failure to localise 53BP1 to DSB sites (Stewart et al., 
2007) (Stewart et al., 2009). Recently, the site of RNF168 ubiquitination on H2A 
and H2AX was identified to be primarily Lys13 and Lys15 (Gatti et al., 2012, 
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Mattiroli et al., 2012). Together, RNF8 and RNF168 E3 activity creates a Lys63- 
and mono-ubiquitin signalling platform that functions in the recruitment and 
retention of downstream repair factors such as 53BP1 and the RAP80/BRCA1 
complex.  
 
In addition to RNF8 and RNF168, the Polycomb E3 ligase RING1B/BMI1 can also 
monoubiquitinate H2A, but on residue Lys119 located away from the Lys13/15 
site. (Wu et al., 2011a, Pan et al., 2011, Ismail et al., 2010, Ginjala et al., 2011). 
This modification could provide an additional independent mechanism to facilitate 
transcriptional silencing around the damage site (Shanbhag et al., 2010, 
Chagraoui et al., 2011). (Figure 6) 
 
 
Figure 6. Ubiquitin cascade in the DSB response. 
Upon DSB formation, ATM phosphorylates H2AX, which recruits MDC1. ATM-
dependent phosphorylation of MDC1 creates a signalling platform to recruit RNF8. 
Together with UBC13 and facilitated by HERC2, RNF8 ubiquitinates H2A and H2AX 
via K63 linkage. The initial ubiquitination is further amplified by the recruitment of 
RNF168 to ubiquitinated H2A. RNF168, together with its E2 UBCH5, further amplifies 
the K63 ubiquitin linkage on flanking chromatin. In addition, BMI1/RING1B also 
ubiquitinates H2A independently on the C-terminus. DSB-induced chromatin 
ubiquitination, in addition to other chromatin modifications such as H4K20 
methylation, is necessary for the recruitment of 53BP1 and BRCA1-RAP80 complex, 
which promotes NHEJ and HR respectively. 
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1.3.3 Role of ubiquitination in recruitment of 53BP1  
53BP1 is a downstream mediator of MRN-dependent ATM signalling and also 
forms foci that colocalise with 𝜸H2AX in response to DSBs. The loss of 53BP1 
leads to mild defects in ATM signalling, such as slightly reduced KAP1 
phosphorylation (Noon et al., 2010) and checkpoint function (Shibata et al., 2010). 
By contrast, 53BP1 has a prominent role in DNA repair. It has been suggested 
that 53BP1 amplifies ATM signalling by concentrating more MRN-ATM complex 
via its BRCT domain (Noon et al., 2010, Lee et al., 2010). As such, 53BP1 is 
required for pKAP1 foci formation at late-repairing heterochromatic sites (Noon et 
al., 2010). The ATM-dependent phosphorylation of KAP1 is required to disperse 
CHD3 from heterochromatin and thereby facilitate chromatin relaxation and repair 
of damage (Goodarzi et al., 2011).  53BP1 is also required for NHEJ of uncapped 
telomeres by increasing the mobility of chromatin ends, which in turn move 
through larger nuclear territories (Dimitrova et al., 2008). In a similar way, 53BP1 
promotes long range synapsis of DNA ends during V(D)J recombination and class 
switch recombination (CSR). 53bp1-/- mice have reduced B and T lineage cells 
and thymocytes display more genomic aberrations, a loss of TCR (T-cell receptor) 
loci and increased apoptosis (Difilippantonio et al., 2008), due to defective long 
range V(D)J recombination. 53BP1 oligomerisation that occurs independent of 
DNA damage is thought to be important in bridging DNA ends together during 
synapsis. 53bp1-/- mice also have defective CSR over long distances: this was 
supported by evidence that 53BP1 promotes intra-chromosomal end joining of I-
SceI induced DSB ends separated by 96kb, but not proximal or trans-
chromosomal ends (Bothmer et al., 2011). 53BP1 also protects DNA ends from 
resection (Bothmer et al., 2010, Bunting et al., 2010), and the loss of 53BP1 can 
rescue the embryonic lethality of brca1-/- by blocking HR, albeit with a resulting 
high level of genomic instability (Cao et al., 2009). Recently, RIF1 was identified 
as the downstream target of 53BP1 that counteracts BRCA1-mediated HR. 
(Chapman et al., 2013, Di Virgilio et al., 2013, Escribano-Diaz et al., 2013, Feng 
et al., 2013, Zimmermann et al., 2013).  
 
The evidence that rnf168-/- mice share a similar phenotype as 53bp1-/- mice in 
defective long range V(D)J recombination, and that RNF168 is required for 53BP1 
foci localisation onto DNA, strongly suggests that ubiquitination plays an important 
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role in 53BP1 recruitment. Its recruitment to foci was shown to be dependent on 
its tandem Tudor domains, which bind dimethylated Histone4 Lys20 (H4K20me2) 
(Botuyan et al., 2006).  Accumulating evidence suggests that the ubiquitination of 
H2A and H2AX by RNF8 and RNF168 allows the histone methylation marks to 
become more accessible, thereby facilitating 53BP1 recruitment (Stewart et al., 
2009, Doil et al., 2009, Bekker-Jensen et al., 2010, Mailand et al., 2007, Huen et 
al., 2007). RNF8 has been shown to act synergistically with CHFR (checkpoint 
protein with FHA and Ring domain) to allow H4K16 acetylation, which leads to 
chromatin relaxation and is required for ATM signalling after IR (Wu et al., 2011b). 
More biochemical data will be required to fully elucidate the mechanism by which 
53BP1 is recruited to DSB. 
 
1.3.4 Role of ubiquitination in the regulation of BRCA1 
BRCA1 is required for efficient repair of DSB by HR, as well as transcription-
coupled DNA repair, DNA crosslink repair and checkpoint control. BRCA1 has a 
N-terminal RING domain, a central SQ/TQ cluster, and two C-terminal BRCT 
domains. BRCA1 is phosphorylated post-IR in an ATM-dependent manner (Gatei 
et al., 2000a), but its recruitment into foci was not changed in A-T cells or after 
ATM inhibitor treatment. BRCA1 activation also requires phosphorylation by 
CHK2  (McGowan, 2002) or interaction with CHK1 (Joughin et al., 2005). In 
addition, chromatin ubiquitination set up by RNF8 and RNF168 is also crucial for 
BRCA1 recruitment (Lukas et al., 2011b).  
 
BRCA1 associates with its partner BARD1, forming a dimeric RING-domain E3 
ligase. This interaction stabilises both proteins in vivo and enhances BRCA1 E3 
activity in vitro (Xia et al., 2003).  BRCA1 retention on DSBs requires interaction 
with the RAP80 complex, but the latter is dispensable for the initial recruitment of 
BRCA1 (Yin et al., 2012, Hu et al., 2011). Hence, it remains unclear how BRCA1 
docks onto ubiquitin conjugates. Another open question is whether the E3 activity 
of BRCA1 is required for HR and tumour suppression. Using a RING mutant 
knock-in, Shakya et al. showed that Brca1I26A mice display normal HR with no 
elevated tumour predisposition (Reid et al., 2008, Shakya et al., 2011). A similar 
mutation in chicken DT40 cells, however, results in hypersensitivity to DNA 
damage induced by camptothecin (Sato et al., 2012). On the other hand, another 
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BRCA1 RING mutant (C61G) does lead to embryonic lethality and DNA repair 
defects, but it could be due to the disrupted interaction with BARD1 rather than 
loss of BRCA1 E3 activity (Drost et al., 2011). Hence, more evidence is required 
to ascertain the role of BRCA1 E3 activity in its function.  
 
Downstream, BRCA1 interacts with CtIP via its BRCT domain and promotes the 
resection ability of CtIP to generate longer tracks of ssDNA for HR. On the other 
hand, RAP80 associates with BRCA1 and restrains excessive resection of ssDNA 
(Coleman and Greenberg, 2011, Hu et al., 2011). CtIP has been shown to be a 
target of BRCA1 E3 activity, which adds Lys6-ubiquitin chains but does not seem 
to target CtIP for degradation (Yu et al., 2006). Rather, CtIP ubiquitination could 
be required for recruitment and colocalisation with BRCA1 into IR-induced foci 
(IRIF). As another important negative regulator of BRCA1 resection, 53BP1 has 
been identified to restore HR and viability after PARP inhibition in Brca1-/- cells 
(Cao et al., 2009, Bunting et al., 2010) (Bouwman et al., 2010) (Figure 7). 
 
 
Figure 7. 53BP1 and BRCA1 regulates the balance between NHEJ and HR modes of 
DNA repair.  
During G0/G1, where BRCA1 is not normally present, 53BP1 inhibits the end-
resection function of CtIP. RIF1, a downstream target of 53BP1, also blocks BRCA1-
mediated HR. During S phase, BRCA1, by an unknown mechanism, inhibits this 
function of 53BP1 at DNA breaks, while also promoting CTIP-mediated end resection 
activity to facilitate HR.  
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1.3.5 UBR5 as a new player in the DNA damage response 
UBR5 (Ubiquitin protein ligase E3 component n-recognin 5, also known as EDD 
or HYD) was first identified in mammalian cells, by differential display, as a 
progestin-regulated gene (Callaghan et al., 1998) and a potential HECT domain 
E3 ligase with the ability to bind ubiquitin in vitro. It is also a homolog of the 
tumour suppressor gene in Drosophila, Hyperplastic discs (hyd) (Mansfield et al., 
1994). Temperature-sensitive mutation of UBR5 in Drosophila leads to the 
overgrowth of imaginal discs, suggesting that it is required for the regulation of cell 
proliferation (Figure 8). 
 
   
Figure 8. Domain structure of UBR5.  
UBR5 has a N-terminal ubiquitin-associated domain (UBA) which can binds mono- as 
well as poly-ubiquitin chains, a nuclear localisation signal (NLS), and a putative zinc 
finger in N-recognin family, a recognition component of the N-end rule pathway. It has 
a C-terminal HECT domain with a catalytic cysteine residue at C2768. Moreover, 
UBR5 has a poly-(A) binding protein  domain (PABP) that mediates binding to and 
regulation of mRNA. 
 
The first link of UBR5 to DDR came from a yeast-two-hybrid study that showed 
UBR5 interacted with TOPBP1, and the interaction required two BRCT domains of 
TOPBP1. Moreover, UBR5 can ubiquitinate TOPBP1 in vitro in the presence of 
E1 and UbcH4 (Honda et al., 2002). The evidence for direct ubiquitination of 
TOPBP1 in vivo was less convincing, as the authors showed separately that Flag-
HYD overexpression results in the formation of ubiquitination substrates, and 
Flag-TOPBP1 can be ubiquitinated in vivo. The ubiquitination of TOPBP1 was 
augmented by proteasome inhibition (MG132), suggesting a degradative form of 
ubiquitination, and was seemingly strongly reduced upon IR, even in the presence 
of MG132. However, one cannot distinguish whether IR prevents the 
ubiquitination of TOPBP1 in the first place, or accelerates the DUB activity.  
 
UBR5 was also shown to regulate CHK2 phosphorylation after IR and interacts 
with the FHA domain of CHK2 (Henderson et al., 2006). Loss of UBR5 led to 
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decreased CHK2 T68 phosphorylation but did not affect other substrates including 
ATM autophosphorylation. Moreover, the knockdown of UBR5 resulted in 
increased colony formation after treatment with radiomimetic drugs and defective 
G2/M checkpoint post IR. However, it is not clear whether this depended on its E3 
ligase activity (Henderson et al., 2006). In addition, UBR5 has also been reported 
to negatively regulate ATM-dependent p53 Ser15 phosphorylation and target 
gene expression after DSBs (Ling and Lin, 2011), in a manner that is independent 
of its E3 ligase activity. Hence, while UBR5 affected DSB-induced CHK2 and p53 
phosphorylation, the mechanism remains enigmatic, as it did not regulate their 
protein stability.  
 
UBR5 also contains a PABP domain in the C-terminus, which suggest a possible 
role in mRNA metabolism. The X-ray structure of the C-terminus also suggests a 
homology to PABP (Poly-A binding protein) (Deo et al., 2001). PABP binds to the 
5’ end of mRNA and is required for translation initiation. Paip1 and 2 (PABP-
interacting protein) negatively regulate PABP and UBR5 was shown to target 
Paip2 for degradation (Yoshida et al., 2006). In mouse, UBR5 is required for yolk 
sac vascularization and chorioallantoic fusion and UBR5 knockout is 
embryonically lethal at E10.5 (Saunders et al., 2004). In human, UBR5 was found 
overexpressed and amplified in a number of cancers including breast and ovarian 
cancers, thereby highlighting its importance in tumourigenesis (Clancy et al., 
2003).  
 
1.3.6 Switching off the damage-induced ubiquitination cascade 
To ensure the reversibility of signalling, damage-induced ubiquitination is also 
highly regulated. A recent study identified TRIP12 and UBR5 in a siRNA-based 
screen that is responsible for suppressing RNF168 chromatin loading and 
retention (Gudjonsson et al., 2012). While the knockdown of these E3 ligases 
leads to expanded 53BP1 and RNF168 foci, it is not clear how they exert their 
inhibitory effect on RNF168, whether by proteolysis or other mechanisms. Several 
other DUBs also regulate the ubiquitin response, such as BRCC36, which is 
directed by the ubiquitin-recruited RAP80 itself, and acts against RNF8-UBC13 
dependent Ly63-ubiquitin synthesis (Shao et al., 2009). OTUB1 also negatively 
regulate the ubiquitin response by directly binding UBC13 and prevents the 
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ubiquitin transfer (Juang et al., 2012, Wiener et al., 2012), thereby suppressing 
RNF168 activity in vivo and in vitro (Nakada et al., 2010). Another DUB, USP3, 
acts specifically on monoubiquitinated H2A and H2B and in turn regulates the 
DSB response as well as S phase checkpoint responses (Nicassio et al., 2007).  
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1.4 The role of ATM and ATR in replication stress 
Replication stress is the interference of replication fork progression caused by 
DNA damage, depletion of deoxyribonucleotide pools, and DNA sequences and 
structures that are inherently difficult to replicate such as repetitive sequences, 
DNA interstrand crosslinks, G-quadruplex structures and others. Drugs such as 
aphidicolin can also block replication by inhibiting DNA polymerase α and δ, while 
hydroxyurea inhibits ribonucleotide reductase and thereby block the production of 
deoxyribonucleotides. ATR is the primary kinase that responds to replication 
stress by stabilising the replication fork, suppressing late origin firing and inhibiting 
mitotic entry (Cimprich and Cortez, 2008, Flynn and Zou, 2011).  
1.4.1 Mechanism of ATR activation and its downstream functions 
Replication stress generates ssDNA through the uncoupling of DNA polymerase 
and helicase at the replication fork (Byun et al., 2005) or through resection by 
nucleases at DSBs (Huertas, 2010). ssDNA is rapidly coated by Replication 
Protein A (RPA) and the ssDNA-RPA acts as the initial signal that recruits ATR, 
as the depletion of RPA impairs ATR activation and foci formation in Xenopus egg 
extracts and human cells (Costanzo and Gautier, 2003, Zou and Elledge, 2003, 
Dart et al., 2004). ATR activation also requires the cofactor ATRIP (ATR 
interacting protein), which interacts stoichoimetrically with ATR independently of 
damage and stabilises the latter (Cortez et al., 2001). ATR and ATRIP colocalise 
at DNA damage foci after inhibition of replication and ATRIP directly binds RPA in 
promoting the recruitment of ATR (Zou and Elledge, 2003, Ball et al., 2005). 
ATRIP has an N-terminal RPA binding domain, a C-terminal ATR interacting 
domain, and a central coiled-coil domain that mediates dimerization and which is 
required for stable interaction with ATR (Ball and Cortez, 2005, Itakura et al., 
2005).  
 
ATR activation requires the activator TOPBP1, which binds to both ATR and 
ATRIP via its PIKK regulatory domain (PRD), stimulates ATR kinase activity in 
vitro and in vivo and is required for its checkpoint functions (Mordes et al., 2008, 
Kumagai et al., 2006). TOPBP1 recruitment, in turn, depends on the 9-1-1 
complex (RAD9-HUS1-RAD1), which is loaded onto the 5’ resected DNA junction 
by the RFC-like clamp loader RAD17 (Zou et al., 2002, Bermudez et al., 2003, 
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Ellison and Stillman, 2003). The phosphorylated C-terminus of RAD9 interacts 
with the BRCT domains of TOPBP1, enabling the latter to associate with and 
activate ATR (Furuya et al., 2004, Delacroix et al., 2007, Lee et al., 2007). The 9-
1-1 complex and TOPBP1 are recruited independently of ATR-ATRIP, thus 
providing additional layers of control in DDR activation in sensing replication fork 
stalling (Melo et al., 2001, Kondo et al., 2001). It is unclear how TOPBP1 activates 
ATR, possibly by a change in conformation that increases the affinity for ATR 
substrates (Cimprich and Cortez, 2008). Recently, the MRN complex has been 
implicated in the recruitment of TOPBP1 to ds-ssDNA junctions and is required for 
ATR activation (Duursma et al., 2013), hence highlighting the potential crosstalk 
between ATM and ATR pathways. 
 
          
Figure 9. Mechanism of ATR activation. 
ssDNA is rapidly coated by RPA, which serves as a signal to recruit ATR via ATRIP. 
ssDNA-RPA also triggers recruitment of a checkpoint clamp, the 9-1-1 complex, 
which is loaded onto the resected dsDNA junction by the clamp loader RAD17 (not 
shown). Phosphorylated 9-1-1 complex facilitates the recruitment of TOPBP1, a 
coactivator of ATR, which binds to both ATR and ATRIP and stimulates ATR kinase 
activity. Activated ATR phosphorylates downstream substrates such as Chk1, which 
executes checkpoint responses.  
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Upon activation, ATR phosphorylates its downstream substrates, CHK1 on sites 
Ser317 and Ser345, which has been used as markers of ATR signalling (Liu et al., 
2000) (Zhao and Piwnica-Worms, 2001). Recently, ATR autophosphorylation at 
T1989 has been shown to be a marker of active ATR and required for ATR 
function (Liu et al., 2011). The auto-phosphorylation was induced by UV, IR and 
HU, and was abolished by T1989A mutation. Reconstitution of ATR-null cells with 
T1989A ATR resulted in defective substrate phosphorylation. Moreover, phospho-
T1989 was shown to be required for TOPBP1 phosphorylation, but not vice versa, 
suggesting that ATR autophosphorylation is upstream of TOPBP1 recruitment. 
Several companies have made commercial antibodies against another site, 
Ser428, but the S428A mutant does not impair CHK1 phosphorylation. Hence, in 
contrast to the multiple autophosphorylation sites on ATM, T1989 is the only site 
identified so far that marks ATR activation. 
 
As the effector substrate of ATR, CHK1 mediates many of its downstream 
functions such as intra S phase checkpoint and G2/M arrest (Feijoo et al., 2001, 
Liu et al., 2000). ATR-mediated phosphorylation of CHK1 promotes the 
dissociation of the latter from chromatin and facilitates the transmission of DNA-
damage signals to downstream targets (Smits et al., 2006). CHK1 and ATR are 
both required for UVC-induced inhibition of replication, which does not depend on 
ATM, NBS or MRE11 (Heffernan et al., 2002). Recently, ATR also been shown to 
phosphorylate MLL (Lysine methyltransferase) after replication stress, which 
protects it from degradation by SKP2 E3 ligase and leads to the stabilisation of 
MLL. As a result, the increase in H3K4 methylation at origins can impair the 
binding of CDC45 and suppress replication initiation (Liu et al., 2010). 
 
CHK1 activation also halts the cell cycle to allow replication block or DNA damage 
to be repaired. CHK1 phosphorylates CDC25A upon its activation by ATR 
(Sorensen et al., 2003), and promotes the proteasome-dependent degradation of 
CDC25A phosphatase. The resulting increase in CDK (cyclin-dependent kinase) 
phosphorylation at Tyr15 residue inhibits CDK activity and induces S phase arrest 
(Zhou and Elledge, 2000) (Bartek and Lukas, 2003). 
 
Another key function of ATR in the protection of genome integrity is the 
maintenance of stalled replication fork. Inhibition of ATR kinase activity induces 
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cell death, defective replication initiation and collapse of replication forks due to 
excessive deregulated activity of SMARCAL1 DNA translocase. ATR 
phosphorylation of SMARCAL1 on Ser652 limits its aberrant processing of 
replication fork, thereby maintaining fork integrity (Couch et al., 2013). Similar 
findings were reported on the role of ATR in preventing fork collapse and 
breakage in SV40 chromatin replication (Sowd et al., 2013).  
 
In addition, ATM was also shown to play an important role in suppressing 
excessive recombination intermediates and promoting bidirectional fork 
progression (Sowd et al., 2013). Hence, ATM and ATR could cooperate in the 
protection of stalled replication forks. Recently, ATM was shown to be required for 
the formation of 53BP1 G1 nuclear bodies at fragile sites (Harrigan et al., 2011, 
Lukas et al., 2011a), which are caused by replication fork collapse after partial 
inhibition of DNA replication (Durkin and Glover, 2007). The 53BP1 nuclear 
bodies were proposed to protect fragile sites and unrepaired DNA from erosion 
and sequester them until the next cell cycle for repair. While ATR is required to 
maintain fragile site stability in mammalian cells (Casper et al., 2002), it is not 
required for the formation of 53BP1 nuclear bodies (Harrigan et al., 2011). Hence, 
while ATR is activated to transduce checkpoint responses immediately following 
replication stress in an early step, ATM could also play a role in preserving 
replication fork integrity and preventing accumulation of DNA damage during 
prolonged replication fork stalling.  
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1.5 ROS-induced DNA damage and the base excision repair 
pathway 
Reactive oxygen species (ROS) are generated endogenously as by-products of 
oxidative respiration in mitochondria, in macrophages and neutrophils, and in 
peroxisomes. ROS can also be induced by exogenous exposure to IR, by the 
presence of heavy metals and drugs such as barbiturates or phorbol esters 
(Klaunig and Kamendulis, 2004). Regardless of the source, free radicals such as 
O2-•,  •OH and H2O2 are generated, the latter being the most damaging given its 
ability to diffuse rapidly through membranes and target DNA (Boveris et al., 2006). 
The first line of defence against ROS is the intracellular pool of antioxidants, such 
as superoxide dismutase, catalase and glutathione peroxidase enzymes and 
nonenzymatic compounds such as vitamins C, E and glutathione. However, when 
oxidants are in excess, ROS induced damage can occur to nucleic acids, lipids 
and proteins, which may affect cellular function and viability.  
 
Amongst the different types of oxidative DNA damage, 7,8-dihydro-8-oxo-guanine 
(8-oxoG) is the most abundant and occurs at a frequency of 1000 per human cell 
per day (van Loon et al., 2010). This also makes it a good biomarker of oxidative 
stress (Klaunig and Kamendulis, 2004). In addition, 8-oxoG is also the most highly 
mutagenic due to its ability to mispair with adenine, leading to G:C to T:A 
transversions if left unrepaired at DNA replication. Other base oxidation products 
include 2,6-diamino-4-hydroxy-5-formamidopyrimidine (faPy-G) and 7,8-dihydro-
8-oxo-adenine (8-oxo-A). Increasing evidence attributes the loss of BER as a 
cause of tumourigenesis; G:C to T:A transversions constitute the most 
predominant form of somatic mutations in many cancers(Greenman et al., 2007), 
germline mutations in MUTYH are associated with MUTYH-associated polyposis 
(Mazzei et al., 2013), polymorphism in OGG1 has been implicated in increased 
susceptibility to lung cancer (Sugimura et al., 1999), and reduced activity of 8-
oxoguanine DNA glycosylase (OGG1) is a risk factor in lung and head and neck 
cancer (Paz-Elizur et al., 2008). Given the mutagenic potential of damaged bases, 
they need to be efficiently detected and repaired by the base excision repair 
pathway.  
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1.5.1 Base excision repair pathway 
As the primary repair system for damaged bases, the base excision repair (BER) 
pathway is initiated by specific DNA glycosylases that recognise damaged bases 
and catalyses base cleavage to form an apurinic/apyrimidinic (AP) site. This is 
followed by cleavage to form an ssDNA break at the site by AP endonuclease I 
(APEI). Further processing by DNA polymerase β generates a one-nucleotide gap, 
which is subsequently filled by short-patch or long-patch repair. During short-
patch BER, DNA pol β synthesises a one-nucleotide repair patch, which is ligated 
by DNA ligase III/XRCC1 heterodimer  (Kubota et al., 1996, Srivastava et al., 
1998). Long-patch BER involves the repair of two to 12 nucleotides, which is 
initiated by DNA pol β (Podlutsky et al., 2001), and then elongated by DNA pol δ 
and ε. Additional factors are required to facilitate strand displacement synthesis 
including RFC, PCNA and FEN1 which cleaves the displaced nucleotides. Unlike 
short-patch repair, the final ligation step in long-patch repair is mediated by DNA 
ligase I (van Loon et al., 2010). An alternative, APE1-independent mode of BER 
by DNA glycosylase/AP lyase NEIL1/NEIL2 has been identified, which acts on 5-
hydroxyuracil (5-OHU), thymine glycol, 8-oxo-G, and uracil. In this pathway, 
NEIL1 and polynucleotide kinase (PNK) act in concert to remove the 3’ terminal 
phosphate group after the ssDNA break, and can also carry out repair initiated by 
other DNA glycosylases (Wiederhold et al., 2004).   
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Figure 10. Mechanism of BER pathway. 
Oxidative damage to DNA results in the formation of 8-oxoG, which is recognised and 
excised by OGG1, followed by SP-BER mediated by DNA pol β and ligated by DNA 
ligase III/XRCC1 to restore to C:G base pair. However, if DNA replication occurs 
before the 8-oxoG is repaired, replicative polymerases misincorporate dAMP opposite 
8-oxoG, resulting in G:C to T:A transversion in the following cell cycle. A:8-oxoG 
mispair is recognised by MUTYH, which cleaves the adenine and initiates LP-BER via 
DNA pol δ, ε, RFC and PCNA. DNA pol ƛ further elongates the newly synthesised 
strand and the resulting flap is removed by FEN1, before ligation by DNA ligase I. The 
C:8oxoG base pair is subsequently targeted by OGG1 and SP-BER to restore to the 
original C:G base pair. 
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In order to counteract the mutagenic effect of 8-oxo-G, cells have conserved DNA 
glycosylases that can detect and cleave the oxidised base from the genome. In 
humans cells, the 8-oxoG system consists of NUDT1 (Nucleoside diphosphate 
linked moiety X type motif 1), OGG1 and MUTYH. NUDT1 is a nucleoside 
phosphatase that hydrolyses oxidised guanine nucleosides and prevents their 
incorporation into the DNA (Furuichi et al., 1994) (Kakuma et al., 1995). NUDT1 or 
MTH1 (MutT homolog 1) was identified from human tumour cell lines that 
possessed 8oxo-dGTPase activity (Mo et al., 1992). Additional homologues, 
MTH2 (NUDT15) and MTH3 (NUDT18) have also been identified (Cai et al., 2003, 
Takagi et al., 2012). NUDT1 has greater activity towards 8-oxo-dGTP, MTH2 
hydrolyses both 8-oxo-dGTP and dGDP with lower affinity, and MTH3 is specific 
towards 8-oxo-dGDP (Takagi et al., 2012).   
 
Once the oxidised nucleotide has been incorporated into the genome, the 8-oxo-G 
is recognised by OGG1, a bifunctional enzyme with both DNA glycosylase and AP 
lyase activity (Figure 10). OGG belongs to the Helix-hairpin-helix (HhH) family of 
BER DNA glycosylases, and was initially identified by its ability to suppress the 
mutagenicity of the fpg muty E.coli mutant and to act towards an 8-oxo-G 
substrate (van der Kemp et al., 1996). Structural data of the free enzyme and 
OGG1-DNA complex demonstrated induced-fit conformational changes upon 8-
oxoG binding, that allows the flipping of the 8-oxoG out of the DNA base pair 
(Bruner et al., 2000, Bjoras et al., 2002). Using a trapped enzyme-DNA 
intermediate, Fromme et al were able to show that the cleaved 8-oxoG acts as a 
cofactor in the subsequent lyase step (Fromme et al., 2003). However, if the 8-
oxoG is not removed before DNA replication, the DNA polymerase may 
incorporate adenine opposite 8-oxoG. In this case, cells rely on MUTYH to 
remove the mismatched adenine, followed by OGG1 mediated cleavage of 8-
oxoG to revert to the G: C base pair. Another member of the endonuclease III 
(Nth) family, NTH1, has also been found to be active against 8-oxoG, as well as 
other substrates such as thymine glycol (Tg), 5-hydroxycytosine, dihydrouracil 
(DHU), urea and other oxidized pyrimidine derivatives (Ikeda et al., 1998, Hilbert 
et al., 1997, Aspinwall et al., 1997, Liu and Roy, 2002). A similar mechanism of 
base flipping occurs in MUTYH-mediated recognition of mismatched A in an A: 8-
oxoG mispair (Fromme et al., 2004), which ensures specific binding only to 
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adenine opposite an oxidised G. While the AP site generated by OGG1 is 
predominantly repaired by SP-BER, as shown by reduced repair efficiency in DNA 
pol β deficient cell line (Fortini et al., 1999) and from in vitro reconstitution of 8-
oxoG BER with human purified proteins (Pascucci et al., 2002), that generated by 
MUTYH is most likely repaired via LP-BER, due to the involvement of replicative 
polymerase δ that is sensitive to aphidicolin and followed by a PCNA-dependent 
mechanism (Weiser et al., 1991) (Einolf and Guengerich, 2001).  
1.5.2 Mouse models of BER pathway 
Despite the mutagenicity and susceptibility to tumourigenesis in the absence or 
reduction in base excision repair in human patients, mouse models lacking the 8-
oxoG genes have not been reported to have a severe phenotype. Ogg1 knockout 
mice were generated by two approaches, either by targeted deletion of exon 2 
and 3 (Minowa et al., 2000) or deletion of the genomic DNA including the 
conserved helix-hairpin-helix motif of OGG1 required for DNA glycosylase/AP 
lyase activity (Klungland et al., 1999). However, despite the increase in 8-oxoG in 
the tissue of mutant animals and elevated spontaneous mutation rate, there were 
no overt phenotypes or malignancies in these mice from the early reports. The 
ogg1-/- mice also did not show increased tumorigenesis in response to long-term 
potassium bromate induced carcinogenesis despite accumulation of 8-oxoG in 
vivo (Arai et al., 2006). Only one report showed that ogg1-/- animals developed 
spontaneous lung adenoma and carcinoma after 1.5 year and this could be 
somehow suppressed by the double knockdown of MTH1 (Sakumi et al., 2003).  
 
Similarly, mutyh-/- mice also display no severe phenotype, with one report of 
increased intestinal tumours at 18 months of age (Sakamoto et al., 2007). 
However, when combined with the APCmin/+ model, APCmin/+ ; mutyh-/- accelerated 
intestinal tumourigenesis compared with APCmin/+ ; mutyh+/+ or APCmin/+ ; 
mutyh+/-  and three Apc mutations in polyps from APCmin/+ ; mutyh-/- mice were 
found to be G:C to T:A transversions which resulted in termination codons (Sieber 
et al., 2004). While mutyh-/- mice have no apparent increase in 8-oxoG in tissues, 
mutyh-/-; ogg1-/- double knockout animals accumulated more 8-oxoG (Russo et 
al., 2004) and was reported to have shorted lifespan (10 months) and increased 
lung tumour incidence (Xie et al., 2004). Moreover, most lung tumours were also 
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found to harbor G to T transversions in codon 12 of K-ras, in line with a defect in 
base excision repair.  
 
Mth1 knockout mice show no difference in survival due to spontaneous 
tumourigenesis compared to wildtype, but were found to have increased tumour 
incidence(Tsuzuki et al., 2001b, Tsuzuki et al., 2001a). Hence, MTH1 could likely 
confer protection against early tumour initiation events, but its loss is not sufficient 
alone to accelerate tumourigenesis. In addition, MTH1 has been found to play a 
protective role against the mutagenicity and cytotoxicity of 8-oxoG accumulation in 
neurons, which contribute to neurodegeneration in a mouse model of Parkinson’s 
Disease (Nakabeppu et al., 2006).  
1.5.3 Regulation of BER pathway 
Given the prevalence of 8-oxoG in the genome, the activities of MUTYH and 
OGG1 must also be regulated to correct for these errors in the timely manner. 
MUTYH activity has been proposed to correlate with DNA replication, since its 
activity needs to be targeted to the newly synthesised DNA. MUTYH directly 
interacts with PCNA and RPA in human and yeast cells, and colocalises with 
BrdU and PCNA in replication foci (Parker et al., 2001, Boldogh et al., 2001). 
Using an in vivo repair system, it was shown that DNA replication increased the 
activity of MUTYH, in a manner that depends on the interaction with PCNA 
(Hayashi et al., 2002). In addition, MUTYH could be regulated by PKC (Protein 
kinase C) mediated phosphorylation, which augments its activity (Parker et al., 
2003).  
 
In contrast, OGG1 protein level does not seem to change appreciably with the cell 
cycle, and induction of its activity after oxidative stress is also variable, possibly 
due to cell type differences (Dhenaut et al., 2000).  OGG1 activity can be boosted 
in liver by regular exercise (Nakamoto et al., 2007), as well as by ischemic 
preconditioning in the brain of rats in order to enhance repair of reperfusion-
induced oxidative damage (Li et al., 2006, Lan et al., 2003). Following the kinetics 
of GFP-OGG1 fusion protein, Amouroux et al showed that OGG1 is recruited to 
euchromatic regions upon oxidative stress and this does not involve binding and 
recognition of 8-oxoG, as a OGG1 F319A mutant which cannot recognise 8-oxoG 
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is still able to localise to open chromatin (Amouroux et al., 2010). Hence, there 
must be additional factors that regulate OGG1 localisation.   
 
OGG1 has been shown to interact with RAD52 in vitro and in vivo, specifically 
after oxidative stress but not after IR. Rad52 mediates HR by facilitating RAD51 
nucleoprotein filament formation on ssDNA and annealing of RPA-coated ssDNA 
(Sung, 1997, New et al., 1998, Shinohara and Ogawa, 1998). While OGG1 
inhibits the strand annealing activity of RAD52, the latter boost the activity of 
OGG1 and colocalises with OGG1 in nuclear foci after H2O2 treatment (de Souza-
Pinto et al., 2009). It was speculated that since OGG1 removes 8-oxoG less 
effectively closer to DNA ends, RAD52 cooperates to enhance OGG1 activity. It 
might also be a way to couple the completion of BER to HR once the template 
DNA has been restored to its original state. OGG1 also interacts with PARP1, and 
the interaction is increased by oxidative stress. While OGG1 stimulates poly(ADP-
ribosyl)ation, PARP1 inhibits OGG1 activity, suggesting that PARP1 could 
regulate OGG1 activity. OGG1 has also been shown to be regulated by 
posttranslational modifications. Dantzer et al reported that OGG1 could be 
potentially phosphorylated by PKC on a serine residue, although it is unclear what 
physiological effect this has on OGG1 activity (Dantzer et al., 2002). Subsequently, 
OGG1 was also found to be phosphorylated by CDK4 and acetylated by p300, 
both of which increase its cleavage activity (Hu et al., 2005, Bhakat et al., 2006). 
 
While MUTYH and OGG1 have been linked to the replication and DSB pathway 
through interactions with DDR factors, it is not clear whether these interactions 
influence the crosstalk between DDR and base excision repair. It is plausible that 
ATM or ATR could help to direct the activity of MUTYH1 and OGG1 to DNA 
damage sites after oxidative stress, but a direct interaction has not been reported 
so far. Moreover, it would be of interest to understand whether base excision 
repair also affects ATM and ATR signalling. This will be further discussed in 
chapter 6. 
  
  52 
Chapter 2. Materials and Methods 
2.1 Materials 
2.1.1 Reagents  
Acetone Sigma-Aldrich 
Acrylamide Sigma-Aldrich 
Agarose Bioline 
Ammonium persulphate Sigma-Aldrich 
Ampicilin Sigma-Aldrich 
Aphidicolin Sigma-Aldrich 
ATM inhibitor Calbiochem 
β-mercaptoethanol Sigma-Aldrich 
Bovine serum albumin Sigma-Aldrich 
BrdU Sigma-Aldrich 
Calcium phosphate CRUK 
Calf intestinal phosphatase New England Biolabs 
Cell strainer (45µm) BD falcon 
Coverslips Menzel-Glaeser 
Cuvettes Fisher scientific 
DAKO fluorescent mounting medium DAKO 
DAPI Sigma-Aldrich 
Dharmafect 1 Life Technologies 
Direct PCR Lysis reagent Viagen Biotech 
Dithiothretol  Sigma-Aldrich 
DMEM  Life Technologies 
DMSO Sigma-Aldrich 
DNA ladder (1kb) Life Technologies 
DyeEx® 2.0 Spin kit QIAGEN 
Dynabeads M-280 Strepavidin Life Technologies 
ECL western blotting detection reagent GE healthcare 
EDTA CRUK 
Eppendorf tubes Eppendorf  
Ethanol Fisher scientific 
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Ethidium bromide Sigma-Aldrich 
Falcon tubes (15ml, 50ml) Corning 
Fuji X-ray film Fisher scientific 
Glycerol Sigma-Aldrich 
GoTaq PCR DNA polymerase Promega 
Harris's haematoxylin CRUK 
Hydrogen peroxide Sigma-Aldrich 
Illustra TM GFX TM DNA Purification kit GE healthcare 
Industrial methylated spirit (IMS) CRUK 
Isopropanol Sigma-Aldrich 
Kanamycin Sigma-Aldrich 
LB medium CRUK 
Lipofectamine-2000 Life Technologies 
Lullaby transfection reagent OZ Biosciences 
Luperox Sigma-Aldrich 
Magnesium chloride CRUK 
Methanol Sigma-Aldrich 
Microscope slides Menzel-Glaeser 
Needles  BD Microlance 
Neutral buffered formalin (NBF) CRUK 
Nitrocellulose transfer membrane Whatman 
NP-40 Sigma-Aldrich 
Nucleofactor transfection reagent Lonzo AG 
Opti-MEM Life Technologies 
Paraformaldehyde Sigma-Aldrich 
PBS CRUK 
Penicillin/streptomycin CRUK 
Phenylmethylsulfonyl fluoride (PMSF) Sigma-Aldrich 
Ponceau S Sigma-Aldrich 
Propidium iodide Sigma-Aldrich 
Protease inhibitor cocktail Sigma-Aldrich 
Protein A-sepharose Sigma-Aldrich 
Protein Assay Dye Reagent Bio-Rad 
Protein G-sepharose Sigma-Aldrich 
Proteinase K Melford Laboratories 
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QIAGEN plasmid Maxi Kit QIAGEN 
QIAprep Spin miniprep kit QIAGEN 
Rainbow protein marker GE healthcare 
Restriction endonucleases New England Biolabs 
RIPA buffer New England Biolabs 
Rnase-free Dnase  QIAGEN 
serological pipettes (5ml, 10ml, 25ml) Corning 
Skimmed milk powder 
A1 Laboratory supplies 
Ltd 
Sodium azide Sigma-Aldrich 
Sodium chloride CRUK 
Sodium dodecyl sulphate Sigma-Aldrich 
Sodium fluoride Sigma-Aldrich 
Sodium orthovanadate New England Biolabs 
Superscript III cDNA synthesis kit Life Technologies 
SYBR green Life Technologies 
Syringes (5ml, 10ml, 25ml) BD Plastipak 
T4 DNA ligase New England Biolabs 
Taq PCR kit QIAGEN 
TEMED Sigma-Aldrich 
Tissue culture dishes (6cm, 10cm) Corning 
Tissue culture flasks (25cm2, 75cm2, 150cm2) Corning 
Tissue culture plates (6-well, 24-well, 96-well)  Corning 
Triton X-100 Sigma-Aldrich 
Trypan Blue Sigma-Aldrich 
Trypsin Life Technologies 
Tween-20 Sigma-Aldrich 
Urea Sigma-Aldrich 
2.2 Buffers and solutions 
ATM IP buffer 
 
RIPA buffer 1x 
NaF 50mM 
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Na3VO4 1mM 
β-glycerophosphate 1mM 
Complete Protease inhibitor cocktail 1% (v/v) 
  
ATM IP wash buffer 
Tris (pH7.5) 100mM 
LiCl  0.5M 
  
Blocking buffer (Immunofluorescence) 
FCS 10% 
Triton X-100 0.10% 
PBS 89.90% 
  
Blocking buffer (Immunohistochemistry) 
Goat serum 10% 
BSA 1% 
PBS 89% 
  
Cell lysis buffer 
Tris-HCl (pH7.2) 80mM 
NaCl 150mM 
NP-40 0.2% (v/v) 
Glycerol 10% (v/v) 
NaF 50mM 
Na3VO4 1mM 
β-glycerophosphate 1mM 
Complete Protease inhibitor cocktail 1% (v/v) 
  
10% Denaturing urea PAGE gel 
40% Acrylamide (29:1) 12.5ml 
Urea 24g 
30% APS 166ul 
TEMED 20ul 
10x TBE 5ml 
ddH2O make up to 
50ml 
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DMEM (complete media) 
DMEM (4.5g/l glucosse, +L-glutamine,+pyruvate) 445ml 
FCS 50ml 
1% penicillin/streptomycin  5ml 
  
  
DNA IP buffer DW 
Tris-HCl 1M pH8.0 20mM 
NaCl 2M 
EGTA 0.5mM 
NP-40 0.03% 
  
DNA IP Buffer B 
HEPES (pH 7.9) 20mM 
BSA 0.05mg/ml 
glycogen 0.05ml/ml 
KCl 300mM 
NP-40 0.02% 
DTT 2.5mM 
Polyvinylpyrrolidone 5mg/ml 
  
DNA IP Buffer G 
Tris (pH 7) 10mM 
MgCl2 1.5mM 
NaCl 100mM 
EGTA 0.2mM 
Potassium glutamate 10mM 
NP-40 0.02% 
DTT 10mM 
PMSF 0.2mM 
  
DNA oxidation buffer 
H2O2 3mM 
CuCl2 100uM 
Sodium ascorbate 100uM 
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PBS 50mM 
  
Fixing solution (Immunofluorescence-UFB) 
TritonX-100 (10%) 0.5ml 
PIPES 1M 0.5ml 
EGTA (0.5M) 0.5ml 
MgCl2 (0.5M) 50ul 
Formaldehyde (37.8%) 2.7ml 
ddH2O make up to 
25ml 
  
GST protein purification buffer 
Tris (pH8) 50mM 
NaCl 200mM 
Triton-X 0.10% 
β-mercaptoethanol 5mM 
Glycerol 10% 
  
Hypotonic buffer 
NaCl 50mM 
FCS 1% (v/v) 
Glucose  0.45% (v/v) 
  
Kinase buffer 
HEPES (pH7.5)  10mM 
Glycerolphosphate 50mM 
NaCl 50mM 
MgCl2 10mM 
MnCl2 10mM 
ATP 5uM 
DTT 1mM 
  
Laemmli buffer 
Tris-HCl (pH6.8) 63mM 
SDS (w/v) 2% (w/v) 
Glycerol 10% (v/v) 
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Bromophenol blue 0.0025% 
(v/v) 
β-mercaptoethanol 2.5% (v/v) 
  
Nuclear/cytoplasmic fractionation buffer A 
HEPES (pH7.9) 10mM 
MgCl2 1.5mM 
KCl 10mM 
DTT 1mM 
NP-40 0.2% (v/v) 
  
Nuclear/cytoplasmic fractionation buffer C 
HEPES (pH7.9) 20mM 
NaCl 420mM 
MgCl2 1.5mM 
DTT 1mM 
EDTA 0.2mM 
Glycerol 25% (v/v) 
  
RPMI media (complete) 
RPMI-1640 media (0.3g/L L-glutamine, 0.001g/L folic acid, 2g/L 
sodium bicarbonate 
445ml 
FCS 50ml 
1% penicillin/streptomycin 5ml 
  
10x SDS-PAGE running buffer 
Tris 300g 
Glycine 1400g 
20%SDS (v/v) 250ml 
ddH2O make up to 
10L 
  
5% SDS Stacking gel 
30% Acrylamide (37.5:1) 1.7ml 
Tris (1M pH6.8) 1.25ml 
10% SDS (w/v) 100ul 
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10% Ammonium persulphate 100ul 
TEMED 10ul 
ddH2O make up to 
10ml 
  
6% SDS resolving gel 
30% Acrylamide (37.5:1) 4ml 
Tris (1M pH8.8) 5ml 
10% SDS (w/v) 200ul 
10% Ammonium persulphate 200ul 
TEMED 16ul 
ddH2O make up to 
20ml 
  
8% SDS resolving gel 
30% Acrylamide (37.5:1) 5.3ml 
Tris (1M pH8.8) 5ml 
10% SDS (w/v) 200ul 
10% Ammonium persulphate 200ul 
TEMED 12ul 
ddH2O make up to 
20ml 
  
Transfer buffer 
Tris 24mM 
Glycine 192mM 
Methanol (v/v) 20% 
SDS (v/v) 0.01% 
  
50x TAE buffer 
Acetic acid  57.1ml 
EDTA (0.5M) 100ml 
Tris base 242g 
ddH2O make up to 
1L 
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20x TBST  
NaCl (5M) 3L 
Tris (1M, pH 7.5) 2L 
Tween-20 200ml 
ddH2O up to 10L 
  
10x TBE  
Tris base 108g 
Boric acd 55g 
EDTA 7.5g 
ddH2O make up to 
1L 
  
Ubiquitin wash buffer A 
NaH2PO4 0.1M 
Na2HPO4 (pH8) 0.1M 
Imidazole 10mM 
Tris (pH8) 0.01M 
Guanidium chloride (6M) 400ml 
 
2.3 Oligonucleotides 
Sequencing primers   
Gene Use Sequence  
atmin forward TCAGCATCTTCTCCAGAGAG
ACAG 
Wildtype430bp 
 reverse CACATGTGTACAGCACATTCA
TTG 
floxed 515bp 
 delta CTCAGGGTACACATACTATG
CTTGC 
deleted 400bp 
Cre forward CGGTCGATGCAACGAGTGAT
GAGG 
Cre 600bp 
 reverse CCAGAGACGGAAATCCATCGCTCG 
nbs1 forward CAGGGCGACATGAAAGAAAA
C 
wildtype 320bp 
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 reverse AATACAGTGACTCCTGGAGG floxed 380bp 
 delta ATAAGACAGTCACCACTGCG delta 590bp 
LSL-
ROSA26-
YFP 
forward 
wiltype 
GGAGCGGGAGAAATGGATAT
G 
wildtype 600bp 
 forward 
mutant 
AAGACCGCGAAGAGTTTGTC mutant 320bp 
 reverse GGAGCGGGAGAAATGGATATG 
ogg1 forward 
neo 
CTGAATGAACTGCAGGACGA 
 reverse 
neo   
CTCTTCGTCCAGATCATCCT 
 forward 
wiltype 
ACTGCATCTGCTTAATGGCC 
 reverse 
wildtype 
CGAAGGTCAGCACTGAACAG 
QPCR  primers 
 
Gene Use Species Sequence 
Trim38 (Pair 1) QPCR F Human  ACGTATGCCAGGGCTACAAG 
Trim 38 (Pair 1) QPCR R Human 
TCAAGTTGCTTCAGTTTTGTC
AC 
Trim 38 (Pair 2) QPCR F Human 
TGAGAGGAAAACAGCCTACC
C 
Trim 38 (Pair 2) QPCR R Human CACCTGCACCTCTATGTGATG 
Huwe1 (Pair 1) QPCR F Human AGAGAGCGGCTGACAGAGG 
Huwe1 (Pair 1) QPCR R Human 
CACTAACCCACTCAGGTCAG
G 
Huwe1 (Pair 2) QPCR F Human TGAATGCTCTGGCTGCATAC 
Huwe1 (Pair 2) QPCR R Human CCCCAGGTTTAGGATCAGATT 
Trim67 (Pair 1) QPCR F Human GCCAAGCACGAGGTGAAG 
Trim67 (Pair 1) QPCR R Human 
CCATTTAAGGCCTGAGATAGT
TGT 
Trim67 (Pair 2) QPCR F Human AGGCAAAGGAAGCAAAGGA 
Trim67 (Pair 2) QPCR R Human CGTAGTCCAGTCCGTTTTCC 
SH3RF2 (Pair 1) QPCR F Human AGACCTGTCGTTTGTGAAAGG 
SH3RF2 (Pair 1) QPCR R Human 
GTTCAAGTTCTGCCTCACTCT
G 
SH3RF2 (Pair 2) QPCR F Human 
CATCAGATGTTCCCTACCAAG
C 
SH3RF2 (Pair 2) QPCR R Human CAGTGGCAGCCAGGAGAG 
ATMIN (set4) QPCR F Human TGGCCTGGAATACGATGGA 
ATMIN (set4) QPCR R Human GACATGCGCAGAGCTGCA 
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ATMIN (set5) QPCR F Human CAAGCACTCGGTGTCAATGG 
ATMIN (set5) QPCR R Human CACAGTGCGCAGGCATCT 
UBR5 Pair1 QPCR F Mouse CACCGAGGACCAGCTCAA 
UBR5 Pair2 QPCR R Mouse 
GTAGCCTGCTCCAGTACATTC
A 
UBR5 pair 2 QPCR F Mouse GCCCAGAAGATTGCCAAAG 
UBR5 pair 2 QPCR R Mouse GGCAAACCATTCCCATGA 
UBR5 pair 3 QPCR F Mouse 
TTCACTTCTTTCAATGATGAGT
CAG 
UBR5 pair 3 QPCR R Mouse ATTGACCAGAACCACCGTTT 
OGG1 pair1 QPCR F Mouse TTATCATGGCTTCCCAAACC 
OGG1 pair1 QPCR R Mouse GGCCCAACTTCCTCAGGT 
OGG1 pair2 QPCR F Mouse TTATGAAGAGGCCCACAAGG 
OGG1 pair2 QPCR R Mouse TCAAGGGCCATTAAGCAGAT 
OGG1 pair1 QPCR Human CTGCATCCTGCCTGGAGT 
OGG1 pair1 QPCR Human CCTGGGGCTTGTCTAGGG 
OGG1 pair2 QPCR Human CCAACAAGGAACTGGGAAAC 
OGG1 pair2 QPCR Human AGGTCGGCACTGAACAGC 
Nbs1 (Pair1) QPCR F Human ACCGATGTGGAAACTGCTG 
Nbs1 (Pair1) QPCR R Human CAACGCCAGTCAAAAGTCTG 
Nbs1 (Pair2) QPCR F Human 
GCATAAATGATGATTATGGTC
AACTAA 
Nbs1 (Pair2) QPCR R Human CCTCCAATGATGTGTGGAAGT 
NBs1 (pair1) QPCR F Mouse 
ACCACATACGTAGCTGACACA
GA 
NBs1(pair 1) QPCR R Mouse 
GGTCTTTCACTCAAAGGCATA
CA 
NBs1 (Pair 2) QPCR F Mouse 
TGAATTTCTCAAAGCAGTTGA
ATC 
NBS1 (Pair2) QPCR R Mouse TCATCAATGGGTGGGTAAAAA 
RNA Pol II (Pair 
1)  QPCR F Mouse AATCCGCATCATGAACAGTG 
RNA Pol II (Pair 
1)  QPCR R Mouse 
TCATCCATTTTATCCACCACC
T 
RNA Pol II (Pair 
2) QPCR F Mouse 
CAGTGATGAAAACAAGATGCA
AG 
RNA Pol II (Pair 
2)  QPCR R Mouse ATCGCAGGAAGACATCATCA 
NUDT1 QPCR F Human GAAGGAGAGACCATCGAGGA 
NUDT1 QPCR R Human CACTGTCAGACCGCTCTCC 
GSTM5 QPCR F Human AGGACTTCATCTCCCGCTTT 
GSTM5 QPCR R Human 
AAACAAAAGACCTCGGAGGA
A 
MutYH QPCR F Human ATGACACCGCTCGTCTCC 
MutYH QPCR R Human GCTTCTGCCTCCCTTCCT 
NUDT1 QPCR F Mouse GACGCCCACAGAAAGTGAAG 
NUDT1 QPCR R Mouse 
GGGAACCAGTAGCTGTCATC
C 
GSTM5 QPCR F Mouse GCTATGAGGAGAAACGGTAC
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ATC 
GSTM5 QPCR R Mouse CCATGAGGTAGGGCAGGTT 
MutYH QPCR F Mouse AGAACACGTGCCCTTAGCA 
MutYH QPCR R Mouse 
AACTCCTCTCTCTTCTGCTTG
G 
ATM QPCR F Human 
TGATAGTAGTGTTAGTGATGC
AAACG 
ATM QPCR R Human 
CAGCTAAAGGATTAATGGCAC
CT 
UBR5 Pair1 QPCR F Human GGATGATACAGCCAGCGAAT 
UBR5 Pair1 QPCR R Human TCGGCATCAAGGAGAGACAT 
UBR5 pair 2 QPCR F Human GCATTTGCAATTGACCTGTG 
UBR5 pair 2 QPCR R Human 
CCATTAGGAATGAGTTCAACC
TG 
ATM pair 1 QPCR F Mouse 
TCTCAAGCAGATGATCAAGAA
GTT 
ATM pair 1 QPCR R Mouse 
TGACTTTGAGACCTGCATCAT
T 
ATM pair 2 QPCR F Mouse TGCAGTCATCATGCAGACCTA 
ATM pair 2 QPCR R Mouse TCTCTGCTGTTGCCATCGT 
 
 
DNA IP oligoes (Tsuji et al., 2008) 
DNA oligo 1 AGCTACCATGCCTGCACGAATTCGTATCAGCGTAATCA
TGGTCATAGCT 
DNA oligo 2 GCATCCTCACCATCAACTCACAGCCCAACATCAACGGG
AAGCCGTCCTCCGACCCCATCGTGGGCTGGGGCAGCT
ACCATGCCTGCACGAATTCGTATCAGCGTAATCATGGT
CATAGCT 
DNA oligo 3 AGCTATGACCATGATTACGCTGATACGAATTCGTGCAG
GCATGGTAGCT 
DNA oligo 6 TTCCCGTTGATGTTGGGCTGTGAGTTGATGGTGAGGAT
GC 
 
siRNA sequences 
 Gene Catalogue number Sequence 
mouse UBR5 D-048858-01 CGAGAAGACUGAAAUACUA 
 
D-048858-02 GGGUGUACAUUCUUUAAUA 
 
D-048858-03 GAAGCUCAAUUACGUUAUG 
 
D-048858-04 AGACAAAUCUCGGACUUGA 
Human UBR5 J-007189-09 GGUCGAAGAUGUGCUACUA 
(ONTARGET J-007189-08 GAUCAAUCCUAACUGAAUU 
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PLUS) 
 
J-007189-07 GAUUGUAGGUUACUUAGAA 
 
J-007189-06 GCACUUAUAUACUGGAUUA 
siGenome D-007189-18 GGUAAAUGGCUGCGGUGAA 
 
D-007189-19 AGUUUGAGAUUACGGGAAA 
 
D-007189-03 CAACUUAGAUCUCCUGAAA 
 
D-007189-02 GGACAGGAAUCUCCCAUUA 
Human ATMIN D-020304-04 GUAAGUGCAGCAAUUCGUA 
siGenome D-020304-03 UUAAUGCCCUUGUCAGUAG 
 
D-020304-02 GAGAUAUCCUCAGAAGUUG 
 
D-020304-01 GCAGAGACAGUAACUCAUA 
Human OGG1 D-005147-01 GAUCAAGUAUGGACACUGA 
siGenome D-005147-04 AGAGGUGGCUCAGAAAUUC 
 
D-005147-23 GGUUCUGCCUUCUGGACAA 
 
D-005147-24 GGAGCAAAGUCCUGCACAC 
Human MUTYH D-012806-03 UAUAUGGGCUGGCCUUGGA 
siGenome D-012806-05 GAUCAACUACUAUACCGGA 
 
D-012806-18 CAGAGCAGCUUCAGCGCAA 
 
D-012806-19 CCAUCUAUUCAGAGACGUA 
Human NUDT1 D-005218-01 GACGACAGCUACUGGUUUC 
siGenome D-005218-02 GAAAUUCCACGGGUACUUC 
 
D-005218-03 CGACGACAGCUACUGGUUU 
 
D-005218-04 AGACGUGGCUGCUGAACAG 
Human GSTM5 D-011178-01 GAAAGUCAGCUACAUGGAA 
siGenome D-011178-02 UGACAUGAAGCGUAUAUUU 
 
D-011178-03 UGGAUUUCCUUGCCUAUGA 
 
D-011178-04 ACAUGAAGCGUAUAUUUGA 
Human RNF168 J-007152-08 GAAAUUCUCUCGUCAACGU 
ONTARGETplus J-007152-07 AGAAGAACAGGACAGGUUA 
 
J-007152-06 CAAAGUAAGGCCUGGUAAA 
 
J-007152-05 GACACUUUCUCCACAGAUA 
Mouse GSTM5 D-049356-04 CCGCAUGCUUCUGGAGUUU 
siGenome D-049356-03 GUUCGCCUCUGCUACAAUU 
 
D-049356-02 GCUAUGAGGAGAAACGGUA 
 
D-049356-01 GUAACGCCAUCCUGAGAUA 
Mouse MUTYH D-048516-04 ACAUCAAACUGACGUAUCA 
siGENOME  D-048516-03 CAUAUCAUCUCUUCAGCGA 
 
D-048516-02 GAACUUAGCCCAGCAGCUC 
 
D-048516-01 CCACAGUGAUCGACUAUUA 
Mouse NUDT1 D-042056-04 GAAAGUGGUCUGAGCGUGG 
siGENOME  D-042056-03 UGCGAGAGGUGGACUCAUU 
 
D-042056-02 GAAGAAAUGCGCCCUCAGU 
 
D-042056-01 CCACAUCUCGUUUGAAUUU 
Human Chk1 J-003255-10 CAAGAUGUGUGGUACUUUA 
ONTARGETplus J-003255-11 GAGAAGGCAAUAUCCAAUA 
 
J-003255-12 CCACAUGUCCUGAUCAUAU 
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J-003255-13 GAAGUUGGGCUAUCAAUGG 
Human NBS1 J-009641-06 CCAACUAAAUUGCCAAGUA 
ONTARGETplus J-009641-07 GCAGAUACAUGGGAUUUGA 
 
J-009641-08 GAAUAGAAACGUCUUGUUC 
 
J-009641-09 AACAAUAUGUGCACUCAUU 
Human RAD18 D-004591-04 GCAGUUUGCUUUAGAGUCA 
siGenome D-004591-03 GAUAAUAUGACCUCAGUAA 
 
D-004591-02 GCAGGUUAAUGGAUAAUUU 
 
D-004591-01 CAUAUUAGAUGAACUGGUA 
MOUSE OGG1 D-048121-01 CAACAUUGCUCGCAUUACU 
siGenome D-048121-02 UGGAAACCCUACACAAGUA 
 
D-048121-03 GACUACGGCUGGCAUCCUA 
 
D-048121-04 CUUAAUGGCCCUUGACAAA 
Human SH3MD2 J-007037-05 GAUCGUAGGUUCUCGAAAU 
ONTARGETplus J-007037-06 AAAGGGACAUCCAUGCAUA 
 
J-007037-07 AAAGGCACAUUACAACGUA 
 
J-007037-08 GGAUGAAUCAGCCUUGUUG 
Human TRIM38 J006929-05 GGCCCUAUUUCCAGGUUUA 
ONTARGETplus J006929-06 CGGAUGGGAUUUAGGAGUU 
 
J006929-07 CAGCAAUGCGAAUAACUAA 
 
J006929-08 GUGUAUAACAGACUUCUUU 
Human HUWE1 J-007185-07 GCUUUGGGCUGGCCUAAUA 
ONTARGETplus J-007185-08 GCAGUUGGCGGCUUUCUUA 
 
J-007185-09 GAGCCCAGAUGACUAAGUA 
 
J-007185-10 UAACAUCAAUUGUCCACUU 
Human Trim67 J-032288-05 GCACAAGGCACAACUAUCU 
ONTARGETplus J-032288-06 GGUAAGGAGACUUUGUGUA 
 
J-032288-07 UAACCUGGCUUUAAUAGUG 
 
J-032288-08 GAAGGUGGCGUGUGCAAGG 
   
Antibodies    
Primary 
antibody 
Species Usage Supplier 
53BP1 rabbit IF 1:400 IHC 
1:200 
Santa cruz 
Actin rabbit WB1:1000 Sigma 
ATM mouse WB 1:500 IP 
1ug 
Santa cruz 
ATR goat WB 1:1000 IF 
1:400 
Santa cruz 
pS1981-ATM mouse WB 1:1000 Epitomics 
pS1981-ATM mouse WB 1:1000 IF Cell signalling 
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1:400 
pS1981-ATM sheep WB1:1000 Rockland 
ATMIN/ASCIZ rabbit WB1:1000 Chemicon 
pS317-Chk1 rabbit WB 1:1000 Cell signalling 
Chk1 mouse WB 1:1000 Cell signalling 
UBR5 rabbit WB 1:1000 Bethyl labs 
FANCD2 rabbit IF:1:400 Novus 
Flag M2 mouse WB 1:5000 Sigma 
GFP mouse WB 1:1000 Sigma 
pS139-H2AX mouse WB 1:1000 
IF1:400 
Upstate 
pS139-H2AX rabbit WB 1:1000 
IF1:401 
Upstate 
HA rabbit WB 1:1000 Sigma 
Kap1 rabbit WB 1:1000 Bethyl labs 
Kap1 rabbit WB 1:1000 Abcam 
pS824-Kap1 rabbit WB 1:1000 Bethyl labs 
MCM6 goat IHC 1:200 Santa cruz 
Myc rabbit WB 1:1000 Sigma 
NBS1 rabbit WB 1:1000 IF 
1:400 
Novus 
p53 mouse WB 1:1000 Santa cruz 
pS15-p53 mouse WB 1:1000 Cell signalling 
PICH mouse IF:1:400 Millipore 
RAD18 rabbit WB 1:1000 
IF1:400 
Epitomics 
SMC1 rabbit WB 1:1000 Abcam 
pS957-SMC1 mouse WB 1:1000 Millipore 
pS966-SMC1 rabbit WB 1:1000 IF 
1:400 
Bethyl labs 
tubulin mouse WB 1:1000 Abcam 
WRNIP1 goat WB 1:1000 IF 
1:400 
Santa cruz 
Secondary 
antibody 
Species Usage Supplier 
Alexa fluor 488 donkey IF 1:400 Life technologies 
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anti-
mouse 
 donkey 
anti-rabbit 
IF 1:401 Life technologies 
 donkey 
anti-goat 
IF 1:402 Life technologies 
 Goat anti-
mouse 
IF 1:403 Life technologies 
 Goat anti-
rabbit 
IF 1:404 Life technologies 
Alexa fluor 546 donkey 
anti-
mouse 
IF 1:405 Life technologies 
 donkey 
anti-rabbit 
IF 1:406 Life technologies 
Alexa fluor 647 donkey 
anti-
mouse 
IF 1:407 Life technologies 
 donkey 
anti-rabbit 
IF 1:408 Life technologies 
 donkey 
anti-goat 
IF 1:409 Life technologies 
HRP-
conjugated anti-
mouse 
goat WB 1:5000 Jackson  
HRP-
conjugated anti-
rabbit 
mouse WB 1:5001 Jackson  
HRP-
conjugated anti-
goat 
mouse WB 1:5002 Jackson  
 
2.4 Plasmids 
The FlagATMIN construct was cloned into pCMVFlag2B using HindIII (N) and 
blunted XhoI (C) sites and XhoI site was destroyed after ligation. Flag-ATMIN N-
terminus (1-354) and C-terminus (625-818) were cloned by PCR into 
pCMVFlag2B using StuI and EcoRI respectively. The Flag-ATMIN wildtype and 
K238R mutant was cloned by PCR into pCMVFlag2B and pMSCV-IRES GFP. 
The MycNBS1 construct was a kind gift from Simon Boulton. The GFP-ATM 
contruct (in pSG5plus) vector was a kind gift from Kum Kum Khanna. The GST-
p53 contruct was a kind gift from Tanya Paull. The Flag-UBR5 expression 
construct (in pSG5 vector) was a kind gift from Colin Watts. The Flag-UBR5 
C2768A mutant was cloned by PCR mutagenesis in the same vector.  
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2.5 Methods 
2.5.1 Molecular biology 
2.5.1.1 DNA preparation and sequencing  
For DNA amplification, DH5𝝰 bacteria were used for transformation. 50ng of DNA 
was added to an aliquot of competent bacteria and incubated on ice for 30 
minutes. The bacteria were heat-shocked at 42°C for 30 seconds and placed on 
ice for another two minutes. 1ml of pre-warmed LB media was added and the 
bacteria was incubated at 37°C for one hour, prior to plating or inoculation in 
antibiotic selection media. From an overnight bacteria culture, the cell pellet was 
obtained by centrifugation and DNA extracted using a Plasmid Maxi Kit (Qiagen).  
For the amplication of large plasmids such as GFP-ATM and FlagUBR5, SURE-2 
competent cells (Agilent) were used and bacteria culture was grown at 30°C for 
two days with gentle agitation.  
 
DNA sequencing was performed by the Equipment Park facility at LRI.  
Sequencing reaction: 
BigDye Terminator 
reaction mix 
8ul 
Sequencing primer (10uM) 0.32ul 
DNA 300ng 
DMSO 1ul 
ddH2O make up to 20ul 
Sequencing PCR: 
Step  Temperature (°C ) Time 
1 95 1min 
2 95 10sec 
3 55 5sec 
4 60 4 minutes 
5 Go to step 2 for 24 cycles 
6 4 end 
Sequencing reaction was purified using the DyeEx 2.0 spin kit (Qiagen) prior to 
sequencing. 
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2.5.1.2 Extraction of genomic DNA and genotyping 
To extract genomic DNA for genotyping, mouse ear snips were incubated in 95ul 
of DirectPCR Lysis Reagent (Viagen) and 5ul of Proteinase K at 56°C overnight 
with shaking. The following day samples were heated at 85°C for 45 minutes to 
inactivate proteinase K. Samples were allowed to cool briefly and centrifuged at 
5000rpm for five minutes. The supernatant was used for genotyping reactions. 
 
Genotyping reaction (Qiagen): 
Coralload PCR 
buffer (10x) 
2ul 
Solution Q 4ul 
dNTPs (25mM) 0.2ul 
Primer (100uM) 0.2ul each 
Taq-Polymerase 0.2ul 
DNA 2ul 
ddH2O make up to 
20ul 
 
Genotyping PCR reaction cycle: 
Step  Temperature 
(°C ) 
Time 
1 94 3min 
2 94 30sec 
3 60 45sec 
4 72 45sec 
5 Go to step 2 for 30 cycles 
6 72 10min 
7 4  
 
PCR products were resolved on a an agarose gel (2-3%) dissolved in 1xTAE with 
1: 10000 ethidium bromide. Electrophoresis was run at 120V for one hour with 
100bp DNA ladder used as a reference of band size. Resolved DNA bands were 
visualised by UV illumination using a UV transluminator.  
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2.5.1.3 RNA isolation and quantitative PCR 
The RNeasy mini kit (Qiagen) was used for extraction of total RNA from cells. Cell 
pellets were passed through a 19-gauge needle at least five times for 
homogenisation. The RNase-free DNase kit (Qiagen) was used for on-column 
DNA digest. Extracted RNA concentration and quality were assessed using a 
Nanodrop Spectrophotometer.  
 
750ng of RNA was used for cDNA synthesis using Superscript III First-Strand 
cDNA synthesis kit (Life Technologies). Random hexamers were used for cDNA 
synthesis and a negative control without reverse transcriptase was included in 
parallel to check for presence of genomic DNA.  
 
For QPCR, cDNA was first diluted in ddH20 (1:5). Each reaction was performed in 
triplicate in a 96 well plate. 
QPCR reaction mix: 
Primers (10uM) 0.5ul each 
Platinum SYBR 
green 
12.5ul 
DNA 2ul 
ddH2O 9.5ul 
 
SYBR binding to newly synthesised double-stranded DNA emits fluorescence, 
measured using a real-time thermal cycler (Applied Biosystems).  The 
fluorescence over background (CT) was used to measure relative amount of cDNA 
compared to a control gene such as actin. In order to eliminate unspecific PCR 
products, primer dimer formation and contamination, a dissociation curve was 
also performed as well as a ‘no DNA’ control reaction for each primer set. 
Average of three Ct values for each sample that differ by not more than 0.2 was 
used to calculate relative mRNA levels. 
      Relative mRNA levels = 2-(sample CT-control CT) 
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2.5.2 Biochemistry 
2.5.2.1 Cell lysis for protein extraction 
Cells were washed once with cold PBS and gently scraped into 3ml of cold PBS 
and centrifuged. After aspirating the PBS, the cell pellet was resuspended by 
pipetting in cold cell lysis buffer and incubated for 20 minutes on ice. The 
suspension was then sonicated with 4x 8 second pulses at 25% power in a 
sonicator. The whole cell lysate (WCL) was centrifuged at 4°C for ten minutes at 
13K rpm. The supernatant was removed and placed into a new tube for western 
blot analysis.  
2.5.2.2 Determination of protein concentration using Bradford assay 
Bradford reagent (Bio-rad) was diluted in ddH2O (1:5). In order to prepare a 
standard curve, 1, 2, 4 and 8ul of 1mg/ml BSA were each diluted into 1ml of 
diluted Bradford reagent, mixed thoroughly by pipetting and absorption measured 
at 595nm in a spectrophotometer. The absorption value was plotted against 
protein concentration to obtain a standard curve. Similarly, 1ul of WCL was mixed 
with 1ml of Bradford reagent and the absorption value used to determine the 
protein concentration based on the BSA standard curve. Equal amounts of WCL 
was calculated and used for western blotting by SDS-PAGE. 
2.5.2.3 Western blotting  
Western blots were performed using standard procedures. Whole cell lysates 
were separated by SDS–PAGE, and subsequently transferred onto nitrocellulose 
membranes by wet transfer. After transfer, the membrane was stained with 
Ponceau S staining and then blocked in 5% milk for 1 hour prior to incubation with 
primary antibodies overnight. 
2.5.2.4 In vivo ubiquitylation 
293T cells in 100-mm plates were transfected with His-ubiquitin, Flag-tagged 
ATMIN and Flag-tagged UBR5 using a calcium phosphate protocol (Profection). 
After 48 hours, cells were harvested and 1/10th volume of the lysate was used for 
standard western blotting to equalise the amount of protein used for pulldowns 
(since ATMIN and UBR5 appear to stabilise each other when overexpressed) and 
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the rest used for pulldown with Ni-NTA beads (Qiagen). For the IP, cells were 
lysed in ubiquitin wash buffer A and incubated with Ni-NTA beads at 4°C 
overnight. Beads were washed three times with buffer A, twice with buffer B (1:5 
dilution of buffer A in 25mM Tris-HCl, pH 6.8, 20mM imidazole) and twice in buffer 
C (25mM Tris-HCl, pH 6.8, 20mM imidazole). The IP mixture was boiled in 2X 
SDS loading buffer in the presence of 200mM imidazole). The eluted proteins 
were analysed by western blot for the ATMIN ubiquitination by probing with Flag-
HRP (Sigma). 
2.5.2.5 Nuclear/cytoplasmic fractionation 
Cells were harvested by trypsin, washed once with cold PBS and spun down by 
centrifugation. Cell pellet was resuspended gently in fractionation buffer A 
supplemented with protease inhibitors by pipetting 8 times and left on ice for 5 
minutes. Cells were then spun at 13K rpm for 10 seconds and the supernatant 
(cytoplasmic extract) was removed and transferred into a fresh tube. The nuclear 
pellet was washed at least 3 times with fractionation buffer and resuspended in 
fractionation buffer C supplemented with protease inhibitors. The nuclear pellet is 
sonicated for 15 seconds at 25% max power and spun at 13K rpm for 10 minutes. 
Finally the supernatant, which contains the nuclear extract is transferred into a 
new tube.   
2.5.2.6 Immunoprecipitation 
For ATM immunoprecipitation, 293T cells were transfected and irradiated prior to 
lysis for 30 min at 4°C in 500 µl of ATM IP buffer and sonication for 4x 8seconds 
at 25% power. After centrifugation, supernatants were pre-cleared using IgG 
beads and incubated overnight at 4°C with ATM antibody prior to binding of 
Protein G-Sepharose beads for 3-4 hours.   
2.5.2.7 In vitro kinase assay  
ATM immunoprecipitates were washed thrice with ATM IP buffer, once with ATM 
wash buffer, and twice with kinase buffer. Kinase reactions were initiated by 
resuspending washed beads in 30 µl of kinase buffer containing 5uM ATP and 1 
µg GSTp53 and incubated for 30 min at 30°C. The mixture was subsequently 
boiled in Laemmli buffer and analysed by SDS-PAGE. 
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2.5.2.8 Mass spectrometry  
For the identification of ATMIN ubiquitylation site in Chapter 2, Flag-ATMIN was 
pulled down after an in vivo ubiquitination experiment using FlagM2 beads and 
separated by SDS-PAGE. Gel slices were isolated and subjected to automated in-
gel trypsin digestion using a Perkin Elmer Janus Workstation. Extracted peptides 
were acidified to 0.1% TFA and analysed using a LC-MS system consisting of a 
Ultimate 3000 RSLC coupled to a LTQ-Orbitrap Velos (both Thermo Fisher 
Scientific). Peak lists were extracted from the raw data using Mascot distiller and 
searched with Mascot v.2.4.1 (Matrix Science). Ubiquitinated peptides were 
identified by searching for a variable mass addition of 114.042927Da on non- C-
terminal lysines, corresponding to the glycine-glycine remnant remaining after 
trypsin digestion of an ubiquitinated protein. 
2.5.3 Cell biology 
2.5.3.1 Cell Culture, Transfection and Infection 
Primary Murine Embryonic Fibroblasts (MEF) cells were derived from E12.5 
embryos. 293 and primary MEF cells were cultured in DMEM supplemented with 
10% FCS, at 37 °C with 5% CO2 and 3% O2. For in vitro deletion of ATMIN, 
ATMINF/F ; cre-ERT MEFs was incubated with DMEM supplemented with 25nM of 
4-hydroxytamoxifen for consecutive 7 days, with daily replacement media. 
 
HEK293T, 293A, HeLa Ohio, HCT116 cell lines were cultured in DMEM 
supplemented with 10% FCS, at 37 °C with 5% CO2 and 20% O2. ATM wildtype 
and null lymphoblastoid cell lines were cultured in RPMI media supplemented with 
10% FCS, at 37 °C with 5% CO2 and 20% O2. 
2.5.3.2 Cell transfection 
Transient plasmid transfections of 293 cells were performed using Lipofectamine 
2000 (Invitrogen) according to manufacturer’s protocol. Namely, 1 million cells 
were seeded onto 10cm dishes at sub-confluent density 24 hours prior to 
transfection. DNA and Lipofectamine 2000 were separately diluted in pre-warmed 
Opti-MEM (500ul each) and then mixed gently and allowed to incubate at room 
temperature for 30 minutes. Cells were washed once with pre-warmed PBS prior 
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to addition of transfection mixture and Opti-MEM to a total volume of 5ml. After 4-
6 hours, the Opti-MEM was aspirated from the cells and replaced with pre-
warmed DMEM and cells allowed at least 24 hours before harvest. siRNA 
SMARTpools and RISC-free control siRNA were obtained from Thermofisher. 
siRNA transfection of 293 cells and HeLa Ohio were performed using Dharmafect 
1 (Invitrogen) and Lullaby reagent (Ozbiosciences) respectively, using the same 
method as Lipofectamine 2000 transfection. siRNA transfection of immortalised 
MEFs was done using Amaxa nucleofactor kit (Lonza). Namely, MEFs were 
trypsinised and mixed with an appropriate amount of siRNA and nucleofactor 
reagent and placed into an amaxa cuvette. Electroporation was done with the 
appropriate programme using an amaxa nucleofactor and MEFs were 
immediately placed into pre-warmed media. Cells were transfected with siRNA for 
72 hours prior to harvest. For FlagUBR5 ubiquitination assays, 293 cells were 
transfected using the calcium phosphate method (Promega). Namely, the 
appropriate amount of DNA and 2M CaCl2 were diluted in HBSS separately. 
CaCl2-HBSS mixture was added dropwise to DNA-HBSS while agitating the tube 
to allow proper mixing. The transfection mixture was incubated at room 
temperature for 30 minutes prior to addition to cells. The cell medium was 
changed prior to transfection and again 24 hours after transfection. Cells were 
harvested 48 hours after transfection for analysis. 
2.5.3.3 Cell infection 
For Cre mediated deletion of floxed alleles (e.g. atminf/f), primary MEF cells were 
infected at passage two with Adeno-Cre-GFP virus (Gene Transfer Vector Core, 
Iowa University). Cells were passaged into one day before infection to achieve 
50% confluency. 10ul of Adeno-Cre-GFP or Adeno-GFP was added to the cells 
and the medium was replaced after 48 hours. Cells were then left for another 48 
hours before being used. Infection efficiency was estimated by quantifying the 
percentage of GFP expressing cells and the efficiency of recombination assessed 
by genotyping from the isolated DNA for the floxed and delta alleles. All infection 
steps were carried out in a Category II Containment Suite.  
 
For retroviral infection of primary or immortalized MEFs, phoenix cells were first 
transfected with the retroviral construct for viral packaging. Phoenix cells were 
seeded 24 hours beforehand and transfected with Lipofectamine 2000 as 
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mentioned above. On the same day, the MEFs were passaged to ensure sub-
confluent density. 24 hours post-transfection, the media was removed from the 
phoenix cells and passed through a 0.45um filter. Polybrene was supplemented at 
10ng/ml to the filtered media, which was then added to the MEFs. MEFs were 
incubated overnight with virus-containing media then allowed to recover for 3-4 
hours in fresh media, before another round of infection. The MEFs were infected 
for 3-4 days repeatedly and finally split into selection media or sorted for GFP 
expression by FACS.  
2.5.3.4 Cell treatments 
Irradiation:  
For cell culture experiments, IR was carried out using a Cs137 Gamma Irradiator 
at 2.1Gy/min. Cells and mice were irradiated at the indicated doses and harvested 
after 3 minutes or 2 hours respectively, unless otherwise stated. 
Osmotic shock: 
Cells were washed once with ddH2O and incubated with pre-warmed osmotic 
shock buffer for 60 minutes. 
H2O2: 
Cells were washed once with PBS and incubated treated with 250uM H2O2 
(Fisher scientific, BP2633-500) diluted in DMEM for 30 minutes, prepared fresh 
from a stock solution immediately prior to use.  
Neocarzinostatin: 
Cells were treated with Neocarzinostatin (Sigma, N9162) at diluted to 200ng/ml in 
DMEM for 20 minutes prior to harvest. 
Aphidicolin: 
Cells were treated with aphidicolin (Sigma, A4487) diluted to 2uM in DMEM for 18 
hours prior to harvest. HeLa lacO stable cells were treated with 0.2uM of 
aphidicolin for 18 hours prior to harvest. Control cells were mock treated with 
DMSO. 
Small-molecule inhibitors: 
Cells were treated with ATM inhibitor Ku-55933 (Calbiochem, 118500) at a final 
concentration of 10uM. DNA-PK inhibitor (Millipore, LY293646) was used a final 
concentration of 50uM. Caffeine was used at a final concentration of 3mM. All 
inhibitors were added one hour prior to other DNA damage treatments.  
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Cycloheximide: 
Cells were treated with a final concentration of 10ug/ml cycloheximide (Sigma, 
C4859) for the indicated times prior to harvest. 
Proteasome inhibitor: 
MG132 (Sigma, C2211) was diluted in media 1:1000 at a final concentration of 
10uM and added to cells for four hours prior to other treatments or harvest. 
2.5.3.5 FACS analysis - BrdU and sub-G1  
Cells were treated with 10uM BrdU (Sigma, B5002) diluted in DMEM for the 
indicated times and trypsinised and washed once with cold PBS. The cell pellet 
was fixed in cold 70% ethanol with gentle vortexing and left at 4°C for at least 4 
hours. The fixed cells were washed twice in PBS and resuspended in 2M HCl at 
room temperature for 30 minutes. The cell pellet was washed twice with PBS and 
incubated with 2ul BrdU antibody (Beckton Dickson) at 20 minutes in the dark. 
Cells were washed once with PBST and incubated with 50 µl secondary antibody 
(made up 1 in 10 in PBST) for 20 minutes at room temperature in the dark. After 
another PBS wash, cells were treat with 50 µl ribonuclease and 150µl propidium 
iodide at room temperature in the dark for at least 30 minutes prior to analysis by 
FACS on LSRII Flow Cytometer (BD) and the data was analysed using Flow Jo. 
For cell cycle and sub-G1 analysis, cells were treated with 20Gy IR and fixed after 
indicated times and washed twice with PBS by centrifugation. The cell pellet was 
treated with 50ul ribonuclease A (stock at 100ug/ml) and after washing, stained 
with 200ul of prodidium iodide (50ug/ml).  
2.5.3.6 Immunofluorescence 
Cells were adhered onto slides, treated as indicated and fixed with 4%PFA at 
room temperature for 10 minutes or ice-cold methanol-acetone (1:1) at -20°C for 
2 hours. For PFA fixation, cells were permeabilised with 0.5% Triton/PBS for 5 
minutes. Cells were then blocked with blocking buffer at room temperature for 1 
hour before addition of the indicated primary antibody diluted in blocking buffer 
overnight. Cells were then washed three times with PBS followed by the addition 
of secondary antibody in blocking buffer for 1 h at room temperature. Cells were 
washed with PBS and incubated with DAPI before mounting in DAKO. For 
immunofluorescence of suspension cells, cells were plated onto poly-L-lysine 
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coated coverslips for 1 hour prior to fixation with 4% PFA and 
immunofluorescence. 
2.5.3.7 Immunohistochemistry 
Mice were euthanised by cervical dislocation and small intestine was prepared for 
histology as described before 20. Sections were cut at 4 µm for H&E staining, 
53BP1 and MCM6 stainings. To quantify the 53BP1-positive cells per crypt, 100 
full crypts were scored.  
2.5.3.8 The G2 trap assay and clonogenic survival assay 
To assess G2/M checkpoint function, cells were irradiated For the G2/M 
checkpoint assay, cells were transfected with the indicated DNA constructs and 
irradiated after 24 hours. Nocodazole was added immediately after IR at 100nM 
and cells were fixed after 18 hours in cold 70% ethanol. Fixed cells were stained 
with phospho-Histone3 antibody and analysed using a BD Biosciences FACScan.  
For post-IR colony formation assay, MEFs were irradiated at the indicated doses, 
after which they were trypsinised cell numbers counted using a Vi-Cell XR cell 
counter (Beckman Coulter). By serial dilutions, cells were diluted to 250cells/ml 
and 1000cell/ml and 1ml of each was seeded onto 6cm plates in triplicates. After 
seven days, the cells were stained with crystal violet and the number of colonies 
on each plate was manually counted and scored as a fraction of unirradiated 
controls. 
2.5.3.9  β-galactosidase senescence assay 
Cellular senescence was measured using the Senescent cells histochemical 
staining kit (Sigma, CS0030). Cells were fixed with fixation buffer for 6 minutes at 
room temperature. After washing twice in PBS, the cells were incubated in a 
sealed environment in staining mixture at 37°C overnight. After staining, the cells 
were washed three times with PBS and analysed under a light microcope for cells 
that stain blue. 
2.5.3.10 Detection of reactive oxygen species using H2DCFDA 
H2DCFDA, a cell-permeable fluorescein, was used as a ROS indicator in cells. 
Upon oxidation within cells, the dye emits fluorescence around 530nm that can be 
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measured by FACS. The dye was reconstituted in DMSO immediately before use 
and added to the cells, which were trypsinised and resuspended in pre-warmed 
PBS, at a final concentration of 10uM for 30 minutes at 37°C in the dark. After 
incubation, cells were centrifuged and cell pellet washed once in PBS, and 
immediately analysed using a LSRII Flow Cytometer (BD). Unlabelled control 
sample and luperox treated sample were used a negative and positive controls 
respectively. 
2.5.4 Mouse studies  
The following transgenic mouse lines were used for this study: 
atmin∆/∆ Kanu et al., 2007 
atminf/f Kanu et al., 2010 
nbs1f/f Frappart et al., 2005 
Rosa26-LSL-YFP Srinivas et al., 2004 
Villin-CreERT el Marjou et al., 2004 
 
2.5.4.1 Tamoxifen injection 
For the results from Chapter 1, mice were injected intraperitoneally with three 
consecutive daily tamoxifen injections (5ul/g body weight of 20mg/ml stock, 
dissolved in peanut oil). Villin-CreERT deletion efficiency and genotyping of mice 
was determined using a PCR based assay using primers specific for the floxed 
exon 4, deleted exon 4 and WT atmin alleles; as well as for the floxed exon 6, 
deleted exon 6 and WT nbs1 alleles. For irradiation experiments, mice were 
subjected to whole-body exposure to gamma irradiation from a 137Cs source (1.7 
Gy/min) and were sacrificed at intervals after exposure as specified. Animals were 
maintained and bred in the LRI Biological Resources. All animal experiments were 
performed in accordance with UK Home Office and institutional guidelines. 
 
2.5.4.2 Generation of primary mouse embryonic fibroblasts 
For the isolation of primary MEFs, embryos were removed at E12.5 and 
transferred into cold sterile PBS. Under a dissecting microscope, the placenta, 
yolk sac, heat, liver and lungs were removed. The head and tail were removed for 
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subsequent genotyping. The remaining embryo was placed in a 6-well plate 
containing 4ml of pre-warmed DMEM and passed through a 18-gauge needle at 
least 10 times to dissociate the tissue.  
2.5.4.3 Extraction of intestinal tissue 
Mice were culled by cervical dislocation and the intestine was removed and 
placed into cold PBS. The colon and small intestine were flushed with cold PBS to 
remove waste and then cut into three sections. A small section was removed for 
protein extraction. The remaining intestine tissue was placed on a gut roller and 
cut open longitudinally on a piece of Whatman paper. The intestine tissue was 
fixed in 10% NBF (Neutral-buffer formalin) overnight and then transferred into 
70% ethanol. To extract epithelial cells from the intestine for protein extraction, 
intestinal tissue was incubated on ice in 30mM EDTA for several hours with 
vortexing. The remaining gut tissue was removed and epithelial cells were 
pelleted by centrifugation at 1500rpm. The cell pellet, which contains villi and crypt 
cells were used for western blot analysis.  
2.5.4.4 Histology 
Tissue embedding in paraffin and staining were performed by the Experimental 
Histopathology Service at LRI. Fixed tissue was serially dehydrated through 30 
minutes in 70% ethanol, 1 hour in 85% ethanol, 1 hour in 95% ethanol and finally 
1 hour in 100% ethanol. The dehydrated tissue was cleared in xylene three times 
at 40°C for one hour and immersed in paraffin wax and cooled for 30 minutes at 
4°C. 4um thick sections were cut by a microtome and mounted onto glass slides.  
2.5.4.5 Haematoxylin and eosin staining 
Haematoxylin is used to stain basophilic structures such as nucleic acids and 
ribosome while eosin is used to stain eosinophilic structures including proteins. 
Paraffin-embedded sections were dewaxed by incubation in xylene for three 
minutes. Sections were hydrated in decreasing ethanol concentration and stained 
in Harris’ haematoxylin for five minutes and then washed under running water for 
five minutes, followed by a differentiation step for five seconds in 1% HCl-70% 
ethanol. Sections were then stained in 1% eosin Y for five minutes and washed 
again under running water for five minutes. Finally, sections were dehydrated in 
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increasing ethanol concentration, prior to clearing in xylene and mounting on 
slides using DAKO.  
2.5.4.6 Immunohistochemistry  
Paraffin embedded sections were first cleared by immersing in xylene, then 
hydrated by an decreasing ethanol concentration to finally in water. For antigen 
retrieval, sections were incubated in pre-heated citrate buffer and heated in a 
microwave for another 10 minutes. After cooling to room temperature, sections 
were incubated in 1.6% H2O2/PBS for ten minutes and washed three times with 
PBS. After blocking with blocking buffer for one hour, sections were incubated 
with primary antibody diluted in blocking buffer overnight at 4°C. The next day, 
sections were washed three times with PBS and incubated with biotin-tagged 
secondary antibodies diluted in blocking buffer for one hour at room temperature. 
After another three washes with PBS, sections were incubated in 
diaminibenzidine/H2O2 (DAB solution, Biogenex) for three to five minutes. The 
staining reaction was terminated by washing the sections in ddH2O. Sections 
were counter stained with Mayer’s haematoxylin for five minutes. The sections 
were then dehydrated by washing twice in 70% ethanol and twice in 100% ethanol, 
and cleared with two three-minute immersions in xylene prior to mounting in DPX 
mounting medium. 
 
2.5.5 Statistics 
Statistical evaluation was performed using the Student’s two-tailed t test. Data is 
presented as mean ± s.e.m. and  p≤0.05 was considered statistically significant. 
 
2.5.6 Genome screen 
Library and cells preparation: The Dharmacon human cDNA library was 
aliquoted into 96-well plates, in triplicates, using an automated robot to achieve a 
final siRNA concentration of 37.5nM per well. A total of 801 plates were used for 
the primary screen. HeLa Ohio cells were expanded into 50 x 175cm2 Flasks and 
incubated at 37ºC, 10% CO2 for three days to let the cells reach 80-90% 
confluency.  
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Cell transfection: Library plates were allowed to thaw at room temperature for 30 
minutes and centrifuged for one minute. Control siRNAs were diluted and pipetted 
into the first two columns of each plate using a automatic multichannel pipette. 
10ul of lullaby transfection reagent diluted (0.2ul in 10ul) in optimem were added 
to each well of the assay plates using WellMate. Plates are gently tapped to mix 
the reagents and incubated at room temperature for 20 minutes. Meanwhile, cells 
were trypsinised and diluted to 5 x104 cells/ml in DMEM. 80ul was added to each 
well using WellMate to achieve a final concentration of 4x103 cells/well. Cells were 
incubated with the transfection mixture at 37°C, 10% CO2 for 3 days. Transfection 
was carried out in batches of 200 plates. 
 
Treatment with Aphidicolin: After 48 hours of transfection, the culture media 
was aspirated using a plate washer and 100ul/well of 2uM aphidicolin was added 
using WellMate. Cells were incubated at 37°C, 10% CO2  overnight. 
 
Cell fixation and staining: The culture media was aspirated using a plate washer 
and 100ul/well of cold methanol was added using WellMate. Plates were sealed 
and stored at -20°C. Prior to staining, the plates were thawed briefly at room 
temperature and washed three times in PBS using a plate washer. 50ul/well of 
blocking buffer was added using WellMate and plates were incubated at room 
temperature for 30 minutes. Blocking buffer was then aspirated and 30ul/well of 
primary antibody solution (diluted 1:400 in blocking buffer) was added using 
WellMate and left to incubate at room temperature for two hours. After three 
washes of PBS, 30ul/well of secondary antibody diluted (1:400 in blocking buffer) 
was added using WellMate and left at room temperature in the dark for a further 
two hours. After another three washes of PBS, 40ul/well of DAPI solution diluted 
(1:10000) in PBS was added and left to incubate in the dark for one hour, prior to 
a final PBS wash and plates were added with 30ul of PBS, sealed and stored at 
4 °C prior to analysis. 
 
Analysis by Cellomics Arrayscan High-content Analysis reader: At least 15 
images were acquired in each of the three channels: DAPI, pATM (Alexa-
fluor488), 53BP1 (Alexa-fluor647). A threshold was established from previous 
optimisation to determine the range of detection of foci. Average number of foci 
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was primarily used as the perimeter in hits selection, and average foci intensity 
and total foci area were also used as control criteria. The z-score for the primary 
screen was calculated using CellHTS2 software. The score for each well is 
normalised as:  normalised well score = (raw well data value - median of sample 
wells on plate) / median absolute deviation of sample wells on plate. The final z-
score from the three replicates was a median of the three z-scores from the 
triplications. The median of plate samples was used because within the primary 
screen, the assumption is that the majority of the siRNAs will not have an effect 
and therefore can act as a background reference. For the secondary and 
deconvolution screens, due to the preselected hits, it cannot be assumed that the 
majority of siRNAs will not have an effect. Thus a standard percent of control 
calculation was used for both of these screens, normalised to a negative control 
such as RISC-free.  
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Chapter 3. ATMIN competes with NBS1 for ATM 
binding 
This work has been a collaboration with Kay Penicud from the lab and has been 
published in Cell Reports (Zhang et al., 2012). 
3.1 ATMIN overexpression impairs ATM signalling after IR 
As a cofactor of ATM, ATMIN shares a conserved C-terminal ATM interaction 
motif with NBS1 (Figure 4). This leads to the hypothesis that that ATMIN may 
compete with NBS1 for ATM binding, thus the protein level and strength of 
interaction of ATMIN and NBS1 could influence ATM pathway choice. In order to 
test this hypothesis, I overexpressed increasing amounts of ATMIN and observed 
a dose-dependent decrease in ATM signalling, thus suggesting that ATMIN level 
could affect ATM signalling after IR (Figure 11A). To test if ATM signalling was 
impaired due to increase in ATMIN levels, proteasome inhibitor (MG132) was 
used which itself led to a decrease in ATM signalling. Adding proteasome inhibitor 
(MG132) in addition to ATMIN overexpression further impaired ATM signalling 
(Figure 11B), suggesting that the effect could be due to further increase in ATMIN 
protein levels due to MG132, or that MG132 and ATMIN could act in parallel 
pathways to impair ATM signalling. The MG132-dependent impairment to ATM 
signalling after IR was also seen by immunofluorescence staining for phospho-
SMC1, a phosphorylation substrate of ATM (Figure 11C). However, if ATMIN is 
depleted by siRNA, the PI effect on ATM signalling is rescued and more cells 
stained positive for pSMC1. This suggests that proteasome inhibition could 
impinge upon ATM signalling via ATMIN, however this does not rule out that there 
are other substrates whose ubiquitin-dependent turnover may be essential for 
robust ATM signalling.  
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Figure 11. ATMIN overexpression impairs ATM signalling after IR. 
(A) 293T cells were transfected with the indicated amounts of FlagATMIN or vector 
plasmid for 24 hours and treated with IR (2Gy). Whole cell lysate was harvested after 
30 minutes for western blot analysis. (B) 293T cells were transfected with FlagATMIN 
or vector control for 24 hours, treated with or without MG132 (4 hours) and then 
irradiated (2Gy). Whole cell lysate was harvested for western blotting. (C) 
Immunofluorescence of pSMC1 on 293A cells transfected with siATMIN or siControl 
for 72 hours and treated with IR (2Gy) prior to fixation. (D) Quantification of 
percentage of cells positive for pSMC1 foci. Cells were scored as positive if they 
harboured more than 10 foci. 
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3.2 The ATM interaction motif of ATMIN is required to impair 
ATM signalling after IR 
To further analyse the function of ATMIN, the N-terminus (ATMIN∆C) or C-
terminus (ATMIN∆N) of ATMIN was used for overexpression, with the latter 
bearing the ATM-interaction motif (Figure 12A). While the C-terminus of ATMIN 
has a similar effect as full length ATMIN in impairing ATM signalling after IR, the 
N-terminus had less significant effect on ATM substrate phosphorylation either by 
immunofluorescence of 53BP1 as a substrate of ATM pathway or by ATM-
phosphorylation of KAP1 (Figure 12B-D). In addition, overexpression of full length 
ATMIN or the C-terminus also abrogated NBS1 recruitment into foci after IR, while 
γH2AX foci formation was unaffected (Figure 12B,C), suggesting that the amount 
of damage is not altered by ATMIN overexpression. This also supports the 
hypothesis that ATMIN, if upregulated, could counteract the interaction of NBS1 
with pATM, and that this is dependent on the ATM-interaction motif of ATMIN. 
Furthermore, the effect of ATMIN overexpression could be overcome by co-
overexpressing NBS1, which suggests a titration effect of NBS1 to rescue ATM 
signalling (Figure 12E).  
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Figure 12. ATMIN-dependent impairment of ATM signalling requires the ATM-interaction 
motif. 
(A) Scheme of ATMIN full-length, N- and C-terminal fragments used for 
overexpression studies. (B) Quantification of immunofluorescence staining of NBS1 
foci in 293A cells (C) after transfection with the indicated ATMIN constructs and 
irradiation (2Gy). Cells were also stained for 𝜸H2AX, 53BP1 and pATM after the same 
treatment. (D) 293T cells transfected with the indicated constructs were irradiated 
(2Gy) and whole cell lysate harvested for western blot analysis. (E) 293T cells were 
transfected with FlagATMIN and increasing amount of MycNBS1 or vector and 
irradiated prior to harvest of whole cell lysate for western blot analysis. 
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3.3 Loss of ATMIN augments ATM signalling after IR 
While increasing ATMIN levels decreased canonical ATM signalling, I wanted to 
test if decreasing ATMIN levels has the opposite effect. I generated immortalised 
atminF/F ; cre-ERT mouse embryonic fibroblasts (MEFs) and immortalised the 
latter with large T antigen. Subsequently, ATMIN deletion was induced in vitro by 
adding 4-hydroxy-tamoxifen. The deletion was confirmed by genoptyping PCR for 
genomic region of atmin, QPCR for atmin transcript and western blotting for 
ATMIN protein level (Figure 13A). The resulting atmin-deficient MEFs, compared 
to atminF/F wildtype, showed increased ATM signalling after low doses of IR 
(Figure 13B). This was validated using HeLa cells in which ATMIN was transiently 
silenced by siRNA, and resulted in an increase in pATM foci intensity as 
quantified by high-throughput microscopy, as well as increased NBS1 recruitment 
(Figure 13B,C). Hence, these data further show that ATMIN plays a role in 
regulating ATM signalling after IR.  
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Figure 13. Loss of ATMIN increases NBS1-dependent ATM activation. 
(A) Confirmation of endogenous ATMIN deletion by genotyping PCR on genomic 
DNA, QPCR using primers against the 3’ UTR of ATMIN mRNA, and western blot to 
detect ATMIN protein from MEF whole cell lysate. (B) atminf/f or atmin∆/∆ MEFs were 
treated with IR and irradiated (1Gy) prior to harvest of whole cell lysate for western 
blot analysis. (C) Immunofluorescence of pATM and NBS1 on HeLa cells after 
treatment with siATMIN or siControl and treated with IR (1Gy). (D) Quantification of 
average pATM foci intensity on HeLa cells treated as in (B) by Arrayscan High-
Content Analysis reader. Cells were fixed after IR at the indicated time points. (*= 
p<0.05)  
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The upregulation of ATM signalling after IR after loss of ATMIN can also be 
observed in vivo. atminf/f; villin-creERT mice were generated (see methods) and 
intestine-specific deletion of ATMIN was induced at 4 weeks of age by intra-
peritoneal injection of tamoxifen. This led to efficient deletion of ATMIN in the 
intestine (atmin∆G/∆G) confirmed by western blotting for total ATMIN protein level in 
gut lysate, as well as checking for YFP reporter expression after cre-mediated 
recombination. (Figure 14A,B). atminf/f or atmin∆G/∆G mice were subjected to 
whole-body irradiation and the intestinal villi and crypts were harvested for 
western blotting. Gut lysate from atmin∆G/∆G mice showed an increase in ATM 
signalling two hours post IR (Figure 14C), which is corroborated by increased 
53BP1 foci in the villus cells by immunohistochemistry (Figure 14D,E). Hence, 
both in vitro and in vivo, the flux through the ATM-NBS1 pathway is increased in 
the absence of ATMIN. 
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Figure 14. Loss of ATMIN in the intestine augments ATM signalling in vivo. 
(A) Small intestine tissue lysate was prepared from atminf/f and atmin∆G/∆G mice and 
analysed by western blotting for ATMIN protein level. (B) Immunohistochemistry 
staining of YFP reporter in the small intestine of atminf/f; villin-creERT; Rosa26-LSL-
YFP animals showing efficiency of recombination two weeks after tamoxifen-induced 
atmin deletion. Brown staining indicates YFP expression. (C) atminf/f and atmin∆G/∆G 
mice were irradiated with IR (14 Gy) and sacrificed after 2 hours. Small intestine 
tissue was homogenised in RIPA buffer supplemented with protease and 
phosphatase inhibitors and analysed by SDS-PAGE. (D) Immunofluorescence of 
fixed paraffin-embedded intestine tissue showing 53BP1 foci in representative crypts 
of the indicated genotypes taken at a similar time-point as for western analysis.  (E) 
Quantification of 53BP1-positive cells by IHC-IF in atminf/f (n=5) and atmin∆G/∆G (N=6) 
mice in intestinal crypts. **p=0.003. 
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3.4 ATMIN directly competes with NBS1 for ATM interaction 
To study if ATMIN has any effect on the direct interaction of ATM and NBS1, ATM 
was immunoprecipitated from cell lysate with overexpressed ATMIN. NBS1 co-
immunoprecipitated with ATM after IR, and this interaction was decreased in the 
presence of ATMIN overexpression (Figure 15A) together with decreased ATM 
autophosphorylation. This was also confirmed by immunoprecipitation using a 
pATM-specific antibody, which pulled down significantly lower amounts of total 
ATM protein in ATMIN overexpressing cells. NBS1 was efficiently 
immunoprecipitated by the pATM antibody, confirming a previous report that 
NBS1 specifically associates with pATM (Uziel et al., 2003). ATMIN 
overexpression also resulted in less NBS1 being pulled down by pATM antibody, 
showing reduced pATM–NBS1 interaction. Hence, ATMIN interferes with IR-
induced ATM signalling by competing with NBS1 for ATM binding.  
 
To investigate if ATMIN directly competes with NBS1 for ATM binding and to rule 
out other factors that might play a role such as RAD50 and MRE11, an in vitro 
translation approach was used to probe the interactions between ATM, NBS1 and 
ATMIN further. Given the large molecular weight of these proteins, especially 
ATM, a transcription coupled translation system was used instead of purifying 
recombinant proteins. Equal amounts of GFP-ATM and Myc-Nbs1 plasmid DNA 
together with increasing amounts of Flag-ATMIN plasmid DNA were translated in 
vitro using the TNT® coupled wheat-germ extract system.  Using this system, a 
stronger western blot band was detected for NBS1 than ATMIN, suggesting that 
NBS1 protein could be expressed more than ATMIN given that both antibodies 
produce approximately equal signal intensity when used on whole-cell lysates. 
GFP-ATM was immunoprecipitated before blotting for Myc-Nbs1 and Flag-ATMIN. 
Under this circumstance, less NBS1 and more ATMIN was pulled down with ATM 
as the amount of ATMIN DNA was increased (Figure 15B). Since Mre11 and 
Rad50 are not present in the extract, this supports the hypothesis that ATMIN 
could compete with NBS1 for ATM binding. Nevertheless, it is impossible to rule 
out that in the cellular context, additional indirect effects are also responsible to 
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mediate the interaction with ATM in addition to the C-terminal interaction of 
ATMIN and NBS1. 
 
Figure 15. ATMIN overexpression impairs NBS1-ATM interaction. 
(A) 293T cells transfected with full-length Flag-ATMIN were treated with IR (2 Gy) and 
whole cell lysate was used for ATM or pATM immunoprecipitation. (B) Equal amounts 
of GFP-ATM and Myc-Nbs1 plasmid DNA together with increasing amounts of Flag-
ATMIN DNA were translated in vitro using the wheat-germ transcription-coupled 
translation system GFP-ATM was immunoprecipitated, and the mixture was analysed 
by western blotting for GFP, Myc and Flag.  
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3.5 Loss of ATMIN rescues proliferation arrest and 
senescence phenotypes in the absence of NBS1 
While dysregulation of ATMIN perturbs NBS1-dependent canonical ATM 
signalling, the significance of this is unclear. Hence, in collaboration with Kay 
Penicud, nbs1f/f, atminf/f and compound floxed mice were generated to study the 
effect of ATMIN-dependent ATM signalling in nbs1-deficient background. While 
nbs1∆/∆ cells have reduced IR-induced pKap1 and pp53 levels, the 
phosphorylation of p53 after hypotonic shock is slightly increased compared to 
wildtype, hence suggesting that NBS1 could also compete with ATMIN for ATM 
interaction after hypotonic shock (Figure 16A). NBS1 is required for proliferation 
and viability of MEFs (Yang et al., 2006). When NBS1 was acutely inactivated by 
adenoviral expression of cre recombinase in MEFs, nbs1∆/∆ cells rapidly ceased to 
proliferate, as shown by cell number and BrdU incorporation (Figure 16B,C), and 
displayed signs of senescence even at low atmospheric oxygen levels (3%) at 
which wildtype MEFs do not undergo senescence, such as a flat enlarged 
morphology and cessation of proliferation at subconfluent densities. Senescence 
in these MEFs was confirmed by using senescence-associated β-galactosidase 
activity (Figure 16C,D). On the other hand, wildtype and atmin∆/∆ MEFs 
proliferated normally and reached confluence. atmin∆/∆; nbs1∆/∆  double mutant 
MEFs partially rescued the proliferation defect and premature senescence of 
nbs1∆/∆ MEFs, hence suggesting that the phenotypes observed in nbs1∆/∆ cells 
could be due to increased ATMIN-mediated ATM signalling, which is ameliorated 
by concomitant loss of ATMIN. 
 
In addition, ATMIN deletion can also rescue the loss of the progenitor pool in vivo 
in NBS1-depleted intestinal tissue. While nbs1 knock-out is embryonic lethal (Zhu 
et al., 2001), the acute deletion of nbs1 in the intestine of tamoxifen-treated 
nbs1F/F; villin-creERT (nbs1∆G/∆G) mice results in disintegration of the intestinal 
mucosa. The phenotype is marked by loss of individual intact villus-crypt units and 
a depletion of progenitor cells marked by MCM6 at the bottom of crypts (Figure 
16E,F) (Haigis et al., 2006). While nbs1∆G/∆G mice showed a substantial 
decrease in MCM6 positive cells, that in the double mutant mice were comparable 
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to wildtype. Hence, the loss of ATMIN rescues the progenitor cell depletion 
phenotype caused by NBS1 deficiency. 
 
Figure 16. Co-deletion of atmin and nbs1 rescues the lethality of nbs1∆/∆. (Kay Penicud) 
(A) Wildtype and nbs1∆/∆ MEFs were either untreated, treated with 135mOsm 
hypotonic shock buffer (HS) (1 hour) or IR (2Gy) and whole cell lysate harvested after 
fifteen minutes for western blotting with the indicated antibodies. (B) Primary MEFs 
were infected with AdenoCreGFP (atmin∆/∆, nbs1∆/∆ and nbs1∆/∆; atmin∆/∆) for 
seven days and seeded at 4X104 cells per well. Total cell number was counted after 
each day in triplicate over four days. (C) MEFs were treated with 10µM BrdU for 
30min and analysed by FACS for BrdU incorporation, and shown as fraction of BrdU 
positive cells relative to wildtype. (*p=0.039)  (D) Quantification of percentage of cells 
positive for b-galactosidase staining (*p=0.0028). (E) H&E staining on representative 
intestinal villi and crypts of mice with the indicated genotypes at 6 weeks of age. (F) 
Immunohistochemistry for MCM6-positive cells on representative intestines of mice 
with the indicated genotypes 5 days after VillinCre-ERT mediated deletion of atmin 
and nbs1. (G) Quantification of percentage of MCM6 positive cells in the crypt. 
(**p=0.0093) 
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3.6 atmin∆/∆; nbs1∆/∆ double mutant MEFs have more 
spontaneous DNA damage but fail to activate ATM in 
response to IR 
In order to study the relative contribution of each cofactor to ATM activation, ATM 
signalling was examined in atmin∆/∆, nbs1∆/∆ or double mutant MEFs after 
spontaneous DNA damage and IR. In basal conditions, both nbs1∆/∆ and 
atmin∆/∆ mutant MEFs showed an increased percentage of cells with γH2Ax foci, 
in line with previous reports (Yang et al., 2006, Kanu et al., 2010) (Figure 17A), 
indicating that NBS1 and ATMIN are both required to protect against endogenous 
DNA damage. Moreover, spontaneous DNA damage was increased even further 
in atmin∆/∆; nbs1∆/∆ double mutant MEFs, indicating that NBS1 and ATMIN could 
act via different pathways due to the additive effect. While basal levels of pATM 
were detected by immunofluorescence in wildtype, nbs1∆/∆ and atmin∆/∆ single 
mutant MEFs, pATM was not detectable in nbs1∆/∆; atmin∆/∆ double mutant cells. 
The lack of ATM activation was confirmed by western blot, which shows no 
detectable pATM or ATM substrate phosphorylation after 5Gy IR, while ATM 
activation after oxidative stress was only slightly impaired (Figure 17B). This 
finding was also confirmed in vivo by immunohistochemistry staining of intestinal 
crypts in nbs1∆/∆; atmin∆/∆, which fail to form IR-induced 53BP1 foci and showed 
no pATM substrate phosphorylation after whole-body irradiation (Figure 17C,D). 
Thus, these data show that in the absence of both NBS1 and ATMIN, ATM cannot 
be activated and phosphorylate substrates after IR.  
 
To address the physiological consequence of the heightened DNA damage and 
lack of ATM signalling in the absence of ATMIN and NBS1, NBS1/ATMIN double 
deficient MEFs and mice were irradiated. Double mutant MEFs showed an 
increased population of sub-G1 cells, a marker of radiosensitivity due to IR-
induced apoptosis that persisted at 48 hours post IR (Figure 17E). While 
nbs1∆G/∆G mice are sensitive to whole-body irradiation, double-mutant mice were 
even more sensitive despite the improved structural integrity of the intestine prior 
to irradiation. In addition to the absence of 53BP1 foci formation and ATM 
substrate phosphorylation in the intestinal cells, histological staining showed 
massive radiation injury and cell loss in the double mutant mice intestine (data not 
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shown). Thus, ATMIN deficiency renders the nbs1-mutant cellular phenotype 
similar to the atm-mutant phenotype, which also display increased radiosensitivity. 
Hence, ATMIN and NBS1 cooperate to mediate ATM signalling and in the 
absence of both cofactors, there is no detectable ATM activity after IR. Hence, 
this argues for the hypothesis that, at least after some stimuli such as IR, ATMIN 
and NBS1 as the only cofactors that can activate ATM, as ATM can be activated 
in the absence of ATMIN and NBS1 by H2O2 treatment. 
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Figure 17. Loss of ATM signalling in the absence of both ATMIN and NBS1 (Kay 
Penicud). 
(A) MEFs were infected with AdenoCreGFP (atmin∆/∆, nbs1∆/∆ and 
nbs1∆/∆;atmin∆/∆) and cultured for seven days, prior to IR (5Gy) and fixation for 
immunofluorescence of pATM and 𝜸H2AX, quantified as percentage of cells positive 
for pATM or 𝜸H2AX foci.  (B) MEFs were treated with either 250µm H2O2 or 5Gy IR 
prior to harvest of whole cell lysate for western blot analysis. (C) IHC of fixed paraffin-
embedded intestine section showing 53BP1 foci in representative crypts after IR. 
Arrows indicate IR-induced 53BP1 foci. (D) Wildtype or nbs1∆/∆; atmin∆/∆) mice were 
irradiated with IR (10Gy) and tissue lysate was prepared from small intestine after 2 
hours and analysed by western blotting. (E) Cells were treated with 20Gy irradiation 
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and fixed at the indicated time points post treatment. The percentage of sub-G1 cells 
was determined by FACS. (F) Four days after Villin-creERT-mediated deletion of 
atmin and nbs1, mice were treated with the indicated doses of irradiation (n = 5 mice 
per genotype per dose). 
 
The in vivo data show that while the genetic deletion of ATMIN rescues the 
proliferation and premature senescence phenotypes of nbs1∆/∆ MEFs, the rescue 
is not complete. This could be due to the role of NBS1 in localising MRE11 and 
RAD50 to the nucleus, as well as additional ATM-independent roles of the MRN 
complex (Deng et al., 2009, Dar et al., 2011, Williams et al., 2010). Hence, any 
other defects due to the loss of NBS1 will persist in nbs1∆/∆; atmin∆/∆ double-
mutant cells. Moreover, the rescue of nbs1Δ/Δ phenotype by loss of ATMIN 
occurs despite greatly heightened level DNA damage in nbs1∆/∆; atmin∆/∆ double-
mutant cells, suggesting that the phenotypes of NBS1-deficiency are not due to 
DNA damage per se; rather, the absence of ATMIN-mediated ATM signalling 
could ameliorate the cellular defects of nbs1∆/∆ cells, such as due to increased 
p53 activity. This could be tested by co-deletion of p53 together with nbs1 whether 
the NBS1-deficiency phenotypes could also be rescued. Hence, while ATMIN and 
NBS1 compete for ATM interaction in vitro, they cooperate to activate ATM in vivo 
and a balance of NBS1- and ATMIN-mediated ATM signalling is required to 
maintain robust DNA damage signalling.  
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Chapter 4. UBR5 as an E3 ligase that modulates 
ATMIN function 
4.1 Immunofluorescence-based screen for the E3 ligase that 
regulates ATMIN 
Since ATMIN has important roles as a cofactor of ATM, and little is known about 
the regulation of its turnover and post-translational modifications, I wanted to 
investigate whether ATMIN could be regulated at the protein level. One 
hypothesis is that ATMIN could be regulated via proteasome-mediated 
degradation by an E3 ligase. It has been previously observed that ATM and 
ATMIN mutually stabilise each other and the instability due to loss of one partner 
could be rescued by proteasome inhibition (Kanu and Behrens, 2007). Moreover, 
endogenous and overexpressed ATMIN can also be stabilised by proteasome 
inhibition, as shown by western blot and immunofluorescence readouts. (Figure 
18A,B) (Kanu and Behrens, 2007). These data suggests that ATMIN’s interaction 
with ATM could stabilise it from ubiquitin-mediated degradation. A cycloheximide 
experiment showed that ATMIN protein has a half-life of approximately 3.5 hours 
(time taken for 50% reduction in signal intensity of ATMIN western blot) at basal 
conditions (Figure 18C,D). 
 
In order to identify the E3 ligase that could act on ATMIN, I made a stable cell line 
expressing GFPATMIN by transfection and antibiotic selection. This cell line was 
sorted by FACS into 3 expression levels of GFPATMIN (H1, H2 and L3) and 
maintained for several passages while protein expression and GFP fluorescence 
was confirmed. L3 stable cell line showed the lowest expression level of 
GFPATMIN and highest fold increase after proteasome inhibitor treatment (Figure 
18E). Previous data from our lab suggested that ATMIN levels could be 
destabilised in the absence of ATM. In the L3 stable cell line, silencing 
endogenous ATM led to decrease in GFPATMIN levels, which suggests that the 
GFPATMIN could be expressed at a more physiological level (Figure 18F). Hence 
this cell line was chosen for the screen. As a control, I also showed that adding 
proteasome inhibitor could increase the protein level and fluorescence intensity of 
GFPATMIN but not GFP alone (Figure 18G). 
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Figure 18. ATMIN is stabilised by proteasome inhibition.  
(A) GFPATMIN was transiently overexpressed in HeLa or 293 cells and whole cell 
lysate harvested after 24 hours after proteasome inhibitor treatment where indicated. 
(B) Immunofluorescence of GFPATMIN overexpression in 293A cells before and after 
MG132 treatment. (C) Whole cell lysate of 293T cells showing ATMIN protein level 
after cycloheximide treatment at the indicated times, quantification of ATMIN 
immunoblot signal intensity normalised over actin shown in (D). (E) Three GFPATMIN 
expressing stable 293 cell lines, H1, H2 and L3 were treated with proteasome 
inhibitor and harvested for western blotting. (F) GFPATMIN expressing stable cell 
lines were treated with siRNA against ATM or control siRNA for 72 hours, before 
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harvesting of whole cell lysate for western blotting. (G) 293T cells were transfected 
with GFP vector and treated with proteasome inhibitor, before harvesting of whole cell 
lysate for western blotting.    
 
In order to further validate the GFPATMIN stable cell lines, I tested the response 
to proteasome inhibitor treatment using GFP fluorescence measured by the high 
throughput cytometer Acumen, and observed that the L3 cell line had the greatest 
fold induction (3 fold) in GFP signal upon proteasome inhibitor treatment (Figure 
19A). Furthermore, the GFP intensity was specific to the overexpression of 
ATMIN construct and not due to auto-fluorescence as the knockdown of ATMIN or 
GFP by siRNA reduced the GFP intensity (Figure 19B).  
 
Hence, using GFPATMIN stabilisation as a readout, the screen was performed on 
a human library of 380 E3 ligases in order to identify if there is an E3 ligase that, 
when silenced, results in a similar increase in GFP fluorescence intensity as 
proteasome inhibition.  With the help of High-throughput screening lab, 
optimisation of siRNA transfection efficiency and signal detection were performed. 
The L3 cell line was reverse transfected in a 96-well format with siRNA pools from 
Dharmacon and each sample was done in triplicate for consistency. In addition, 
two non-target siRNAs (OT-NT and RISC-free) and siRNA against ATMIN were 
used as negative controls. In addition to proteasome inhibitor treatment, siRNA 
against ubiquitin B (ubb) was also used as a positive control. 72 hours post-
transfection, proteasome inhibitor (MG132) was added to the control wells for 4 
hours prior to fixation and scanned on Acumen laser scanning cytometer for 
average percentage of GFP positive cells in each well. For analysis, each raw 
score was normalised to the median value for each plate, as well as to negative 
controls, to obtain a normalised z-score (Figure 19C). 
 
As expected, proteasome inhibitor treatment resulted in the highest z-score in all 
the plates (z-score 8.88), as well as siRNA against ubiquitin (highest z-score 1.67). 
However, DMSO alone also increased the GFP fluorescence (highest z-score 
2.53) as well as RISC-free control siRNA. The stabilisation effect of DMSO alone 
was not observed in previous tests, and the effect of RISC-free could only be 
speculated that it perhaps interfered with GFPATMIN degradation. ON-NT non-
target control, however, behaved as expected without significant effect on GFP 
fluorescence, hence it was used as the negative control for normalisation.  
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Based on the z-score of average GFP intensity per well, four top hits were 
selected whose knockdown gave rise to the highest GFP fluorescence and the 
most reproducible result. These were, TRIM38 (z-score 2), SH3MD2 (z-score 
1.52), TRIM67 (z-score 1.41) and HUWE1 (z-score 1.37).   
 
 
Figure 19. E3 ligase screen for regulators of ATMIN stability.  
(A) GFPATMIN stable cell lines were treated with proteasome inhibitor or DMSO and 
analysed for GFP fluorescence by Acumen highthroughput cytometer. (B) GFPATMIN 
L3 cell line was transfected with siRNA against ATMIN, GFP or control siRNA for 72 
hours, then treated with proteasome inhibitor or DMSO and analysed for GFP 
fluorescence as above. (C) Normalised z-score of top in hits from the screen, ranked 
in descending order. RF: risc-free control siRNA, OT-NT: Non-target control siRNA, 
ubb: siRNA against ubiquitin B. 
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TRIM38 has been recently described as an E3 ligase that has a role in the 
immune response (Xue et al., 2012). SH3MD2, also known as POSH, is a RING-
finger containing E3 ligase that has been described as a negative regulator of 
death receptor mediated apoptosis through the modulation of caspase-8 activity 
(Christian et al., 2011). TRIM67 has been shown to regulate Ras signalling via 
degradation of 80K-H, which results in neural differentiation such as 
neuritogenesis (Yaguchi et al., 2012). HUWE1, a HECT domain E3 ligase, has 
been recently shown to play roles in cell proliferation and DNA damage response 
by regulating p53 levels (Chen et al., 2005), DNA polymerases β (Parsons et al., 
2009) and Pol λ (Markkanen et al., 2012). 
 
The four top hits from the screen were validated using siRNA pools from 
Dharmacon to silence the respective target genes in 293 cells, and checking the 
effect on ATMIN stabilization using both FlagATMIN and MycATMIN 
overexpression (Figure 20A-D). The efficiency of siRNA knockdown was also 
confirmed by quantitative PCR (Figure 20E). In addition, in order to validate if the 
hits have a functional role in regulating ATMIN function, I tested the effect of the 
knockdown on ATM signalling (Figure 20F). I have made the observation that 
ATMIN, when overexpressed, impairs ATM signalling after IR (Figure 11). Hence, 
if an E3 ligase negatively regulates ATMIN stability, its knockdown should also 
impair ATM signalling. However, of the four top hits, none of them reproducibly 
resulted in both endogenous ATMIN stabilisation and impaired ATM signalling. 
Some of the siRNA, such as siHUWE1, resulted in an increase in overexpressed 
ATMIN protein level. However, no consistent effect was observed on endogenous 
ATMIN. Hence, these hits did not fulfill the validation criteria and most likely do not 
regulate ATMIN function in vivo. However, in the end I chose to proceed with an 
alternative approach (Chapter 4.2). In retrospect, the screen could also have been 
repeated with IR to identify any E3 ligase activity that was augmented by IR or 
other stimuli.  
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Figure 20. Validation of hits from E3 ligase screen. 
(A, C) 293T cells were treated with siRNA against selected screen hits for 72 hours 
and FlagATMIN or MycATMIN was overexpressed during the last 48 hours. One 
sample was treated with proteasome inhibitor prior to harvest of WCL for western 
blotting. (B, D) Quantification of intensity of Flag- or MycATMIN western blot over 
actin. (E) QPCR showing mRNA levels after siRNA knockdown of selected hits for 72 
hours. (F) 293T cells were treated with siRNA against selected hits for 72 hours, and 
treated with IR (2Gy) and harvested 30 minutes post-IR for western blotting using the 
indicated antibodies. 
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4.2 IP-MS screening using reconstituted MEFs 
 
As an alternative, I used an immunoprecitation and mass spectrometry (IP-MS) 
approach to identify any ATMIN interactors including potential E3 ligases. In order 
to identify potential interactors, I used an ATMIN-deficient MEF cell line 
reconstituted with FlagATMIN, which is expressed at a higher level than 
endogenous ATMIN in vector reconstituted MEFs. By deleting the endogenous 
ATMIN, I would potentially enrich for the interactors pulled down by FlagATMIN. 
ATMIN-deficient MEFs were infected with retrovirus expressing FlagATMIN and 
sorted by FACS according to GFP expression from an IRES-GFP (Figure 21A). 
These MEFs were checked for their ATMIN protein levels by western blotting 
(Figure 21B), mRNA level after reconstitution (Figure 21D) as well as cre-
mediated genomic deletion of floxed ATMIN allele (Figure 21E). In addition, 
expression of MycATMIN was able to partially rescue the defective ATM substrate 
phosphorylation after replication stress in ATMIN deficient MEFs (Figure 21C). 
These suggest that ATMIN function was partially rescued in the reconstituted 
MEFs and hence these cells were used for IP-MS experiments.  
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Figure 21. Reconstitution of ATMINf/f MEFs for IP-MS.  
(A) Scheme of ATMINf/f MEF reconstitution. (B) Western blot of WCL showing ATMIN 
protein levels before and after tamoxifen treatment. (C) MEFs were treated for 
hydroxyurea for 4 hours and whole cell lysate harvested for western blotting using the 
indicated antibodies. (D) QPCR on MEFs showing ATMIN mRNA levels in each cell 
line. (E) Genomic DNA of MEFs before and after tamoxifen treatment were harvested 
for genotyping PCR using ATMIN flox, wildtype and delta primers. (F) Protein gel 
staining after flag immunoprecipitation showing FlagATMIN bands that were analysed 
by MS (left panel). Western blot showing corresponding position of FlagATMIN was 
used to confirm the pull down. 
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Using this approach, ATMIN was successfully identified through MS and from 
bands present in the ATMIN pull-down but not present in vector controls. Some 
interesting hits were consistently identified, such as ubiquitin activating enzyme 
E1 (Uba1) and ubiquitin carboxyl-terminal hydrolases. Hence, this supports the 
hypothesis that ATMIN could be regulated by ubiquitination. While ATMIN was 
consistently identified by mass spectrometry using both FlagATMIN reconstituted 
MEFs and 293 cells transiently transfected with 293T (Figure 21F), there were no 
E3 ligases amongst the proteins identified. Different treatment conditions such as 
replication stress, IR and proteasome inhibition were also used. An E1 enzyme, 
Uba1, was pulled down in three independent experiments. In addition, two 
deubiquitinases, Usp18 and UBP4, were also pulled down as interactors of 
ATMIN. This suggests that there is high probability of ubiquitination associated 
with ATMIN; however, the inability to pull down E3 ligases could be due to the 
latter’s low abundance and relatively weak interaction with their substrates that 
make them difficult to detect using this approach. Hence, as the aim of the 
experiment was to identify E3 ligases that regulate ATMIN, the interactors were 
not followed up. 
 
4.3 Identification of UBR5/EDD, an E3 ligase that interacts 
with ATMIN 
 
Using a similar approach, a previous colleague from the lab, Janet Cronshaw, 
used a large-scale endogenous IP of ATMIN to identify interactors. Approximately 
25 litres of 293T cells were used for the IP under basal or chloroquine treated 
conditions, and one E3 ligase was identified by mass spectrometry to interact with 
ATMIN under both of these conditions (Figure 22A). UBR5 is a HECT domain E3 
ligase that was initially identified in Drosophila melanogaster, where its 
inactivation led to overgrowth of imaginal discs in larvae (Mansfield et al., 1994, 
Martin et al., 1977). As a member of the HECT domain family of E3 ligases, UBR5 
is a large nuclear protein of 309kDa and the crystal structure of the C-loop of the 
HECT domain has been solved (Matta-Camacho et al., 2012). Moreover, UBR5 
has been shown recently to play a role in the DNA damage response. UBR5 
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interacts with and ubiquitinates TOPBP1, targeting it for degradation (Honda et al., 
2002). There is also evidence that it interacts with and is required for the 
activation of CHK2 (Henderson et al., 2006), and p53 (Ling and Lin, 2011), but 
this occurs independently of its E3 ligase activity.  
 
The interaction between endogenous UBR5 and ATMIN was confirmed by co-
immunoprecipitation (Janet Cronshaw, unpublished) as well as in an 
overexpression system (Figure 22B,C). Namely, FlagUBR5 and GFPATMIN were 
overexpressed separately in 293 cells and whole cell lysates were combined for 
co-IP. This was due to the observation that co-overexpression of both constructs 
in cells led to mutual stabilisation, which interferes with interpretation of data. 
Moreover, I also tried to map the ATMIN domain of interaction with UBR5, by 
cloning 4 overlapping ATMIN fragments for co-IP with FlagUBR5. All 4 fragments 
showed increased interaction when co-overexpressed in the presence of 
FlagUBR5, although there was some non-specific pull-down in the absence of 
FlagUBR5 (Figure 22D,E). Nevertheless, fragments A, B and D saw a higher 
enrichment over control IP than fragment C, suggesting that UBR5 most likely 
interacts with ATMIN over an extensive three-dimensional surface.   
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Figure 22. ATMIN interacts with UBR5.  
(A) Gel stain after ATMIN immunoprecipitation using in-house ATMIN antibody, 
showing the bands that were analysed by MS, from which UBR5 was identified. (B) 
Endogenous ATMIN was immunoprecipitated using an in-house ATMIN antibody and 
probed with an antibody against UBR5. (C) GFPATMIN and FlagUBR5 were 
overexpressed separately in 293T cells. WCLs were harvested and mixed for 4 hours 
before flag pull-down. (D) Scheme of overlapping GFPATMIN fragments that were 
used to map interaction with UBR5. (E) GFPATMIN fragments (A-D) or full length (FL) 
were overexpressed with or without FlagUBR5 and WCL was used for flag IP and 
later blotted using GFP antibody.  
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Both ATMIN and UBR5 localise to the nucleus, under basal conditions and after 
IR. However, as they both show a diffuse pan-nuclear staining but no distinct foci 
formation, it is thus not possible to visualise any colocalisation with ATM after IR 
(Figure 23A). However, when UBR5 is silenced by siRNA, ATMIN protein level is 
not overall affected, after IR as well as by cycloheximide (Figure 23C). Hence, 
while UBR5 was identified as an ATMIN-interacting E3 ligase, silencing UBR5 
does not change the ATMIN protein level appreciably, as would be expected for 
degradative ubiquitination. Moreover, it was observed that UBR5 knockdown 
decreases ATM and Kap1 phosphorylation after IR (Figure 23C). This will be 
discussed subsequently. 
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Figure 23. ATMIN and UBR5 localisation.  
(A) GFPATMIN was overexpressed in 293A cells and treated with IR (2Gy) or HU 4 
hours before fixation and staining for immunofluorescence. (B) Nuclear fraction of 
293T cells before and after IR and fractions were analysed by SDS-PAGE and 
probed using the indicated antibodies. (C) 293T cells were transfected with siRNA 
against UBR5 for 72 hours and treated with IR (2Gy) before harvesting WCL for 
western blot. (D) Same as in (C), with the addition of cycloheximide immediately after 
IR (0 hr) and WCL was harvested at the indicated times after IR. 
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4.4 UBR5 ubiquitinates ATMIN in a stimulus dependent 
manner 
To investigate whether ATMIN could be ubiquitinated endogenously, a His-
ubiquitin pull-down was performed and endogenous ATMIN ubiquitination was 
detected after IR (Figure 24A). This ubiquitination was dependent on UBR5, since 
when UBR5 was silenced by siRNA, ATMIN ubiquitination as seen from a nickel 
NTA pull-down of His-ubiquitin decreased (Figure 24B). Conversely, when UBR5 
was overexpressed, ATMIN ubiquitination increases drastically, suggesting that 
UBR5 is the E3 ligase that ubiquitinates ATMIN (Figure 12C). In addition, the 
ubiquitination of ATMIN is enhanced after IR, and can be consistently observed 
when the ubiquitin pull down was performed in the absence of proteasome 
inhibitor. Hence it is likely that the ubiquitination on ATMIN by UBR5 is non-
degradative and induced in an IR-dependent manner. Since the most 
predominant ubiquitinated species appears as a single band around 8-10kDa 
higher than unmodified ATMIN, this suggests that the ubiquitination of ATMIN 
could be via a short mono- or di-ubiquitin modification.   
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Figure 24. ATMIN ubiquitination by UBR5. 
(A) Ubiquitin pulldown from 293T cells, showing ubiquitination of endogenous ATMIN. 
(B) Ubiquitin pulldown from 293T cells transfected with siRNA against UBR5 or 
control siRNA (siControl) followed by transfection with Flag-ATMIN and His-ubiquitin 
constructs. Cell were treated with IR (2Gy) and total cell lysate harvested after 30 
minutes for Ni-NTA pulldown. His-ubiquitin was immunoprecipitated with Ni-NTA 
beads from lysates previously equilibrated for Flag-ATMIN input levels due to 
stabilisation of FlagATMIN in the presence of Flag-UBR5. (C) Ubiquitin pulldown from 
293 cells expressing Flag-ATMIN and Flag-UBR5 and treated with or without IR 
(2Gy). 
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4.5 UBR5 ubiquitinates ATMIN in the N-terminus 
Next, I went on to investigate the site of UBR5 ubiquitination of ATMIN. Firstly, I 
used the N- or C-terminus of ATMIN as a substrate in an in vivo ubiquitin assay. 
As observed previously, co-overexpression of UBR5 and many domains of ATMIN 
lead to mutual stabilisation, possibly due to tight interaction of UBR5 with ATMIN. 
I observed that the N-terminus (amino acids 1-352), but not the C-terminus (amino 
acid 625-818) of ATMIN was ubiquitinated, although both fragments were 
stabilised in the presence of UBR5 (Figure 25A). Furthermore, the ubiquitination 
of ATMIN N-terminus is dependent upon the E3 ligase activity of UBR5, as a 
C2768A catalytically dead mutant of UBR5 shows impaired ATMIN ubiquitination 
(Figure 25B).  
 
Next, I used an IP-MS approach, whereby FlagATMIN N-terminus was 
immunoprecipitated following ubiquitination assay, and an additional gel band at 
the position of expected ATMIN ubiquitination was detected and analysed by 
mass spectrometry (Figure 25C). From this band, a single ubiquitination site was 
identified, lysine 238, in the presence of overexpressed UBR5. Protein sequence 
alignment showed that lys238 is conserved across species (Figure 25D). 
Importantly, when this residue was mutated to arginine and used as a substrate 
for in vivo ubiquitination assay, no ubiquitin modification was observed (Figure 
25E). Since ATMIN ubiquitination is triggered by IR, I wanted to investigate 
whether any of DNA damage kinases of the PI3K family (ATM, ATR and DNA-PK) 
is responsible for UBR5 activation. When cells were treated with ATM inhibitor, or 
caffeine, which inhibits all PI3K family kinases (Sarkaria et al., 1999), IR-induced 
phosphorylation of ATM substrates were inhibited and ATMIN ubiquitination was 
reduced, whereas DNA PK inhibitor had little effect (Figure 25F). Thus efficient IR 
stimulation of ATMIN ubiquitination by UBR5 requires ATM activity.  
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Figure 25. UBR5 ubiquitinates ATMIN in the N-terminus. 
(A) Ubiquitin pulldown from 293T cells transfected with FlagATMIN N-terminus (amino 
acids 1-354) or C-terminus (625-818) and harvested after 48 hours. (B) Ubiquitin 
pulldown from 293T cells transfected with the indicated constructs and either wild 
type Flag-UBR5 (+) or C2768A mutant (E3 ligase-defective) Flag-UBR5 for 48 hours 
and treated with IR (2Gy). (C) Sypro ruby staining of SDS-PAGE gel of flag IP 
following in vivo ubiquitination of FlagATMIN N-terminus. (D) Scheme of ATMIN 
domains and conserved ubiquitination site Lys238. (E) Ubiquitin pulldown from 293T 
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cells transfected with FlagATMIN N-terminus wildtype or K238R mutant. (F) Ubiquitin 
pulldown (left) and western blots of whole cell lysates (right) from 293T cells 
transfected with the indicated constructs for 48 hours and treated with either ATM 
inhibitor, caffeine (Caf.) or DNA-PK inhibitor 1 hour before IR treatment (2Gy). Cells 
were harvested 30 minutes post-IR for Ni-NTA IP.  
 
From the result of IPMS, it is likely that UBR5 mediates ATMIN ubiquitination on 
lys238. In addition to understanding the site of ubiquitination, I also investigated 
the type of ubiquitination linkage on ATMIN. Using an ubiquitin-K0 mutant that 
cannot be extended into chains in an in vivo ubiquitin assay, I also observed the 
mono-ubiquitination band similar to using wildtype ubiquitin (Figure 26A,B). 
Furthermore, the K0 ubiquitin resulted in an increase in the ATMIN mono-
ubiquitination band intensity and a decrease in the higher molecular weight bands 
intensity, suggesting a shift to more ATMIN mono-ubiquitination (Figure 26B). In 
addition, the mono-ubiquitination band was also observed by using K48 and K63 
ubiquitin mutants, which can only extend ubiquitin chain at K48 or K63 positions 
respectively due to mutation of all other lysines to arginines (Figure 26C). These 
data strongly suggest a mono-ubiquitination on ATMIN K238 by UBR5.  
 
In order to confirm that the modification on ATMIN is indeed ubiquitination and not 
neddylation, an ubiquitin assay was performed in the presence of neddylation 
inhibitor (MLN4924), and this did not result in any reduction of ATMIN 
ubiquitination (Figure 26D). Though it is not possible to rule out other 
modifications that may occur subsequent to ATMIN ubiquitination, the major 
modification that is UBR5-dependent and triggered by IR is the mono-
ubiquitination. Furthermore, to confirm that the full-length ATMIN also gets 
ubiquitinated in a manner that depends on the K238 residue, I performed an in 
vivo ubiquitination assay using wildtype or K238R full-length ATMIN, and 
observed that while full length wildtype ATMIN ubiquitination increases in the 
presence of FlagUBR5, that of mutant FlagATMIN does not increase when 
FlagUBR5 was added (Figure 26E) (We cannot rule out the presence of other E3 
ligases that could target other lysine residues on ATMIN). Hence, it is likely that 
UBR5 ubiquitinates ATMIN only on K238 residue. Moreover, the increased UBR5-
mediated ubiquitination of ATMIN appears to be specific to IR-stimulus because 
there is no change in ubiquitination after hypotonic shock (Figure 26F).   
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Figure 26. UBR5 catalyses ATMIN mono-ubiquitination. 
(A,B) Ubiquitin pulldown following transfection of 293T cells with wildtype or K0-
mutant ubiquitin. (C) Ubiquitin pulldown of 293T cells following transfection with 
wildtype, K48 or K63 ubiquitin mutants. (D) Ubiquitin pulldown of 293T cells after 
transfection with the indicated constructs and treatment with neddylation inhibitor 
MLN4924 (Neddi) for 4 hours prior to harvest. (E) Ubiquitin pulldown following 
transfection of 293T cells with wildtype full-length FlagATMIN or K238R full length 
FlagATMIN. (F) Ubiquitin pulldown following transfection of 293T cells with the 
indicated plasmids and treatment with or without hypotonic shock for 1 hour prior to 
harvest of whole cell lysate for immunoprecipitation. 
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4.6 Loss of UBR5 impairs ATM signalling after IR 
UBR5 has been shown previously to regulate ATM-mediated phosphorylation of 
p53 (Ling and Lin, 2011) and activation of CHK2 after IR (Henderson et al., 2006). 
However, the regulation of CHK2 and p53 was not shown to be dependent on the 
E3 ligase activity of UBR5, furthermore no direct effect on ATM has been shown 
so far. I observed that silencing UBR5 impairs ATM signalling after IR, as seen by 
pKap1 and pSMC1 levels, indicating that ATM signalling partly depends on UBR5 
(Figure 27A). Silencing UBR5 also diminishes IR-induced 53BP1 and pATM foci 
formation (Figure 27B,C). This is in agreement with previous data that 
overexpression of ATMIN competes with NBS1 for ATM binding and reduces 
NBS1 foci formation (Zhang et al., 2012). Since UBR5 ubiquitinates ATMIN on 
Lys238, I wanted to investigate whether this could be the mechanism by which 
UBR5 regulates ATM signalling. I overexpressed wildtype or K238R FlagATMIN 
(Lys238 mutated to Arg), with or without UBR5 knockdown, and checked the 
interaction of ATMIN with endogenous ATM by co-immunoprecipitation. Silencing 
UBR5 increases the interaction of wildtype FlagATMIN and ATM, and a similar 
pull-down was observed when FlagATMIN K238R was used regardless of UBR5 
silencing (Figure 27D). Hence, this shows that ATMIN lysine 238 ubiquitination is 
required to regulate ATM-ATMIN interaction after IR, most likely by disrupting 
ATM-ATMIN complex to facilitate ATM-NBS1 interaction; a K238R mutant that is 
unable to be ubiquitinated binds strongly to ATM in a manner that is similar to loss 
of UBR5.  
 
This model also predicts that knockdown of UBR5 should impair NBS1 interaction 
with ATM. Indeed, NBS1 foci formation following IR is impaired in the absence of 
UBR5 (Figure 27E,F). Hence, ATMIN overexpression and UBR5 knockdown have 
similar phenotypes in reducing NBS1-dependent ATM signalling.  
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Figure 27. Loss of UBR5 impairs IR-induced NBS1-dependent ATM signalling. 
(A) 293T cells were transfected with siUBR5 or siControl for 72 hours and treated with 
IR (2Gy) prior to harvest of WCL for western blotting. Arrow indicates the band that 
corresponds to UBR5 protein knockdown. (B) 293A cells were transfected with 
siUBR5 or siControl and treated with IR (2Gy) after 72 hours prior to fixation and 
immunofluorescence staining for 53BP1 and pATM. (C) Quantification of 53BP1 
positive cells. Cells with at least 6 distinct foci were scored as positive. Error bars 
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represent s.e.m. (**p <0.01). (D) 293T cells were transfected with siUBR5 or 
siControl, and after 24 hours with Flag-ATMIN wild type or K238R mutant. Whole cell 
lysates were harvested 48 hours later for Flag IP. (E) 293A cells were transfected with 
siUBR5 or siControl for 72 hours and treated with IR (2Gy) prior to fixation and 
immunofluorescence staining for NBS1 and pH2AX. (F) Quantification of NBS1 
positive cells. Cells with at least 5 distinct foci were scored as positive. Error bars 
represent s.e.m. (***p <0.005). 
 
While silencing UBR5 impairs ATM signalling after IR, the defect can be partially 
rescued by concomitant loss of ATMIN (Figure 28A), suggesting that UBR5 acts 
via ATMIN to affect ATM signalling. The rescue is only partial, possibly because of 
reduced efficiency of knockdown using double siRNA. Similarly, using ATMINf/f or 
ATMIN∆/∆ MEFs, knock down of UBR5 only impairs ATM signalling in the presence 
of ATMIN (Figure 28B). Hence, ATMIN is required in UBR5-dependent 
impairment of ATM activation after IR.  
 
Whilst ATMIN overexpression causes impairment in ATM signalling, when UBR5 
was co-overexpressed with ATMIN, this rescued the ATMIN-dependent defect in 
ATM signalling, while overexpression of UBR5 alone has no effect (Figure 28C,D). 
These data imply that UBR5 and ATMIN could be acting in a complex whereby 
their levels must be regulated in order to ensure proper ATM activation after IR; 
an excess of ATMIN could titrate the activity of UBR5 and result in suppression of 
ATM activation, whilst an excess of UBR5 over ATMIN would have no effect as 
there would be no substrate to act on. To test this, I checked the IR-induced foci 
formation of 53BP1, pATM and NBS1. In agreement with western blot data, the 
co-overexpression of ATMIN and UBR5 rescued ATMIN-induced ATM signalling 
defect after IR, but does not affect the damage per se as shown by pH2AX 
staining (Figure 28D-G). 
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Figure 28. Overexpression of UBR5 rescues ATM signalling defect due to ATMIN 
competition. 
(A) 293T cells were transfected with siUBR5, siATMIN or siControl for 72 hours and 
treated with IR (2Gy), prior to harvest for western blot. (B) ATMINf/f (wild type) or 
ATMINΔ/Δ MEFs were transfected with siUBR5 or siControl for 72 hours and treated 
with IR (2Gy), prior to harvest for western blot. (C) 293T cells were transfected with 
FlagUBR5, FlagATMIN or both for 48 hours and treated with IR (2Gy), prior to harvest 
for western blot. (D) 293A cells were transfected with Flag-ATMIN, Flag-UBR5 or both 
and irradiated after 48 hours, prior to fixation and immunostaining for 53BP1 and 
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pATM. (E) Quantification of 53BP1 positive cells. Cells with at least 6 distinct foci 
were scored as positive. Error bars represent s.e.m. (*p <0.05). (F) 293A cells were 
transfected with Flag-ATMIN, Flag-UBR5 or both and irradiated after 48 hours, prior 
to fixation and immunostaining for NBS1 and pH2AX. (G) Quantification of cells 
positive for NBS1 foci. Cell with at least 5 distinct foci were scored as positive. Error 
bars represent s.e.m. (*p <0.05). n.s., not significant. 
 
4.7 ATMIN ubiquitination mutant has defective ATM signalling 
and checkpoint responses  
 
If excess ATMIN-ATM interaction impairs ATM signalling, and ATMIN 
ubiquitination is required to disrupt ATM-ATMIN interaction, then ATMIN K238R 
mutant should also act as a dominant negative suppressor of ATM signalling after 
IR. ATM is required for cell cycle checkpoints, including the G2/M checkpoint in 
response to IR. In order to investigate the role of ATMIN K238 ubiquitination in the 
ATM-dependent DNA damage response, we measured IR-induced G2/M 
checkpoint activation in 293T cells expressing either wild-type ATMIN or the 
ATMIN-K238R mutant by detection of phosphorylated histone 3 (pH3) by FACS 
and using nocodazole to arrest cells that escape the G2/M checkpoint in mitosis.  
When FlagATMIN K238R mutant is overexpressed in 293T cells, it abrogated the 
G2/M checkpoint after IR with a higher mitotic index than vector or FlagATMIN 
wildtype (Figure 29A).  However, due to the presence of endogenous ATMIN, the 
defect may be less pronounced. Hence, I reconstituted ATMIN-null MEFs with 
wildtype or K238R FlagATMIN; specifically, atminf/f cre-ERT MEFs were 
immortalised with large T antigen and infected with vector, FlagATMIN wildtype or 
FlagATMIN K238R expressing retrovirus and sorted by FACS.  
 
The reconstituted MEFs were deleted for endogenous ATMIN by in vitro 
tamoxifen treatment, and vector-reconstituted (without tamoxifen treatment) was 
used as a control (Figure 29B). Deletion of endogenous ATMIN was checked by 
QPCR (Figure 29C) and expression level of ectopic wildtype or mutant ATMIN 
wildtype were comparable, as confirmed by western blot (Figure 29D). Upon IR 
treatment, ATMIN∆/∆ reconstituted with K238R mutant ATMIN showed the greatest 
impairment in the ATM signalling compared to wildtype MEFs or ATMIN∆/∆ MEFs 
reconstituted with wildtype ATMIN (Figure 29E).  
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Figure 29. ATMIN ubiquitination is required for ATM signalling and function. 
(A) G2/M trap and FACS analysis of mitotic index in 293T cells transfected with vector 
(CTR), Flag-ATMIN wild type (wtATMIN) or Flag-ATMIN K238R (ATMIN-K238R). 
Cells were irradiated 24hrs after transfection and nocodazole was immediately added 
to the media. After 18 hours, cells were harvested by trypsinization, fixed and stained 
for phospho-histone 3 (pH3) to indicate mitotic cells. (B) Scheme of FlagATMIN MEF 
reconstitution. (C) QPCR of reconstituted MEFs using ATMIN primer sets detecting 
exon 1 and the 3’ UTR respectively. In ATMINF/F; Rosa-creERT cells, ATMIN 
(including the 3’ UTR) is flanked by loxP sites and deleted upon tamoxifen-mediated 
cre activation (Kanu and Behrens, 2007). The reconstitution constructs do not contain 
ATMIN 3’ UTR. (D) Western blots of whole cell lysates from reconstituted MEFs. (E) 
Western blot of wild-type MEFs transfected with empty vector (ATMINf/f+CTR) or 
ATMIN-null MEFs reconstituted with either wild type Flag-ATMIN full length (ATMINΔ/Δ 
+wtATMIN) or K238R mutant Flag-ATMIN full length (ATMINΔ/Δ +ATMIN-K238R). Cells were 
treated with IR and whole cell lysate harvested after 30 minutes.  
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Moreover, the ATMIN K238R reconstituted MEFs are also defective in 53BP1 and 
pATM foci formation after IR (Figure 30A,B). Consequently, these mutant MEFs 
are also radiosensitive, as seen by reduced colony-formation ability after IR 
(Figure 30C). Hence, this shows that ATMIN ubiquitination by UBR5 at Lys238 
has an important role in mediating the full activation of ATM-dependent DNA 
damage response and loss of the E3 ligase or the ubiquitination site impairs ATM 
signalling and function after IR. 
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Figure 30. ATMIN ubiquitination is required for ATM signalling and function.  
(A) Immunofluorescence staining of wild-type MEFs transfected with empty vector 
(ATMINf/f+CTR) or ATMIN-null MEFs reconstituted with either wild type Flag-ATMIN full 
length (ATMINΔ/Δ +wtATMIN) or K238R mutant Flag-ATMIN full length (ATMINΔ/Δ +ATMIN-
K238R). Cells were treated with IR, and fixed after 30 minutes for 53BP1 and pATM 
staining. (B) Quantification of 53BP1 positive cells. Cells with at least 6 distinct foci 
were scored as positive. Error bars represent s.e.m. (C) Radiosensitivity assay of 
reconstituted MEFs, showing percentage of surviving colonies 7 days after the 
indicated dose of IR. Error bars represent s.e.m. (***p <0.005, **p<0.01). Error bars 
represent s.e.m. (D) Western blot of 293T cells transfected with FlagUBR5 for 48 
hours and treated with proteasome inhibitor for 4 hours prior to harvest of WCL. 
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Since the E3 ligase activity of UBR5 appears to be augmented after IR, it is 
possible that UBR5 itself could undergo post-translational modifications that are 
required for its activation. Data from proteomics screens have shown that UBR5 
has SQ/TQ sites (Mu et al., 2007, Matsuoka et al., 2007), which are potential 
targets for ATM and or ATR. Indeed, when cells were treated with ATM inhibitor or 
caffeine, decreased UBR5-dependent ATMIN ubiquitination was observed (Figure 
25F). Another observation was that UBR5 protein level was destabilised after IR 
in the absence of ATMIN (ie. atmin∆/∆ MEFs) (Figure 28B). It is possible that UBR5 
could display auto-ubiquitination activity when its substrate is absent. This is 
supported by the stabilisation of overexpressed FlagUBR5 in the presence of 
proteasome inhibitor (Figure 30D). If this is correct, this suggests that UBR5 
requires its substrate, ATMIN, to bind and become a substrate for its E3 ligase 
activity. In the absence of ATMIN, if UBR5 is activated post-IR, this will lead to 
UBR5 auto-ubiquitination and degradation.  
 
In summary, UBR5 is activated post IR, perhaps by low levels of ATM and or 
ATR-mediated phosphorylation, and mono-ubiquitinates ATMIN on lys238. While 
the ubiquitination does not target ATMIN for degradation, it acts as a molecular 
switch to disrupt the basal ATMIN-ATM interaction and facilitate ATM-NBS1 
interaction and subsequent ATM signalling post IR. This modification appears 
specific to IR but not to non-canonical stimuli of ATM activation such as osmotic 
stress. Loss of UBR5 or ATMIN mutant that cannot be ubiquitinated leads to 
impaired ATM signalling due to sequestering of ATM by ATMIN. Consequently, 
this leads to increased radiosensitivity and reduced viability of cells post IR. 
Hence, UBR5 is an important factor in ensuring the robust activation of ATM by 
contributing to the molecular decision favouring the ATM-NBS1 pathway over the 
ATM-ATMIN pathway after IR.  
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Chapter 5. The role of ATMIN in regulating ATM 
function after replication stress 
Replication stress can be induced by external agents, such as drugs like 
aphidicolin and hydroxyurea, or internal natural barriers to replication, such as 
repetitive DNA sequences and DNA secondary structures. Following replication 
stress, replication stalls to preserve the integrity of the replication fork and allow 
time for replication restart once the stress is removed or internal barriers are 
overcome. However, under conditions of prolonged replication stress, the 
replication fork may collapse and forms a DSB due to endonuclease processing or 
due to ssDNA break. Sometimes, cells may progress to G2 with under-replicated 
DNA, which lead to the formation of anaphase bridges if the under-replicated DNA 
is segregated during mitosis. A sub-class of these anaphase bridges, called 
ultrafine anaphase bridges (UFBs) stain positively for BLM and PICH proteins but 
are DAPI-negative (Baumann et al., 2007) (Chan et al., 2007), which are believed 
to be progressively resolved during anaphase under normal conditions.  
 
Another consequence of replication stress is the expression of chromosome 
fragile sites (CFS), which manifest as breaks on metaphase chromosomes 
following low level of replication stress by low doses of aphidicolin (Aph) (Glover 
et al., 1984). CFS represent regions of chromosome instability as they undergo 
sister chromatid exchange as well as translocations and deletions (Glover and 
Stein, 1987, Glover and Stein, 1988, Wang et al., 1993). ATR has been shown to 
regulate CFS stability; in the absence of ATR, cells show increased CFS following 
aphidicolin treatment and even under untreated conditions. (Casper et al., 2002) 
In addition to ATR, 53BP1 also has been shown to play a role in guarding genome 
stability. A recent study showed that 53BP1 forms nuclear bodies that accumulate 
after partial replication inhibition (low dose of aphidicolin 0.2uM) and act to protect 
under-replicated chromosome regions (such as fragile sites) that are not resolved 
by mitosis from further erosion (Lukas et al., 2011a, Harrigan et al., 2011).  The 
recruitment of 53BP1 to underreplicated DNA is thought to depend on ATM, not 
ATR (Lukas et al., 2011a). Hence, in addition to ATR, ATM also has a role in 
suppressing chromosome instability arising from replication stress.  
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While the recruitment and activation of ATM at DSB via the MRN complex has 
been well characterised, its activation following replication stress is less well 
understood. Difilippantonio et al showed that ATM autophosphorylation and p53-
Ser15 phosphorylation is unaffected in the absence of NBS1 (Difilippantonio et al., 
2005). Hence, ATM may be recruited by an NBS1-independent mechanism after 
replication stress to fragile sites. Previous published data on ATMIN showed that 
it is required for ATM signalling after replication stress (Kanu and Behrens, 2007). 
In collaboration with Nnennaya Kanu, we wanted to investigate if ATMIN could act 
as a cofactor, akin to NBS1 after DSBs, which helps to localise ATM to sites of 
replication stress. While some of the biochemistry experiments were done by 
Nnennaya Kanu, I performed the immunofluorescence experiments and some 
additional biochemistry studies. 
 
5.1 ATMIN is required for ATM signalling after replication 
stress 
The possibility that ATMIN could play a role in replication stress stems from the 
defects observed in ATMIN deficient MEFs (atmin∆/∆). Following aphidicolin 
treatment in wildtype MEFs, pATM and 53BP1 formed distinct foci that mostly 
colocalise. However, atmin∆/∆ MEFs are defective in forming these foci after 
aphidicolin (Figure 31A,B). Moreover, blotting for pKap1, a downstream substrate 
of ATM, also shows a lower signal in atmin∆/∆ MEFs, whilst that after IR is 
unaffected (Figure 31C). Using human lymphoblastoid cell lines, ATM wildtype 
cells increased 53BP1 foci and Kap1 phosphorylation whereas ATM knockout 
cells failed to do so (Figure 31D,E), suggesting that formation of 53BP1 foci and 
Kap1 phosphorylation upon Aph treatment are indeed ATM-dependent. In order to 
assess if ATMIN deficiency affected recovery and replication restart of cells, cells 
were arrested by hydroxyurea (HU) and then released into fresh medium 
containing BrdU and the cell cycle profiles were analysed. Compared with 
wildtype, atmin∆/∆ MEFs had higher percentage of cells in S phase after release 
from HU (Figure 31F). A similar result was obtained by using Aph-induced arrest 
and release of 293T cells depleted of ATMIN by siRNA (Figure 31G). Hence, 
ATMIN-deficient MEFs have defective ATM signalling upon replication stress and 
slower recovery from replication stress.  
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Figure 31. ATMIN is required for ATM signalling after replication stress. 
(A) Immunofluorescence staining of pATM and 53BP1 on atminf/f and atminΔ/Δ MEFs. 
Cells were treated with aphidicolin 2uM for 18 hours prior to fixation. (B) 
Quantification of percentage of cells with 53BP1 foci. Cells with more than 10 foci are 
scored as positive. (*=P<0.05). (C) Whole cell lysate from atminf/f and atminΔ/Δ MEFs 
were harvested for western blotting after treatment with HU for 4 hours or IR (2Gy). 
(D) ATM wildtype (AH) or null (GP, HW) human lymphoblastoid cell lines were treated 
with Aph and stained for immunofluorescence using antibodies against the indicated 
proteins. (E) The same cells were treated with Aph or mock treated and whole cell 
lysate harvested for western blot analysis. (F) atminf/f and atminΔ/Δ MEFs were 
arrested with HU overnight or mock treated and released into fresh media containing 
BrdU for 6 hours, before fixation and analysis by FACS. (G) 293T cells were 
transfected with siATMIN or siControl for 72 hours and arrested by Aph overnight. 
Next, the cells were released into fresh media containing BrdU for 10 hours, before 
fixation and analysis of cell cycle profile by FACS. 
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5.2 WRNIP is a novel interactor of ATMIN and also interacts 
with RAD18 
In order to dissect the mechanism by which ATMIN could play a role to localise 
ATM after replication stress, potential interactors were identified from earlier IP-
MS studies using FlagATMIN (Janet Cronshaw, unpublished), including WRNIP1 
(Werner helicase interacting protein1) as an interactor of ATMIN under basal 
conditions and after chloroquine treatment (Figure 32A). The interaction between 
ATMIN and WRNIP1 was confirmed by endogenous co-immunoprecipitation as 
well as by using overexpressed proteins (Figure 32B,C). FlagWRNIP was able to 
pull down MycATMIN in basal conditions as well as after aphidicolin. 
Colocalisation between pATM, 53BP1 and WRNIP foci could also be detected by 
immunofluorescence (IF) specifically after Aph (Figure 32D). Since ATMIN was 
found to associate with ATM after replication stress from previous work published 
from our lab (Kanu and Behrens, 2007), and WRNIP interacts with ATMIN and 
could form foci that colocalise with ATM, one hypothesis is that the formation of a 
WRNIP-ATMIN complex could be required to localise active ATM and its 
substrate 53BP1 after Aph. Unfortunately, due to the lack of suitable antibodies 
against ATMIN for IF, it was not possible to visualise directly a colocalisation 
between ATMIN and WRNIP in this study.  
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Figure 32. WRNIP1 as a novel interactor of ATMIN-ATM pathway. 
(A) A large-scale IP was done on 293T cells treated with chloroquine for 4 hours or in 
untreated conditions, followed by SDS-PAGE and analysis by MS. Arrow indicates 
the band corresponding to WRNIP1 that is present in ATMIN pulldown but not in 
control IP. (Janet Cronshaw) (B) Endogenous co-IP was performed on 293T cells 
under basal conditions using an in-house ATMIN antibody. (Janet Cronshaw) (C) 
293T cells were transfected with FlagWRNIP and MycATMIN for 24 hours and treated 
with or without Aph prior to harvest of WCL for co-IP. (Nnennaya Kanu) (D) 
Immunofluorescence of pATM, WRNIP and 53BP1 showing colocalisation after Aph 
treatment.  
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Mammalian WRNIP1 has been shown to localise in foci in replication factories 
marked by RPA, and responds by increasing the number of foci after treatments 
such as HU or UV that induce replication stalling, in a manner that depends on its 
UBZ domain (Crosetto et al., 2008). Furthermore, the yeast homologue of WRNIP, 
Mgs1, was shown to be recruited, via interactions between its UBZ domain and 
polyubiquitinated PCNA, to sites of replication stalling (Saugar et al., 2012). 
Similarly, human WRNIP1 can also interact with ubiquitinated PCNA in an NTA 
pull-down assay (Figure 33A) (Atanu Chakraborty). Since RAD18 is the E3 ligase 
that mono-ubiquitinates PCNA after replication stalling (Hoege et al., 2002), we 
wanted to test if Rad18 can interact with the ATMIN-WRNIP complex.  
 
By immunofluorescence, WRNIP1 and RAD18 both form foci after Aph, the 
majority of which colocalise after Aph (Figure 33B). Moreover, overexpressed 
MycWRNIP could pull down FlagATMIN and FlagRAD18, suggesting that these 
three proteins could interact in a WAR complex (WRNIP1-ATMIN-RAD18) after 
replication stress (Figure 33D) (Nnennaya Kanu). In order to investigate the 
nature of these WRNIP1 and RAD18 foci, I co-stained with RPA, a marker for 
single-strand DNA (ssDNA) (Zou and Elledge, 2003), and observed colocalisation 
of both WRNIP1 and RAD18 with RPA foci after Aph, but not before. Hence, it is 
likely that WRNIP1 and RAD18 colocalise to stalled replication forks marked by 
RPA after Aph treatment (Figure 33E). In order to further probe the requirement 
for WRNIP1 and RAD18 foci formation, the genes were silenced individually. 
Silencing RAD18 by siRNA led to a reduction in the percentage of cells that were 
positive for WRNIP1 foci after Aph (Figure 33B, C), while knockdown of WRNIP1 
does not significantly affect RAD18 foci formation. This shows that WRNIP1 foci 
formation after Aph is dependent upon RAD18, but not vice versa.  
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Figure 33. WRNIP1 and RAD18 colocalise to sites of replication stress 
(A) Recombinant proteins FLAG-WRNIP was incubated with recombinant His-PCNA 
or ubiquitinated (Ub-) His-PCNA for 1 hr and mixture immunoprecipitated with Ni-NTA 
beads. (Atanu Chakraborty) (B) Immunofluorescence staining of WRNIP1 and RAD18 
foci on 293A cells transfected with siWRNIP1, siRAD18 or siControl for 72 hours and 
treated with Aph prior to fixation and staining. (C) Quantification of percentage of cells 
with WRNIP1 and RAD18 foci normalised to siControl, cells were scored as positive if 
they harbour more than 6 foci. (N.S= not significant, ***=p<0.001) (D) 293T cells were 
transfected with MycWRNIP1, FlagATMIN and FlagRAD18 for 24 hours and whole 
cell lysate harvested for Myc IP. (Nnnenaya Kanu) (E) Immunofluorescence of 
WRNIP1, RPA and RAD18 colocalisation in 293A cells after treatment with Aph.  
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5.3 WRNIP1, ATMIN and RAD18 are all required for ATM 
signalling after replication stress, but not after IR 
Since the loss of ATMIN impaired ATM signalling after replication stress, we 
wanted to investigate whether WRNIP1 or RAD18 has a similar phenotype. 
Knockdown of WRNIP, RAD18 and ATMIN all led to a decrease in pATM and 
53BP1 foci after Aph (Figure 34A,B), with RAD18 having the strongest phenotype, 
followed by WRNIP, then ATMIN. Hence, ATMIN, WRNIP and RAD18 are all 
required to localise pATM and 53BP1 to sites of replication stress. This is further 
confirmed by western blotting for ATM substrate Kap1 and p53 phosphorylation 
(Figure 34C), both of which are impaired most strongly upon silencing WRNIP1 
and RAD18. To check whether the loss of WAR complex affects ATM activity, I 
immunoprecipitated endogenous ATM after Aph treatment and performed in vitro 
kinase assay on GST-p53 substrate. In agreement with western blot data, ATM 
kinase activity is reduced most strongly in siRAD18 and siWRNIP1, and to a 
lesser extent after siATMIN (Figure 34D). While the loss of WAR impairs ATM 
substrate phosphorylation after Aph, the phosphorylation of CHK1, an ATR 
substrate, was not affected. Hence, the WAR complex is required for ATM 
signalling but not ATR signalling after replication stress (Figure 34C). 
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Figure 34. Loss of WAR complex impairs ATM signalling after Aph. 
(A) 293A cells were transfected with siRNA against ATMIN, WRNIP1, RAD18 or 
Control siRNA for 72 hours and treated with Aph before fixation and staining for 
pATM, 53BP1 and WRNIP1 immunofluorescence. (B) Quantification of cells positive 
for 53BP1 or pATM foci from (A). Cells were scored as positive if they harboured 
more than 6 foci. (C) 293T cells were transfected with the indicated siRNAs for 72 
hours and treated with Aph before harvesting of whole cell lysate for western blot 
analysis. (D) Total ATM was immunoprecipitated from whole cell lysate as in (C) and 
used for in vitro kinase assay with GST-p53 substrate. Graph shows the quantification 
of phospho-p53 western blot intensity relative to GST-p53. 
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While the WAR proteins are required for full ATM signalling after Aph, the 
knockdown of the WAR proteins had no appreciable effect on ATM signalling and 
foci formation after IR (Figure 35A,B) (Tianyi Zhang, Nnennaya Kanu). Hence, the 
WAR proteins are not required for ATM signalling after IR-induced canonical 
DSBs, but specifically after replication stress.   
 
Figure 35. WAR complex is not required for IR-induced ATM signalling 
(A) 293A cells were transfected with siRNA against ATMIN, WRNIP1, RAD18 or 
Control siRNA for 72 hours and treated with IR (2Gy) before fixation and staining for 
pATM, 53BP1 and WRNIP1 immunofluorescence. (B) 293T cells were transfected 
with the indicated siRNAs for 72 hours and treated with IR (2Gy) before harvesting of 
whole cell lysate for western blot analysis.  
 
To confirm if pATM and 53BP1 localisation depends on the ability of WRNIP1 to 
interact with ubiquitin, we made use of an Ubiquitin Binding Zinc finger (UBZ) 
mutant of WRNIP1. Mutation to alanine of the highly conserved aspartate residue 
at position 37 of WRNIP1 (D37A) abolishes binding to both mono- and poly-
ubiquitin (Crosetto et al., 2008). Endogenous WRNIP1 was first depleted using 
siRNAs directed against the wrnip1 3’UTR, achieving almost complete knockdown 
as seen by WRNIP1 immunofluorescence. Complementation with wild-type 
siRNA-resistant WRNIP1 rescued 53BP1 and pATM focus formation in WRNIP1-
depleted cells. In contrast, complementing with D37A WRNIP1 mutant protein 
was unable to rescue pATM and 53BP1 focus formation (Figure 36A,B). This 
suggests that the UBZ domain of WRNIP1 is required to localise WRNIP1, pATM 
and 53BP1 to sites of replication stress.  
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Figure 36. 53BP1 and pATM localisation depends on WRNIP ubiquitin-binding domain. 
 
(A) 293A cells were transfected with siRNA targeting the 3’UTR of WRNIP1 for 48 
hours, followed by transfection with either vector, FlagWRNIP1 wildtype or the D37A 
UBZ mutant for another 24 hours, and treatment with Aph overnight prior to fixation 
and staining for immunofluorescence. Arrowhead indicates cells that have WRNIP1 
knockdown or re-expression. (B) Quantification of the percentage of WRNIP1 
transfected cells with 53BP1 or pATM foci. Cells were scored as positive if they 
harboured more than 6 foci. 
 
5.4 Knockdown of ATMIN increases ultrafine bridge formation 
during anaphase 
Along with ATR, ATM has been implicated in promoting the recovery of collapsed 
replication forks and prevention of DSB accumulation (Trenz et al., 2006). Our 
data show that ATMIN could play a role in regulating ATM function after 
replication stress. A sub-class of anaphase bridges, called ultrafine anaphase 
bridges (UFBs), were recently identified to contain DNA and coated with PICH 
(Plk1-interacting checkpoint helicase) and BLM (Blooms syndrome DNA helicase), 
but they are DAPI-negative. (Chan et al., 2007, Baumann et al., 2007) UFBs are 
commonly found at fragile sites in human cells during mitosis, and are believed to 
represent catenated DNA from incomplete DNA replication (Chan et al., 2007, 
Chan et al., 2009, Rouzeau et al., 2012). 
 
By co-staining with PICH and FANCD2, I observed a significant proportion of UFB 
formation (30% of all anaphases), as confirmed in both HCT116 and HeLa cell 
lines, in line with that of other published data (Chan et al., 2007) (Figure 25A). 
PICH, is believed to stabilise unresolved DNA under tension during anaphase and 
promote the resolution of concatenated DNA at anaphase. The frequency of UFB 
  138 
formation was elevated upon silencing ATMIN to a similar extent as Aph treatment 
(Figure 25B). Moreover, treatment with Aph in addition to silencing ATMIN does 
not further increase UFB formation, suggesting that the loss of ATMIN induces 
replication stress that phenocopies Aph treatment and that ATMIN could act in the 
same pathway as Aph in up-regulating UFB formation. 
 
To test whether UFB formation depends on ATM or ATR, cells were treated with 
either ATM inhibitor or siRNA against ATR and scored for UFBs. As expected, the 
loss of ATR increased UFB formation, presumably due to S phase checkpoint 
defect and failure to replicate unresolved DNA regions. The inhibition of ATM 
activity also increased UFB formation to a similar extent as ATR depletion (Figure 
25C,D). Hence, this suggests that in addition to ATR, ATM could also function in 
the detection and/or resolution of intermediates of stalled replication fork. 
Knocking down both ATM and ATR increased UFB formation more than individual 
knockdown alone, suggesting that both kinases have non-overlapping roles in 
suppressing UFB formation. Moreover, this role of ATM in suppressing UFB 
formation is dependent upon ATMIN but not on NBS1, as the knockdown of NBS1 
does not significantly increase UFB formation (Figure 25C). The knockdown of 
RAD18 also increases UFB frequency, similar to that of ATMIN knockdown, which 
supports that they could act in the same pathway. Furthermore, the knockdown of 
RAD18 in combination with ATM inhibition did not further increase UFB formation 
compared to siRAD18 alone, in line with the hypothesis that RAD18 functions in 
the same pathway as ATM. Hence, these data suggest that ATMIN, RAD18 and 
ATM could function in the same pathway in suppressing unresolved mitotic DNA 
structures as a result of replication stress. 
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Figure 37. ATMIN-mediated ATM signalling suppresses UFB and γH2AX formation. 
(A) Immunofluorescence of PICH and FANCD2 in HCT116 and HeLa cells, marking 
anaphase UFBs. (B-D) HCT116 or HeLa cells were transfected with the indicated 
siRNA for 72 hours and treated with Aph prior to fixation and immunofluorescence 
staining for PICH and FANCD2. Quantifications show the percentage of anaphases 
that display at least 1 UFB. (E) Quantification of total H2AX foci per metaphase after 
transfection of HCT116 with the indicated siRNA for 72 hours and treatment with Aph 
prior to fixation. Images were acquired as z-stacks in order to quantify all H2AX foci 
present. 
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In order to distinguish between the role of ATM in canonical DSB signalling versus 
signalling in response to replication stress, to show that the decrease in ATM 
signalling and foci formation is not due to a decrease in DSB formation, I 
investigated whether the knockdown of ATMIN or WRNIP affected 𝜸H2AX foci 
formation at metaphases. The loss of ATMIN or WRNIP increases, rather than 
decreases 𝜸H2AX formation, while ATM signalling is impaired (Figure 37E). This 
suggests that WAR-ATM pathway could be responding to another class of 
substrates, such as complex ssDNA-dsDNA or chicken-foot structures, which 
trigger ATM activation distinctly from the MRN-mediated DSB response.  
 
5.5 ATM signalling after replication stress does not depend 
on ATR 
Since ATR is the primary kinase that is recruited to ssDNA during replication 
stress, I wanted to investigate whether the ATM response is dependent upon ATR 
or if recruitment of both kinases occurs in parallel. The knockdown of ATR does 
not impair 53BP1 or RAD18 foci formation after Aph, hence suggesting that loss 
of ATR does not prevent RAD18 localising to sites of replication stress and that 
ATR is not required for ATM signalling after Aph (Figure 38A). Furthermore, the 
loss of ATR even upregulates ATM substrate phosphorylation after Aph compared 
to siControl by western blotting (Figure 38B), this could be due to the increased S 
phase damage in the absence of ATR. These data suggest that ATR and ATM 
are independently activated and recruited to sites of replication stress, and that 
ATR could even perhaps limit ATM activation until a later stage. One could 
speculate that early or prolonged activation of ATM in early S phase could direct 
cells to an apoptotic response, thus the activation of ATR in the first instance 
might inhibit ATM activation to allow the ATR-activated S phase checkpoint to 
resolve the replication problem, and only activating the ATM response if the 
barrier to replication persists after S/G2.  
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Figure 38. Knockdown of ATR does not impair ATM signalling after Aph. 
 
(A) 293A cells were transfected with the indicated siRNA for 72 hours and treated 
with Aph, prior to fixation and immunofluorescence staining. (B) 293T cells were 
transfected with siControl or siATR for 72 hours and treated with Aph, prior to harvest 
of WCL for western blotting.  
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Together with the UFB data, this suggests a model whereby ATR, as the central 
kinase that responds to replication fork stalling during S phase, might act in 
concert with ATM to suppress UFB formation. While they are independently 
recruited to sites of replication stress, ATR could act in an early step to preserve 
the integrity of the replication fork and limit the activation of ATM. When the 
replication stalling is prolonged, ATM is subsequently activated via the WAR 
complex and possibly in response to specific DNA structures and continues to 
protect any ssDNA and recombination intermediates until they are repaired during 
the next G1 phase. In addition to ATR, ATM could have a role in sequestering any 
underreplicated DNA that arises from prolonged replication stress from breakage 
to form DSBs, and this most likely involves the activity of 53BP1, which shields 
the underreplicated DNA nuclear bodies until the next cell cycle. 
 
Thus, ATMIN-mediated ATM signalling after replication stress is dependent on the 
WRNIP-ATMIN-RAD18 complex and could be activated by ubiquitinated PCNA 
along with other complex replication intermediate structures that is distinct from 
canonical IR-induced DSB stimuli. This could represent a novel mechanism of 
ATMIN-dependent ATM activation post-replication stress that is required for the 
protection of underreplicated DNA intermediates and maintenance of genomic 
stability.  
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Chapter 6. ATMIN genome screen for novel 
components of ATM-ATMIN pathway 
ATMIN is required for ATM signalling after non-canonical stimuli such as 
replication stress, chloroquine and hypotonic stress (Kanu and Behrens, 2007). It 
is also required for pATM and 53BP1 localisation after replication stress (Figure 
19A-C). In order to identify additional components of the ATM-ATMIN signalling 
pathway, we decided to use a genome-wide siRNA screening approach and 
immunofluorescence markers as readouts. The genome screen (primary and 
secondary screens) was carried out in collaboration with Joanna Loizou and the 
high-throughput screening facility at CRUK-LRI. I performed the deconvolution 
screen with the help of the high-throughput screening facility at CRUK-LRI and 
conducted the experiments to follow up the hits. 
6.1 Screening approach, controls and optimisation 
Initially, attempts were made at detecting endogenous ATMIN by 
immunofluorescence, using different in-house and commercial antibodies. 
However, while some of these antibodies gave nuclear foci stainings, there was 
no difference in staining observed in ATMIN wildtype or ATMIN-null MEFs (Figure 
39A, Janet Cronshaw). Hence, due to the lack of good antibody for IF, it was not 
possible to screen for endogenous ATMIN foci formation. Next, I tried to 
overexpress GFP-ATMIN and look for foci formation after such as after Aph or 
MMS. Previously, it has been reported that GFPATMIN localises to foci after MMS 
treatment (McNees et al., 2005). However, only a small fraction of GFPATMIN foci 
colocalised with 53BP1 after MMS; most of the GFPATMIN was pan-nuclear. The 
latter also did not form discrete foci after Aph or colocalise with Aph-induced 
53BP1 foci (Figure 39B). Moreover, the GFPATMIN foci, some of which partially 
colocalise with 53BP1 foci, were also observed in some cells in untreated 
conditions. Since the GFPATMIN foci formation did not appear to be stimulus 
specific possibly due to overexpression artefacts such as protein aggregation, as 
well as the low frequency of foci formation, it was not feasible to perform a 
genome screen with GFPATMIN as an immunofluorescence readout. Hence, an 
indirect approach was taken using pATM and 53BP1 foci, which could be 
visualised using commercial antibodies.  
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Figure 39. ATMIN immunofluorescence and localisation. 
(A) Immunofluorescence of endogenous ATMIN using in-house ATMIN antibody or 
commercial ASCIZ antibody under basal conditions. (Janet Cronshaw) (B) 
GFPATMIN was overexpressed in 293A cells for 24 hours and treated with MMS or 
Aph for 4 hours prior to fixation and immunofluorescence staining.  
 
In order to establish controls for the screen, several genes were chosen including 
ATMIN whose knockdown should result in decrease in pATM and 53BP1 foci after 
Aph, as evidenced by the ATMIN∆/∆ MEF data (Figure 19). ATMIN siRNA was 
used as a positive control, the knockdown of which results in a three-fold 
reduction in pATM and 53BP1 foci after Aph (Figure 40, Figure 41A,B). The aim 
would be to look for genes whose knockdown gives a similar reduction in foci 
formation as ATMIN. In addition, 53BP1 and ATM siRNA were also used as 
positive controls, while si53BP1 led to an efficient reduction in 53BP1 foci, siATM 
did not produce a consistent reduction in pATM foci (Figure 41A). This could be 
due to the pATM antibody recognising other phospho-epitopes that are similar to 
pATM. Despite optimising several pATM antibodies, we did not find one that gave 
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a clean reduction upon knocking down ATM, although the knockdown was 
confirmed by western blotting for total ATM. Hence, we proceeded with the screen 
using a highly-specific 53BP1 antibody and a less specific pATM antibody and 
also used siATMIN+siATM double knockdown as another positive control, which 
results in a greater reduction in foci than ATM alone. As such, the results of the 
screen as discussed later will be mainly based on 53BP1 results and that of pATM 
is used a secondary guide.  
 
RNF168 has been shown to play a role in amplifying the ubiquitination of 
chromatin around the DSB and in the retention of 53BP1 foci (Lukas et al., 2011a). 
Hence we also used RNF168 as a positive control. siRNF168 decreased 53BP1 
foci formation after Aph, and to a lesser extent pATM (Figure 41A,B). Lastly, we 
also used Chk1 as a control, since the Chk1 has been shown to play a role in an 
ATR/ATM-independent checkpoint response (Rodriguez-Bravo et al., 2006) and 
its knockown increases apoptosis (Cho et al., 2005). The knockdown of Chk1 
decreased foci formation but gave an intense pan-nuclear staining of pATM. 
Hence, hits that give a similar phenotype as siChk1 would be excluded. Using 
53BP1, ATMIN, ATM, RNF168 and CHK1 as controls, the screen was carried out 
aiming to identify genes whose knockdown decreases 53BP1 and pATM foci, 
which could imply that they play a role in ATM-ATMIN signalling pathway.  
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Figure 40. Immunofluorescence on HeLa Ohio cells after transfection with siRNA 
against control genes for 72 hours and Aph treatment. Images were acquired on 
Arrayscan high content analysis reader. 
 
 
Figure 41. Screen controls optimisation and primary screen control siRNA distribution. 
(A,B) pATM and 53BP1 foci were quantified by Arrayscan HCA reader after 
knockdown of control genes and treatment with Aph. (C) Distribution of control siRNA 
knockdown population mean z-score for pATM and 53BP1 after normalisation to 
correct for plate-to-plate variations. (OTP: Non-target control, rf: RISC-free control 
siRNA, sc: scrambled siRNA) 
 
Optimisation was performed on a 96-well plate format to select the optimal 
transfection reagent, cell density and Aph treatment conditions. HeLa Ohio cells 
were chosen based on their adherent morphology to facilitate 
immunofluorescence staining and rapid proliferation. The cells were reverse 
transfected with the siRNA library for 72 hours and treated with Aph during the 
last 24 hours before fixation. Different fixation and staining methods were also 
compared to optimise signal-to-noise ratio. Through re-iterative optimisation with 
the help of the High-throughput Screening facility, we established a consistent 
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signal to noise ratio and set thresholds to quantify 53BP1 and pATM foci using a 
Thermo Scientific Cellomics Arrayscan High Content Analysis Reader. Foci that 
fall below or above a set intensity and size were excluded from the quantification. 
Using a 96-well format, the primary screen was performed against a Dharmacon 
human cDNA library of 21289 genes in triplicates (Figure 42A). For each sample 
well, 15 images were acquired by random sampling in each of the three channels, 
DAPI, 53BP1 and pATM, so that at least 300-500 cells were sampled for each 
well. The z-scores were calculated from the average number of foci per cell for 
each sample, normalised against the median value of control siRNA for each plate 
in order to correct for plate-to-plate variations. From the control distribution of 
mean foci count per cell across the whole population, knockdown of ATMIN 
decreased mean 53BP1 foci z-score but had less effect on pATM foci z-score 
compared to non-target siRNA control (OTP), scrambled siRNA (SC) or risk-free 
siRNA (RF) (Figure 41C). This could be due to variability of pATM antibody 
staining or that the effect of ATMIN knockdown on pATM foci formation is not 
always consistently observed across all the plates.  
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Figure 42. Scheme of genome-wide siRNA screen. 
(A) Overview of screen strategy. HeLa Ohio cells were reverse transfected in 96-well 
format with human siRNA genome library for 72 hours, and Aph was added in the last 
24 hours prior to fixation and staining for immunofluorescence. Plates were analysed 
by Cellomics Arrayscan HCS reader. (B) Scheme of screen approach. Primary screen 
was carried out on a genome-wide level, followed by a secondary screen using repeat 
conditions, untreated conditions and IR. Selected hits were taken through another 
round of deconvolution screen. 
 
From the primary screen of 21289 genes, the 53BP1 and pATM z-scores were 
correlated to look for interesting hits that decreased both 53BP1 and pATM, 
increased both channels or decreased one channel but not the other (Figure 43A-
C). To select initial hits, we used a lower cut-off of -1.86 for 53BP1, which 
corresponds to the effect of ATMIN siRNA, and -2 for pATM as a more stringent 
threshold, and z-score greater than 2 was used an upper cut-off. Hits that 
decreased cell numbers by more than z-score of 2 based on the number of DAPI 
positive cells scored were discarded. By classifying the hits according to different 
cut-off zones, we identified 729 interesting candidates as shown by the coloured 
regions in Figure 43C. Bioinformatics analysis using the PANTHER classification 
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system shows that a majority of these hits are involved in cell metabolic 
processes (Figure 43D). Functional categorisation of genes using DAVID 
database revealed that the most enriched group encode for proteins involved in 
transcription and DNA metabolic processes (Figure 42E), which suggests that the 
selected hits are of physiological relevance, as ATMIN has been implicated in 
these processes. 
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Figure 43. Analysis of primary screen hits. 
(A,B) Scatter plot of z-scores from the primary screen for pATM and 53BP1 foci 
respectively. Arrows indicate the positions of controls and known genes such as 
MDC1 and TERF1. Dotted lines (-1.86 for 53BP1 and -2 for pATM) indicate 
thresholds used in the selection of hits. (C) Correlation of 53BP1 and pATM z-scores 
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and grouping of hits by category. Coloured regions represent the hits selected from 
the primary screen for further analysis. (D) PANTHER analysis of the selected hits for 
statistically significant sets according to their biological processes. The most 
significant categories of biological processes are represented in the pie chart 
(http://www.pantherdb.org). (E) Gene-ontology analysis using the DAVID database of 
genes from the most enriched group of biological processes 
(http://david.abcc.ncifcrf.gov). 
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6.2 Secondary screen and identification of hits 
In order to further dissect the roles of these initial hits whose knockdown de-
regulates 53BP1 and or pATM, a secondary screen was performed. For this 
screen, cells were treated with Aph, IR, or analysed under basal conditions 
(Figure 42B). Since ATMIN is not required for ATM signalling after IR, the 
secondary screen would reveal hits that are required strictly for ATM signalling 
pathway after Aph but not after IR and therefore may work with ATMIN, as well as 
any effects on ATM signalling under basal conditions. The secondary screen was 
repeated using the same conditions as before except for the addition of IR treated 
or untreated plates after siRNA transfection. 211 genes were selected from the 
secondary screen that successfully repeated the primary screen data. These were 
subsequently taken into a deconvolution screen using Aph treatment where an 
individual siRNA oligo was used instead of a pool of 4 siRNAs. 176 of the hits 
from the deconvolution screen were confirmed with at least 2 siRNA oligos 
showing a similar result as the pooled siRNA.  
 
From the secondary screen, there were hits that increased foci in all three 
conditions, or decreased in all three conditions, and those that increased in one 
condition and decreased in another. Some hits were common to both IR and Aph 
pathways, such as RNF8 and MDC1, which have been shown to play a role in the 
IR-induced DSB signalling. RNF8 is recruited to DSB sites via its FHA domain 
with phosphorylated MDC1, and is required for histone H2A ubiquitination and 
subsequent 53BP1 and BRCA1 localisation (Huen et al., 2007, Mailand et al., 
2007, Kolas et al., 2007). In line with published literature, knockdown of RNF8 
decreases 53BP1 foci formation after IR. Interestingly, 53BP1 foci formation after 
Aph is also impaired. A similar result is observed for MDC1. Hence, this suggests 
that RNF8 and MDC1 are upstream in 53BP1 recruitment after both IR and Aph. 
Conversely, there were some hits such as RAD9A and RAD51 that decreased foci 
after Aph and increase foci after IR. These were similar to the phenotype after 
ATMIN knockdown, which slightly increases ATM signalling after IR (Zhang et al., 
2012) and decreases foci formation after Aph. Hence, these hits are likely to play 
a similar role as ATMIN in regulating ATM signalling (Figure 44). 
  154 
 
Figure 44. Summary of secondary screen results. 
(A) Heat map showing fold change in 53BP1 foci compared to control siRNA under 
basal, Aph or IR conditions. Highlighted region represents hits of interest that 
decrease foci after Aph and increases after IR when depleted by siRNA. (B) Pie-chart 
showing number of hits from deconvolution screen and their effects after Aph and IR. 
(C) Representative images from the secondary screen showing hits that decrease foci 
after Aph and IR (RNF8, MDC1) and hits that decrease foci after Aph and increase 
after IR (RAD9A, RAD51). 
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Of the hits confirmed by deconvolution screen, we identified four genes that are 
involved in the protection against oxidative damage (Figure 45). OGG1, the DNA 
glycosylase that specifically removes 8-oxo-guanine (8-oxoG) from DNA, was 
identified as a top hit in reducing 53BP1 foci formation after Aph. Furthermore, 
loss of OGG1 has no effect on basal 53BP1 foci formation, and slightly increased 
foci formation after IR. Another highly related DNA glycosylase, MUTYH (MutY 
homolog), which cleaves the mismatched adenine from an A: 8-oxoG base pair, 
was also amongst the confirmed hits. Another enzyme of interest was NUDT1 
(also known as MTH1), the nucleoside diphosphatase that cleaves oxidised 
purine triphosphate to monophosphates and thereby prevents the 
misincorporation of oxidised bases into DNA, was also identified as a positive hit 
after Aph. These three enzymes constitute the 8-oxoG system that prevents the 
incorporation of oxidised bases and initiates the base excision repair of oxidised 
lesions. In addition, another cytoplasmic enzyme, GSTM5 (Glutathione s-
transferase mu 5) was also amongst the hits that decreased 53BP1 foci after 
replication stress. (For simplicity, these four genes will be collectively referred to 
as the 8-oxoG genes). 
 
Figure 45. Components of the 8-oxoG system identified through the screen. 
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8-oxoG occurs at a frequency of approximately 1000-2000 lesions per human cell 
per day (van Loon et al., 2010), thus making it the most prevalent form of DNA 
oxidative damage. 8-oxo-G is also highly mutagenic due to its ability to mimic 
thymine and form a mismatch base pair with adenine, leading to C:G to A:T 
transversion mutations.  C:G to A:T transversions have been reported to 
constitute one third of all somatic mutations in a small-cell lung cancer cell line 
(Pleasance et al., 2010b). Moreover, they have been identified as the second 
most prevalent mutational signature in melanoma cells in a study of somatic 
mutations from an individual cancer genome (Pleasance et al., 2010a). Ingenuity 
pathway analysis shows the biological networks in which these 8-oxoG genes 
have a known role, and there is no data showing any interaction with ATM (Figure 
46). Despite no previous link with ATM, that the 8-oxoG system and oxidation 
protection enzymes were identified as top hits in the screen implies a hitherto 
unknown link between base excision repair and ATM signalling.  
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Figure 46. Ingenuity pathway analysis of OGG1, GSTM5, MUTYH and NUDT1 and their 
interaction networks respectively. Symbols that represent classes of genes and arrows 
that represent relationship are shown above and below.  
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6.3 The knockdown of 8-oxoG genes impairs ATM signalling 
after replication stress, but not after IR 
In order to validate the hits, siRNA experiments were repeated on a 24-well format 
with HeLa Ohio cells. As observed for the screen, the knockdown of 8-oxoG 
genes led to a decrease in 53BP1 and pATM foci formation upon Aph treatment 
(Figure 47). Some hits, such as NUDT1, have a greater effect, while others such 
as GSTM5 have a less dramatic phenotype. This could be due to specificity of 
action of some proteins and redundancy of others in the pathway, as such I also 
used MUTYH and OGG double siRNA knockdown to check for additive effects. 
The additive effect of combined knockdown of MUTYH and OGG1 implies that 
they could have redundant roles in the pathway.
 
Figure 47. Loss of 8-oxoG genes impairs ATM signalling after Aph. 
(A) Immunofluorescence of pATM and 53BP1 foci on HeLa Ohio cells after 72 hours 
transfection with the indicated siRNA and treated with Aph during the last 24 hours 
prior to fixation. (B) Quantification of percentage of cells positive for 53BP1 foci. Cells 
were scored as positive if they harboured more than 8 foci.  
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The immunofluorescence data was further validated in 293 cells, whereby 
knockdown of the 8-oxoG genes led to similar decreases in 53BP1 and pATM foci 
formation. To test whether the loss of foci depends on reactive oxygen species 
(ROS), a superoxide dismutase mimetic, TEMPOL (4-hydroxy-2,2,6,6-
tetramethylpiperidin-1-oxyl), was used as a ROS scavenger, which has previously 
been shown to protect against H2O2-induced oxidative damage (Hahn et al., 
1992, Hahn et al., 1997). Addition of TEMPOL rescued the 53BP1 and pATM foci 
formation after Aph in each 8-oxoG gene knockdown, with OGG and GSTM5 
having the highest rescue to near wildtype levels (Figure 48A-C).  This was also 
confirmed by western blot showing ATM substrate phosphorylation. While the 
knockdown of ROS genes led to decrease in phosphorylation of ATM substrates 
such as Kap1, SMC1 and p53, the addition of TEMPOL increased the 
phosphorylation levels for most 8-oxoG genes (Figure 48B). These data suggest 
that ATM signalling after Aph is impaired in the absence of 8-oxoG genes, and 
removal of oxidative stress by TEMPOL could augment ATM signalling in 
replication stress conditions.  
 
To rule out any possible off-target effects of the siRNA, I also deconvoluted the 
siRNA pools against the hits of interest by cloning each siRNA sequence into an 
shRNA vector, and observed that the two best shRNAs gave a similar effect on 
ATM signalling as that seen in siRNA knockdowns (Figure 49A). Also, I verified 
that TEMPOL does not induce ATM signalling on its own, I compared ATM 
substrate phosphorylation by western blot after control siRNA treatment with or 
without TEMPOL treatment and saw no significant increase at basal conditions or 
after Aph. Hence, TEMPOL is able to exert its effect in augmenting ATM signalling 
only after 8-oxo-G dependent impairment in ATM signalling (Figure 49B).  
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Figure 48. ROS scavenger TEMPOL rescues ATM signalling. 
(A, B) Immunofluorescence of pATM and 53BP1 in 293A cells after 72 hours 
transfection with the indicated siRNA and Aph treatment prior to fixation, either with or 
without the addition of TEMPOL to the medium throughout the duration of the 
transfection. (C) Quantification of percentage of cells positive for 53BP1 foci. Cells 
were scored as positive if they harboured more than 8 foci. (D) 293T cells were 
transfected with the indicated siRNA with or without TEMPOL for 72 hours and 
treated with Aph in the last 24 hours prior to harvest of whole cell lysate for western 
blot analysis. 
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TEMPOL has been previously reported to protect cells against IR-induced 
chromosome aberrations such as dicentric, ring and triradial chromosomes and 
protect mice against whole body irradiation (Mitchell et al., 1991, Liebmann et al., 
1994, Johnstone et al., 1995). Recently, it has also been shown to directly 
counteract the increase in oxidative DNA lesions such as 8-oxoG and sister 
chromatid exchange caused by vorinostat (histone deacetylase inhibitor) 
treatment (Alzoubi et al., 2013). Hence, the decrease in ATM signalling after Aph 
could be due to an increase in 8-oxoG lesions, which is rescued after treatment 
with TEMPOL.  
 
Figure 49. Deconvolution of screen hits and effect of TEMPOL on ATM signalling. 
(A) 293T cells were transfected with the indicated shRNA constructs for 72 hours and 
treated with Aph prior to harvest of WCL for western blotting. (B) 293T cells were 
treated with or without TEMPOL for 72 hours and treated with Aph prior to harvest of 
WCL for western blotting. (C) 293T cells were transfected with the indicated siRNA for 
72 hours prior to labelling with CM-H2DCFDA and total cellular ROS level was 
quantified by fluorescence intensity by FACS. Luperox treatment (1 hour, 10uM) was 
used as a positive control. 
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In order to test whether the effect on ATM signalling is due to changes in overall 
cellular ROS levels, or accumulation of oxidised nucleotides such as 8-oxoG, 
ROS labelling was performed to measure the ROS levels after knockdown of 8-
oxoG genes. Using CM-H2DCFDA as a general ROS label and luperox (a highly 
active peroxide) treatment as a positive control, I observed that the knockdown of 
8-oxoG genes did not change the overall ROS level appreciably compared to 
control (Figure 49C). Hence, the effects on ATM signalling is most likely due to 
other forms of oxidation such as 8-oxoG formation and not a change in overall 
ROS levels. However, a direct measurement of 8-oxoG level by 
immunofluorescence was not successful, this could be due to the epitope being 
too small to be detected by IF. Moreover, I also tried to validate the data using 
ogg1∆/∆ primary MEFs isolated from ogg1∆/∆ mice (Klungland et al., 1999). IF 
studies showed that ogg-null MEFs were still able to form 53BP1 and pATM foci 
after Aph compared to WT (Figure 50A). By western blot, both Ogg wildtype and 
knockout MEFs show ATM substrate phosphorylation after Aph, with even higher 
levels in the knockout, and knockdown of MUTYH in these MEFs also did not 
have any effect (Figure 50B). This discrepancy could be due to species-specific 
differences and redundancies in the GO pathway in mouse cells that are not 
present in human HeLa or 293 cells. Hence, the MEF system was not used any 
further for this study.  
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Figure 50. Validation using Ogg1 knockout MEFs.  
(A) Immunofluorescence showing pATM and 53BP1 staining on Ogg1 wildtype or 
knockout MEFs after treatment with Aph. (B) Ogg1 wildtype or knockout MEFs were 
transfected with siMUTYH or siControl for 72 hours and treated with Aph prior to 
harvest of WCL for western blot analysis. 
  
While the knockdown of 8-oxoG genes impaired ATM signalling after Aph, the 
ATM-mediated DSB response after IR was not affected, as judged by pATM and 
53BP1 foci formation and ATM substrate phosphorylation (Figure 51). Hence, the 
effect of 8-oxoG genes on ATM signalling is specific to replication stress and does 
not affect MRN-dependent ATM activation after IR. 
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Figure 51. knockdown of 8-oxoG genes do not affect IR-induced ATM signalling. 
(A) Immunofluorescence of pATM and 53BP1 in 293A cells after 72 hours 
transfection with the indicated siRNA and treatment with IR (2Gy) prior to fixation. (B) 
Western blot of 293T cells with the same treatment as in (A) and whole cell lysate 
harvested for western blot analysis. (C) QPCR of total mRNA from the same 
experiment as in (A) to show the siRNA knockdown efficiency of the indicated genes. 
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6.4 Loss of 8-oxoG genes impairs RAD18 foci formation after 
replication stress 
Since we have previously shown that RAD18 is required to localise pATM and 
53BP1 to sites of replication stress, I investigated whether the impairment in 
53BP1 foci formation could be due to a defect in RAD18 recruitment. Indeed upon 
the knockdown of 8-oxoG genes, there was a reduction in RAD18 foci formation, 
which could be rescued to wildtype levels by addition of TEMPOL (Figure 52A,B). 
RAD18 has been previously reported to bind to forked DNA structures as well as 
ssDNA tails in vitro via its SAP (SAF-A/B, Acinus and PIAS) domain (Tsuji et al., 
2008). A biotinylated DNA template with 40-mer dsDNA and 80-mer ssDNA was 
used in a pull down assay with recombinant human RAD18. While RAD18 was 
bound to the unmodified DNA template, oxidation of the DNA using H2O2 
decreased the RAD18 interaction (Figure 52C, right panel). Published data 
showed that the lower concentration of H2O2 (3mM) was sufficient to generate 
34.95nmol/mg 8-oxoG DNA as measured by gas-chromatography mass 
spectrometry (Whiteman et al., 2002), but was not high enough to degrade the 
DNA template as analysed by separating the DNA strands on a denaturing urea-
PAGE (Figure 52C). Hence, the knockdown of 8-oxoG genes could affect RAD18 
binding to ds-ssDNA junctions due to the oxidation of DNA. The SAP domain on 
RAD18 has a helix–extended-loop–helix structure that is homologous to that of 
PIAS, which is proposed to bind in the minor groove of DNA (Tsuji et al., 2008, 
Okubo et al., 2004). One could speculate that in the absence of functional 8-oxoG 
genes, the excessive base oxidation may distort the conformation of the DNA 
minor groove, thereby preventing RAD18 binding to ssDNA-dsDNA junctions at 
stalled replication sites.  
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Figure 52. Knockdown of 8-oxoG genes and DNA oxidation impairs RAD18 binding to 
DNA. 
(A) Immunofluorescence of RAD18 foci in 293A cells transfected with the indicated 
siRNA for 72 hours and treated with Aph prior to fixation. (B) Quantification of 
percentage of cells with RAD18 foci. Cells were scored as positive if they harbour 
more than 8 foci. (C) In vitro pull-down of RAD18 using biotinylated DNA oligos. 
Biotinylated annealed DNA oligos were oxidised in vitro with H2O2 or untreated and 
then incubated with recombinant RAD18 before immunoprecipitation with streptavidin 
beads and blotting against RAD18 (right panel). (Beads: no DNA oligo, Input: no 
beads or DNA oligo). An aliquot of DNA fragment was subjected to denaturing urea-
PAGE (left panel) to check for presence of both strands. 
  168 
6.5 Knockdown of 8-oxoG genes increases ultrafine bridge 
formation during anaphase 
If the knockdown of 8-oxoG genes affects RAD18 localisation to sites of 
replication stress and thereby impairs 53BP1 foci formation, I wanted to 
investigate whether this has a similar functional consequence as the loss of 
ATMIN in anaphase bridge formation. Indeed, under basal conditions, the 
knockdown of 8-oxoG genes induces a heightened frequency of anaphase 
bridges coated with PICH and are sometimes DAPI-positive (Figure 53A,B). 
These anaphase bridges can also be suppressed with TEMPOL, which correlates 
with the rescue of foci and signalling. That the loss of 8-oxoG genes has a similar 
phenotype could be due to the increased barrier to replication posed by 8-oxo-G 
and other products of DNA oxidation, which also impairs RAD18 from binding 
DNA and downstream ATM activation. 
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Figure 53. Knockdown of 8-oxoG genes increases anaphase bridge formation. 
(A) Representative images of different types of anaphase bridges that can be 
observed in untreated HCT116 cells, marked by DAPI and/or FANCD2 and PICH 
immunofluorescence staining. (B) Quantification of percentage of anaphases that 
display at least one UFB. HCT116 cells were transfected with the indicated siRNA for 
72 hours and fixed for PICH and FANCD2 immunofluorescence staining as in (A).  
 
6.6 Knockdown of 8-oxoG genes reduces RAD18, ATM and 
53BP1 localisation to induced fragile sites 
In order to directly visualise the localisation of 53BP1 at replication stress site, I 
used a traceable Lac operator-harbouring cell line that has stable integration of 
256 repeats of the Lac operator (LacO) site, followed by 18 nucleotide ISceI 
restriction site and 96 copies of the tetracycline response element TetO on 
chromosome 3 (Figure 54) (Soutoglou et al., 2007). It has been shown that, when 
combined with fluorescent lacR expression, the lacO site can act as an inducible 
fragile site that also undergoes UFB formation and stains positively for PICH 
(Jacome and Fernandez-Capetillo, 2011). Hence, this system represents a 
method of directly visualising protein localisation at an induced fragile site. 
 
Figure 54. Schematic of the stable lac operator HeLa cell line. (Adapted from Soutoglou 
et al., 2007) 
 
By using this system, I observed Rad18, 53BP1 and pATM colocalise with cherry-
lacR foci when the latter is overexpressed (Figure 55A). Furthermore, the 
colocalisation with 53BP1 is enhanced upon Aph treatment (Figure 55B), which 
enhances fragile site expression. In agreement with data on 53BP1 foci formation 
and ATM signalling, the loss of 8-oxoG genes reduced the colocalisation of 
cherry-lacR with pATM and 53BP1 and this is most likely due to reduced RAD18 
localisation to the site.  
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Figure 55. 8-oxoG genes are required for 53BP1 and pATM localisation to inducible 
fragile site cherrylacR.  
(A) 293A cells were transfected with the indicated siRNA for 72 hours. After 24 hours, 
they were transfected with cherrylacR. In the last 24 hours, they were treated with 
Aph prior to fixation and immunofluorescence staining. (B) Quantification showing 
percentage of cherrylacR positive cells that also harbours a colocalised 53BP1 fous 
with or without Aph treatment. (C) Quantification of percentage of cells with 
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cherrylacR that also shows colocalisation with RAD18, pATM or 53BP1 from 
experiment in (A). At least 100 cells were scored for each treatment. (D) 
Quantification of percentage of cells with cherrylacR that also shows colocalisation 
with ATR after a similar experimental set-up as in (A). (E) Quantification of 
percentage of cells with cherrylacR that also shows colocalisation 53BP1. Cells were 
treated as in (A), with the exception of treatment with ATM inhibitor 1 hour prior to 
Aph treatment. 
 
On the other hand, ATR recruitment to the inducible fragile site was not changed 
in the absence of 8-oxoG genes (Figure 55D). Since ATR recruitment depends on 
the RPA-ssDNA signal, it is most likely not affected by the loss of 8-oxoG genes. 
In order to understand the relative contribution of ATR and ATM to the GO 
phenotype, I checked the effect of ATR knockdown or ATM inhibition on 
cherrylacR-53BP1 colocalisation. While the inhibition of ATM activity decreased 
53BP1 colocalisation with cherrylacR, the knockdown of ATR slightly increased 
53BP1 it. Hence, the data suggest that the localisation of 53BP1 to the cherrylacR 
fragile site is dependent on the ATM pathway, but not ATR.  
 
 
Figure 56. OGG1 interacts with ATM when overexpressed. 
293T cells were transfected with GFP-OGG1 or vector for 24 hours and treated with 
Aph prior to harvest of WCL for ATM IP and western blot analysis.  
 
In addition to affecting RAD18 foci formation, another mechanism by which OGG1 
could contribute to ATM signalling could be by interacting with it.  Using co-
immunoprecipitation, I observed that GFP-OGG interacts with endogenous ATM 
under basal conditions and to a lesser extent after Aph (Figure 56). Furthermore, 
overexpression of OGG1 slightly increases ATM signalling after Aph as shown b y 
pKap1 and pP53 phosphorylations. One could speculate that as it scans the DNA 
for mismatched 8-oxo-G:C basepairs, OGG1 may form a signalling platform on 
which inactive ATM docks. This perhaps facilitates its activation on chromatin 
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where oxidative DNA lesions stall replication. Upon Aph treatment, the limiting 
pool of ATM would be activated via the WAR complex, thus leaving the OGG1 
platform and leading to less OGG1-ATM interaction. Thus, it could be possible 
that in addition to its role in base excision repair, OGG1 positioning at strategic 
locations on the chromatin also facilitates the activation of ATM upon replication 
stress, as oxidised DNA could serve as an early signal of a replication problem. 
Recently, a novel interaction has been identified between OGG1 and PARP1, that 
OGG1 is required to facilitate PARP1 activity in DNA repair and can stimulate 
PARP1 activity in vitro (Noren Hooten et al., 2011). Hence, a similar mechanism 
could exist that facilitates ATM activation after oxidative or replication stress, 
making use of a protein that is specifically recruited to sites of oxidised DNA.  
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Chapter 7. Discussion 
7.1 ATMIN NBS1 competition model 
7.1.1 ATMIN can influence NBS1-dependent ATM signalling at DSBs by 
competition. 
We have shown that altering ATMIN levels can directly impinge upon ATM 
signalling via the canonical MRN-dependent pathway. Increasing ATMIN by 
overexpression impairs ATM signalling and damage foci formation after IR, and 
reduces ATM-NBS1 interaction. Conversely, depleting ATMIN genetically or by 
siRNA leads to an increase in ATM signalling even in basal conditions. This most 
likely depends on the C-terminal ATM interaction motif of ATMIN, which is 
necessary and sufficient for the competition with NBS1. The ATMIN-dependent 
downregulation in ATM signalling can be rescued by overexpression of NBS1, 
which suggests a controlled stoichiometry is required to maintain the balance 
between these two cofactors. Hence, the protein level, localisation or affinity of 
ATMIN and NBS1 must be tightly regulated in the cell to ensure the correct 
balance and appropriate pathway of ATM activation.   
 
Conversely, NBS1 can also influence, to some extent, ATMIN-dependent ATM 
signalling after osmotic stress. This suggests that the competition could act in 
both ways; although the effect of NBS1 on osmotic stress-induced ATM signalling 
is less dramatic, this could be due to additional mechanism on NBS1 that are 
required to regulate NBS1’s interaction with ATM in addition to protein levels. For 
instance, it has been shown that ATM can still interact with the MRN in the 
absence of NBS1 C-terminal ATM interaction motif (Difilippantonio et al., 2007) 
and evidence from gel filtration experiments also showed that ATM can make 
contacts with MRE11/RAD50 in the absence of NBS1(Lee and Paull, 2004). 
 
7.1.2 nbs1∆/∆; atmin∆/∆ double mutant cells have a similar phenotype as 
atm-/- cells 
nbs1-null MEFs undergo premature senescence and have poor viability in culture, 
whereas atm-null MEFs are viable in culture. The loss of ATMIN rescues cell 
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viability and proliferation of nbs1-null cells, despite the high levels of endogenous 
DNA damage in the double knockout cells. This suggests that the phenotypes of 
nbs1-null cells cannot be ascribed solely to accumulation of DNA damage per se, 
rather the deleterious effects could be due to enhanced ATMIN-dependent ATM 
signalling, possibly via heightened activity of p53 or other ATM substrates.  
 
In response to IR, nbs1-/-; atmin-/- double knockout cells are extremely 
radiosensitive owing to the complete absence of ATM signalling. Similarly, 
atminΔG/ΔG; nbs1ΔG/ΔG mice are extremely sensitive to whole-body irradiation; 
the intestines shows extensive DNA damage and cell loss, with no IR-induced 
53BP1 foci formation and ATM signalling. As such, the concomitant loss of ATMIN 
and NBS1 shifts the cellular phenotype to that of ATM knockout. These data also 
implicate ATMIN and NBS1 as the only cofactors of ATM; in the absence of NBS1, 
the residual ATM signalling could be ATMIN-dependent.  However, ATM 
activation by disulphide-crosslinking appears to be unaffected in the absence of 
NBS1 and ATMIN (Figure 17B). This could represent a mode of ATM activation 
that does not require any cofactor binding. 
 
7.1.3 Future perspectives 
The loss of ATMIN can rescue the embryonic lethality in NBS1-null mice, as well 
as the loss of the progenitor population in the intestinal crypts when NBS1 is 
deleted in the intestine by villin-creERT. It would be interesting to find out if 
deletion of ATMIN can also rescue the phenotypes in the humanised NBS1 
mouse model (Difilippantonio et al., 2005), such as microcephaly, 
immunodeficiency, increased cancer predisposition and radiosensitivity. It is still 
unclear which of the NBS1 phenotypes is a direct consequence of NBS1-ATM 
signalling. If ATMIN loss can rescue some of these phenotypes, it could imply that 
competition with NBS1 in the regulation of NBS1-ATM signalling plays a key role 
in vivo. 
 
One could speculate that the competition model could also have therapeutic 
potential in radiotherapy. In NBS1-proficient scenario, it has been reported that 
ATM signalling conferred protection against IR-induced enteritis in mice (Westphal 
et al., 1997). Hence, perhaps the specific downregulation of ATMIN in the 
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intestine could boost ATM signalling and hence reduce the side effects of enteritis 
in radiotherapy? Conversely, if ATMIN expression could be upregulated in tumour 
cells, this might reduce NBS1-dependent ATM signalling and make the latter more 
susceptible to IR-induced apoptosis at a lower dose that results in less damage to 
healthy tissue.  
 
Figure 57. Competition between ATMIN and NBS1 regulates ATM signalling pathway 
choice. 
(A) Under basal conditions, ATM exists predominantly as an inactive dimer. It is able 
to associate with either ATMIN or NBS1 as its cofactor depending on the stimuli. After 
IR, ATM preferentially interacts with NBS1, which lead to its activation. Upon osmotic 
shock, replication stress and other chromatin-modifying stimuli, ATM preferentially 
interacts with ATMIN and the non-canonical pathway is activated. (B) In the absence 
of ATMIN, ATM signalling after IR is augmented, resulting in greater intensity of foci 
formation and increased ATM substrate signalling. (C) Increase in ATMIN level 
impairs ATM-NBS1 interaction and dampens IR-induced ATM signalling.  
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7.2 UBR5-mediated ATMIN ubiquitination is required for IR-
induced ATM signalling 
While ATM associates with NBS1 or ATMIN under different stimuli, it is unclear 
how this change in interaction is regulated. If ATMIN is the cofactor that binds 
inactive ATM under basal conditions and contributes to the basal state of ATM 
signalling (Kanu and Behrens, 2007), how does ATM rapidly shift to interact with 
NBS1 upon IR? Our data suggests that UBR5 could be regulating ATMIN affinity 
for ATM by N-terminal ubiquitination on ATMIN, and this post-translational 
modification is required for canonical NBS1-dependent ATM activation. 
 
7.2.1 ATMIN ubiquitination is required for IR-induced ATM signalling 
UBR5 is a HECT domain E3 ligase that interacts constitutively with ATMIN in the 
nucleus, whose E3 activity is augmented rapidly after IR (Figure 24). However, 
the ubiquitination does not appear to affect ATMIN protein stability and loss of 
UBR5 has little effect on ATMIN levels. We showed that the ubiquitination occurs 
on the N-terminus of ATMIN (Lys238) and seems to be a mono-ubiquitination 
(Figure 25). In the absence of UBR5 we observed a reduction in ATM signalling 
and a concomitant increase in ATMIN-ATM interaction. This is phenocopied by 
using a mutant ATMIN that cannot be ubiquitinated. Hence, the ubiquitination 
could act as a molecular switch that regulates ATMIN’s affinity for ATM. In the 
absence of this PTM on ATMIN, as shown by the ATMIN K238R reconstituted 
MEFs, ATM signalling and checkpoint functions are severely impaired (Figure 29).  
 
Interestingly, given that ATMIN has many lysine residues, the site of ATMIN 
ubiquitination is separated by about 500 amino acids in primary amino acid 
sequence from the ATM interaction motif, a main point of ATMIN/ATM interaction 
(Kanu and Behrens, 2007, Zhang et al., 2012), raising the question of how 
ubiquitination is able to affect interaction with ATM. One could speculate that 
ATMIN ubiquitination may impair ATM binding by steric interference, or could 
induce an allosteric change in ATMIN that decreases affinity for ATM.  
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7.2.2 Regulation of UBR5 activity and stability 
In response to IR, UBR5-mediated modification of ATMIN is stimulated, resulting 
in increased ATMIN ubiquitination. While it is possible that this is due to increased 
availability of the K238 site, or other changes, IR stimulation may also induce 
post-translational modification of UBR5 itself directly to increase its enzymatic 
activity. UBR5 is a heavily phosphorylated protein, and many phosphorylation 
sites on UBR5 have been reported in the literature, mostly identified by large 
scale proteomics studies. In particular, UBR5 was found to be phosphorylated on 
9 SQ/TQ sites, predicted phosphorylation sites of ATM/ATR kinases, in response 
to DNA damage (Mu et al., 2007, Matsuoka et al., 2007). It is therefore 
conceivable that increased activity of UBR5 after IR is at least in part mediated by 
DNA damage-induced UBR5 phosphorylation. Our finding that inhibition of DNA 
damage-induced kinases reduced ATMIN ubiquitination (Figure 25E) supports this 
notion. While it may seem paradoxical that ATM is required for UBR5 activation 
and UBR5 is also required for ATM activation after IR, this could be due to a 
positive feedback mechanism that is common in DNA damage signalling to 
facilitate the rapid activation and recruitment of multiple factors to amplify the 
signalling cascade. 
 
Whilst silencing UBR5 in cells does not change ATMIN levels appreciably, UBR5 
levels greatly decrease in response to IR in atminΔ/Δ cells (Figure 28), and ATMIN 
overexpression can significantly increases UBR5 protein levels (data not shown). 
Many E3 ubiquitin ligases regulate their protein levels by auto-ubiquitination, and 
that proteasome inhibition can stabilise UBR5 protein level (Figure 30D) suggests 
that this is also the case for UBR5. Owing to its large molecular weight, UBR5 
ubiquitin assay was made technically difficult. Nevertheless, it is possible that if 
the preferred substrate ATMIN is not available, IR-induced UBR5 activity may 
result in auto-ubiquitination, and thus degradation. 
 
7.2.3 Ubiquitination mediates the switch from ATMIN- to MRN-dependent 
ATM signalling 
 
The MRN complex is responsible for the initial recognition of DSBs upon 
genotoxic stress and recruits ATM to DNA damage foci for its subsequent 
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activation (Lee and Paull, 2005). NBS1 is a key component of the MRN complex, 
which serves as a bridging factor for the interaction of Mre11 with ATM (Williams 
et al., 2007). Thus, NBS1 is central to the ability of the MRN complex to activate 
ATM. 
Interestingly, NBS1 as well as ATMIN is modified by ubiquitination upon IR 
treatment. Recently, it has been shown that Skp2 E3 ligase is a critical regulator 
required for the recruitment of ATM by the MRN complex, and subsequent ATM 
activation in response to DSBs. Skp2 triggers K63-linked ubiquitination of NBS1, 
which increases NBS1 interaction with ATM, in turn facilitating activation and 
recruitment of ATM to DNA damage foci (Wu et al., 2012).  
 
While ATMIN ubiquitination decreases its affinity for ATM, NBS1 ubiquitination 
increases its interaction with ATM, thereby mediating the switch from ATMIN- to 
MRN-dependent ATM signalling in response to IR. In addition, the competitive 
relationship between ATMIN and NBS1 implies that reduced interaction with 
ATMIN also contributes to this switch by making more active monomeric ATM 
available for interaction with MRN. Thus, the data suggest that IR-induced 
ubiquitination of two key molecules that determine ATM pathway choice, ATMIN 
and NBS1, is an essential mechanism in promoting ATM signalling at DSBs 
(Figure 42). 
 
Given that the Drosophila homologue of UBR5 was initially identified as a tumour 
suppressor, it is somewhat surprising that in some human cancers including 
breast, ovarian and colon, more than 50% of cancers are associated with UBR5 
gene copy number gains (COSMIC database). One hypothesis is that tumour 
cells may upregulate UBR5 expression to facilitate ATM signalling to protect 
against the increased DNA damage load or to gain resistance to radiotherapy. 
However, one cannot rule out other targets of UBR5 that could also play a role in 
tumourigenesis. Future studies using an in vivo conditional UBR5 mouse model 
will provide additional insight to its role in DNA damage signalling and during 
development. 
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Figure 58. Model showing how ubiquitination of ATMIN and NBS1 facilitate ATM 
interaction with the MRN complex at DSBs.  
Upon IR stimulation, ATM monomerises and can bind either NBS1 or ATMIN. IR-
induced UBR5 E3 activity ubiquitinates ATMIN and decreases the interaction of the 
latter with ATM, while SKP2 ubiquitinates NBS1 and this promotes the NBS1-ATM 
interaction, thereby ensuring that ATM interacts with the correct cofactor after IR. 
  
  180 
7.3 The WRNIP-ATMIN-RAD18 complex and ATM signalling 
after replication stress 
7.3.1 ATMIN is required for ATM signalling after replication stress 
We have shown that ATMIN is required as a cofactor of ATM for signalling in Aph 
conditions. The loss of ATMIN phenocopies the loss of ATM in failure to form 
53BP1 foci and impairment in ATM substrate phosphorylation after replication 
stress (Figure 31). The loss of ATMIN results in increased DNA damage and 
chromosome segregation errors as seen by increased anaphase bridge formation 
(Figure 25). Furthermore, cells that have lost ATMIN also have difficulty 
recovering from replication stress (Figure 19F,G). Mechanistically, ATMIN 
interacts with WRNIP1, which, like its yeast homologue MGS1 (Saugar et al., 
2012), can interact with ubiquitinated PCNA at sites of replication stress. WRNIP 
can also interact with RAD18, the E3 ligase that mono-ubiquitinates PCNA at 
Lys164 to activate translesion synthesis (Stelter and Ulrich, 2003, Kannouche et 
al., 2004, Watanabe et al., 2004). This is further supported by the data that 53BP1 
and pATM foci formation depends on a functional UBZ domain on WRNIP1, as a 
mutant WRNIP1 that is unable to bind ubiquitinated proteins fails to rescue 53BP1 
and pATM foci formation. 
 
7.3.2 The WAR complex is specific for ATM signalling after Aph 
WRNIP1, RAD18 and 53BP1 form foci, which colocalise at sites of replication 
stress after Aph, marked by RPA. While ATMIN, WRNIP1 and RAD18 are all 
required for 53BP1 foci formation and ATM substrate phosphorylation after Aph, 
they are not required for ATR-mediated phosphorylation of CHK1 (Figure 22). 
This suggests that the WAR complex is not required for ATR activation, which 
depends on ssDNA-RPA, the 9-1-1 complex and TOPBP1 (Cimprich and Cortez, 
2008, Flynn and Zou, 2011). Moreover, the knockdown of ATR does not impair 
ATM activation by the WAR complex, hence suggesting that this pathway of ATM 
signalling does not seem to lie downstream of ATR (Figure 26).  
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Furthermore, the WAR complex is not required for canonical ATM signalling in 
response to IR-induced DSBs (Figure 23). This suggests that ATM activation by 
WAR could be intrinsically different from that mediated by the MRN complex. It 
cannot be ruled out that the MRN complex could also play a role during replication 
stress, as it was shown recently that NBS1 is required for an alternative pathway 
of ATR activation to phosphorylate RPA32 (Shiotani et al., 2013). The MRN 
complex has been reported to colocalise with PCNA during unperturbed S phase 
(Maser et al., 2001) and is required for S phase checkpoint following IR (Gatei et 
al., 2000b, Zhao et al., 2000, Wu et al., 2000, Lim et al., 2000). In addition to its 
role in ATM-dependent G2/M checkpoint following IR, NBS1 is also required for 
ATR-dependent and replication-independent checkpoint response to UV (Stiff et 
al., 2008). 
 
However, there is also some evidence that NBS1 is dispensable for replication 
stress signalling by ATM. nbs1-null B cells show similar ATM and p53 
phosphorylation after replication stress as wildtype cells (Difilippantonio et al., 
2005). Furthermore, it has been shown recently using deficient cell lines, that 
ATM, Mre11, and Rad50, but not Nbs1 and H2AX, are required for cell survival 
and recovery from gemcitabine-induced stalled replication forks (Ewald et al., 
2008). Hence, while the MRN complex contributes to ATR signalling after 
replication stress, it has not been shown to be required for ATM signalling after 
replication stress, which as our data suggests, depends on WRNIP1, ATMIN and 
RAD18. More biochemical evidence is required to fully dissect the involvement of 
the WAR complex in activation ATM in response to Aph. The identification of the 
DNA substrate responsible for ATM activation under Aph conditions, using 
techniques such as 2-D agarose gel electrophoresis, together with recombinant 
proteins or cell-free extracts would provide an in vitro approach to analyse the 
components required for ATM activation after replication stress.  
7.3.3 WAR-dependent ATM signalling does not depend on ATR 
ATR has been shown to be the primary kinase that responds to replication stress 
(Flynn and Zou, 2011) and ATM is believed to be activated following replication 
stress due to the DSBs formed when DNA polymerases encounter SSBs or basic 
sites. In addition, Stiff et al. showed that ATM autophosphorylation following UV or 
hydroxyurea is dependent on ATR, which could also phosphorylate ATM S1981 
  182 
site in vitro (Stiff et al., 2006). Our data suggests that at least under Aph 
conditions, the transient knockdown of ATR does not decrease ATM 
autophosphorylation or substrate phosphorylation; ATM signalling and IRIF were 
increased compared to control (Figure 38). The difference could be due to the 
type and duration of drug treatment used (short treatment of hydroxyurea versus a 
prolonged treatment with aphidicolin), or cell type differences between hTERT-
immortalised ATR-Seckel fibroblast and 293 cells. It could be possible that ATR is 
required for ATM activation at early time points immediately after replication stress, 
but during a prolonged replication stress, further ATM activation occurs 
independently of ATR via the WAR complex. Furthermore, treatment with either 
the ATM inhibitor or the knockdown of ATR increases UFB formation, and the 
combined treatment further increases UFB formation suggests ATR and ATM 
have non-overlapping roles in suppressing UFB formation (Figure 37).  
 
 
Nevertheless, the WAR complex has physiological relevance as cells undergo 
increased anaphase bridges and segregation errors in its absence, similar to the 
effect of ATM deficiency. Recent evidence suggests a role of ATM in protecting 
fragile sites by regulating 53BP1 nuclear bodies (Lukas et al., 2011a, Harrigan et 
al., 2011). The G1 53BP1 nuclear bodies were proposed to shield unrepaired 
lesions against degradation left over from the previous cell cycle. It is possible that 
these 53BP1 nuclear bodies arise during S/G2 phase and progressively diminish 
as the majority of S phase damage is repaired. Only a few foci remain at sites of 
late or unreplicated DNA when the latter escape detection by cell cycle 
checkpoints by an unknown mechanism. However, it is unclear whether ATM and 
53BP1 remains at fragile sites at mitosis, or come off and are reloaded onto 
fragile sites in the next cell cycle, as these proteins do not form any detectable 
foci during mitosis. Hence, the WAR complex mediated ATM signalling after Aph 
could represent a novel pathway of ATM function that link its recruitment to sites 
of replication stress to its role in protecting fragile sites from genomic instability.  
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Figure 59. Model of ATM recruitment at stalled replication fork by the WAR complex.  
Upon replication fork stalling, such as that induced by Aph, RAD18 mono-
ubiquitinates PCNA on Lys164, and WRNIP1 could interact with ubiquitinated PCNA 
and RAD18 and gets recruited to the site. ATMIN could act as a bridging adaptor in 
bringing ATM to the stalled replication fork. 
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7.4 8-oxoG genes are required for ATM signalling after 
replication stress 
7.4.1 The knockdown of 8-oxoG genes impairs ATM signalling after Aph 
OGG1 was identified as the top hit in the genome screen for genes that affect 
53BP1 foci formation after Aph, and similarly other proteins that function in the 8-
oxoG repair pathway including NUDT1, MUTYH and GSTM5 were also required 
for 53BP1 foci formation after replication stress. While the data could be validated 
in different cell lines, it is not clear how the consequent increase in base oxidation 
in the absence of these genes would decrease ATM signalling. One hypothesis 
would be that in the absence of OGG1, MUTYH or both enzymes, there is 
reduced cleavage of oxidised bases and less fewer apurinic/apyrimidinic sites 
would be formed, which could potentially reduce the number of ssDNA gaps that 
need to be filled by DNA polymerases and hence replication stress to trigger ATM 
signalling. However, this does not explain why the loss of NUDT1 or GSTM5 also 
have a similar impairment in 53BP1 foci formation and ATM signalling, as they 
increase nucleotide oxidation with no known effect on the repair of 8-oxoG. 
Furthermore, from the screen results, the loss of 8-oxoG genes does not 
significantly change 53BP1 and pATM foci formation in basal conditions. Hence, it 
is unlikely that the loss of ATM signalling is due to a decrease in SSBs formed. 
 
A second scenario would be that the presence of 8-oxoG at sites of replication 
stalling directly impairs ATM signalling. Our data suggest a model whereby 
WRNIP-ATMIN-RAD18 forms a complex that activates ATM independently of 
ATR upon Aph, and the presence of 8-oxoG could inhibit the interaction of the 
WAR complex with DNA. This is supported by in vitro data that RAD18 binding to 
primer-template DNA decreases when the DNA is oxidised, as well as decreased 
RAD18 recruitment to induced cherrylacR fragile site after the knockdown of 8-
oxoG genes. It has also been shown that the MRN complex is less able to bind 
DNA in the presence of H2O2 and therefore defective in activating ATM in vitro 
under oxidative conditions. (Guo et al., 2010a). As a result of impaired RAD18 
recruitment, it could be possible that the signal for ATM activation under Aph is 
diminished. Following up this study, this hypothesis could be tested by artificially 
tethering RAD18 to the lacO-tetO site by overexpression of a RAD18-GFP-TetR 
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fusion protein, and this should be able to rescue the ATM signalling if the 
hypothesis is true. DNA oxidation could also impair the E3 ligase activity of 
RAD18, thus reducing PCNA monoubiquitination. This hypothesis would require 
an in vitro ubiquitination assay to study RAD18 E ligase activity as the changes in 
in vivo PCNA monoubiquitination of mammalian cells were difficult to detect (data 
not shown).  
 
Similarly to the knockdown of the WAR complex, the knockdown of 8-oxoG genes 
increases UFB formation but does not affect ATM signalling after IR. This also 
suggests that the 8-oxoG genes could function in the same pathway as WAR in 
regulating ATM signalling after Aph. While the knockdown of 8-oxoG genes affect 
ATM signalling, both ATR signalling and foci recruitment to cherrylacR sites are 
not impaired. This suggests that base oxidation does not affect the formation of 
ssDNA-RPA and ATR activation during S phase. Hence, the effect of 8-oxoG 
genes on ATM signalling does not act via ATR signalling. 
 
In addition, one could speculate that some of the 8-oxoG components such as 
OGG1 could form a complex with ATM and directly facilitate its recruitment to G:C 
rich regions, which are prone to both replication stalling and base oxidation. A 
preliminary experiment suggests that overexpressed OGG1 could interact with 
ATM under basal conditions and after Aph. It would be interesting to test for any 
interaction between the 8-oxoG proteins and with ATM. Furthermore, by knocking 
down both the WAR complex and 8-oxoG genes, it could potentially reveal any 
epistatic relationship between the two pathways. However, the reduced 
transfection efficiency of multiple siRNAs could make it technically difficult to test 
this hypothesis.  
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Figure 60. Possible model of the GO pathway regulating ATM signalling at a replication 
stalled fork via the WAR complex. 
 
7.4.2 TEMPOL rescues ATM signalling in the absence of 8-oxoG genes 
Another interesting question is how TEMPOL rescues ATM signalling in the 
absence of 8-oxoG genes after Aph treatment. TEMPOL can act as a superoxide 
dismutase mimetic by quenching superoxide anions to form hydrogen peroxide. It 
has been reported to function as a much better ROS scavenger than other 
antioxidants such as N-acetylcysteine or vitamin C, and has also been used 
extensively to rescue oxidative stress in animal models and even lengthen the 
lifespan of animals and reduce tumour incidence (Mitchell et al., 2003, Wilcox, 
2010). At the cellular levels, TEMPOL rescued ATM signalling, RAD18 foci 
formation at fragile sites and suppress UFB formation after the knockdown of 8-
oxoG genes. However, it does not seem to increase ATM signalling in control 
wildtype cells, suggesting that its effect is only prominent when base oxidation is 
elevated. One could speculate that a threshold of 8-oxoG accumulation needs to 
be reached prior to ATM activity being stimulated by TEMPOL and this threshold 
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could be sensed by the binding of 8-oxoG genes such as OGG1 for instance. It 
would also be interesting to investigate if TEMPOL affects OGG1-ATM interaction 
or has any effect on the activity of OGG1 directly through in vitro assays. 
7.4.3 ATM signalling after replication stress requires a functional 8-oxoG 
system, the WAR complex, but does not depend on ATR 
Data from Chapters 4 and 5 showed that ATM signalling was impaired after the 
knockdown of the WAR complex or that of 8-oxoG system under Aph conditions. 
On the other hand, ATR-mediated Chk1 phosphorylation was unaffected after the 
knockdown of the WAR complex and ATR recruitment to the induced cherrylacR 
fragile site was also unaffected by the knockdown of 8-oxoG genes. Conversely, 
the knockdown of ATR increases ATM signalling after replication stress, possibly 
due to the increase in conversion of SSBs into DSBs in the absence of ATR-
mediated checkpoint function, or that ATR suppresses ATM activation possibly by 
competing with ATM binding at the sites of replication stress. It is possible that 
there is a DNA substrate/intermediate generated during replication stress that 
serves as the stimulus for ATM signalling and 53BP1 localisation and whose 
formation does not depend on ATR. Since both RPA and 𝜸H2AX localises to 
cherrylacR foci, the DNA substrate could be a complex ssDNA-dsDNA 
intermediate that could recruit RAD18 and activate ATM distinctly from the 
canonical MRN-dependent activation of ATM after IR-induced DSBs. This is also 
supported by the evidence that the knockdown of NBS1 does not increase UFB 
formation, unlike the knockdown of ATM or ATMIN (Figure 37C).  
 
7.4.4 Future validation in mouse models 
As discussed in the introduction, single knockout mouse models of the GO 
pathway do not manifest severe phenotypes until 1.5 years of age. Double 
knockout mutyh-/- and ogg-/- mice show accumulation of 8-oxoG in tissues, but 
still have a relatively long latency of tumourigenesis (10months) (Xie et al., 2004). 
It would be interesting to investigate whether the loss of a tumour suppressor 
gene such as p53 would accelerate the tumour formation in the mutyh-/- and   
ogg-/- knockout mice. Given the possible link between BER and ATM signalling in 
vitro, one would expect that ATM signalling after replication stress would be 
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impaired in ogg-/- ; mutyh-/- double knockout mice. Similarly, any defect in the 
recruitment and function of RAD18 in these double knockout mice would also 
confirm the in vitro data. Furthermore, if ATM signalling is impaired in the ogg-/- ; 
mutyh-/- double knockout mice, it would be interesting to assess the function of 
ATM signalling after replication stress in vivo, whether it would promote 
chromosome segregation errors and genome instability especially in tissues with 
high cell turnover such as the skin and intestine.  
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7.5 Concluding remarks 
In summary, in this thesis I have elucidated four mechanisms that influence ATM-
ATMIN signalling. I have shown that ATMIN can compete with NBS1 for ATM 
interaction and thereby influence the MRN-dependent ATM signalling after IR. I 
have also shown that ATMIN can be ubiquitinated by UBR5 in an IR-dependent 
manner, which modulates the affinity of ATMIN for ATM and allow the latter to be 
activated via the MRN-dependent pathway.  
 
Moreover, I have investigated the mechanism by which ATMIN could contribute to 
ATM signalling after replication stress via WRNIP1 and RAD18-mediated 
ubiquitination of PCNA. Through a genome screen approach, I have identified a 
novel link between the 8-oxoG system and ATMIN-dependent ATM signalling. I 
have shown that genes involved in 8-oxoG removal are required for RAD18 
recruitment and ATM signalling after replication stress. I have shown that ATMIN 
is an important interactor of ATM and loss of ATMIN can lead to deleterious 
effects in cells.  
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